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Abstract 
 
Cancer is one the leading causes of death in the United States. Researchers have 
focused on designing and developing therapeutics aimed at DNA in order to treat cancer 
and other disorders. In this dissertation, the DNA-binding interactions of small organic 
molecules were investigated. We developed a highly sensitive methodology to determine 
the DNA-binding mode of small molecules unambiguously unlike other conventional 
techniques. Furthermore, we established structure-property relationships for a set of 
newly synthesized small molecules that allows tailoring of the DNA-binding mode by 
modifying the electron acceptor properties of the heterocyclic core of the binding 
molecule. By understanding how small organic molecules bind and interact with DNA, 
this work could have a profound impact on the design and development of small organic 
molecules, such as therapeutics, aimed at DNA. 
The DNA-binding mechanism of small organic molecules, such as DNA-targeted 
drugs and fluorescent nuclear dyes, is key to their performance. Therefore, understanding 
the DNA-binding mechanism is critical for the design and development of molecules 
targeted at DNA. The purpose of this present research is to investigate the DNA-binding 
interactions of small organic molecules by employing ultrafast nonlinear spectroscopy. 
While basic design principles are proposed, the DNA-binding modes of many small 
organic molecules cannot be unambiguously assigned based either on their structure, or 
through the use of many well-established spectroscopic techniques. A new methodology 
xviii 
 
utilizing two-photon spectroscopy was developed to determine the DNA-binding modes 
of small organic molecules definitively, contrarily to other well-established spectroscopic 
techniques. The impact of this work is imbedded with the ultrafast nonlinear 
spectroscopic studies of the DNA-binding interactions of small organic molecules. The 
newly developed methodology demonstrated superior sensitivity at both low drug and 
DNA concentrations by more than order of magnitude in comparison to circular 
dichroism (CD). This indicates that our approach can be used to probe DNA-drug 
interactions at biologically relevant conditions, which is critical in drug research and 
development.  
The impact of this work also investigated the DNA-binding interactions of newly 
synthesized fluorescent nuclear dyes. This study has led to the emergence of structure-
property relationships of DNA-binding molecules that adopt a crescent or V-shaped 
scaffold. The findings reveal that the structure of these fluorophores can be designed to 
either intercalate or groove bind with DNA by structurally modifying the electron 
acceptor properties of the central heterocyclic core. This is important because it allows 
the performance, specificity, and localization of a DNA-binding molecule to be 
controlled. The localization and cellular uptake of these small molecules were evaluated 
by conducting a series of bio-imaging studies in live HeLa cells. This work is significant 
because the design strategy can be applied towards the development of small molecules 
aimed at DNA.  
In addition to examining the DNA-binding interactions of small organic molecules, 
the research presented in this dissertation focused on the synthesis and characterization of 
silicon hybrid materials and polymers. A new class of cross-linked microporous 
xix 
 
silsesquioxane-based materials was synthesized by the Piers-Rubinsztajn (oxysilylation) 
reaction. These materials offer high specific areas (> 700 m
2
/g) and high thermal stability 
(> 300 
o
C) with pore sizes of 0.6 – 2.0 nm. Moreover, these materials are attractive 
because multiple functionalities can be introduced to the system, which opens further 
applications. Because of this, the microstructure, chemical composition, surface 
properties, and porosity can be tailored. Another portion of the dissertation concentrated 
on synthesizing silicon compounds from biogenic silica sources, such as rice hull ash. We 
developed a new route for the synthesis of alkoxysilanes by a base-catalyzed 
depolymerization of silica. This is the first example that has demonstrated a direct 
synthesis of alkoxysilanes from silica, which has been examined for over 80 years 
without success. Our process is an alternative to the carbothermal reduction of silica, 
which offers several advantages as it is not a high energy/temperature process, does not 
produce toxic byproducts, and does not leave a large carbon footprint. Since these 
alkoxysilanes can be distilled, they can be easily purified meaning that this process can 
be employed for applications that require high purity silicon. This is significant because 
this process has the potential to reduce the cost of many silicon containing products. 
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Chapter 1 
Introduction and Background of the DNA-Binding Interactions of Small Organic 
Molecules 
 
 
1.1 Dissertation Outline 
In Chapter 1, the introduction is presented. The objective of the introduction is to 
provide the reader a background with regards to the research. The introduction discusses 
the motive behind the present work. It is important to connect the research to the big 
picture as it is directly to cancer. Cancer is major concern in today’s society. As a result, 
DNA has been a major target to treat cancer. Unlike chemotherapy which requires the use 
of radiation, DNA-targeted drugs do not expose cells to radiation and are more selective 
towards cancerous cells. The work presented will focus on the DNA-binding interactions 
of small organic molecules. It is important to understand such interactions because the 
performance and selectivity of DNA-targeted drugs and fluorescent nuclear dyes are 
dependent on the DNA-binding mechanism. However, there remain limitations with the 
convention techniques used to understand the DNA-binding interactions of small organic 
molecules as these techniques offer ambiguous interpretations and low sensitivity. An 
overview of the background and methodologies used to investigate the DNA-binding 
interactions of small organic molecules will be presented. 
2 
 
The instruments and techniques employed in this dissertation are discussed in Chapter 
2. Explanations of steady-state spectroscopy, two-photon spectroscopy, time-resolved 
spectroscopy (fluorescence upconversion, time-correlated single-photon counting), 
circular dichroism, and fluorescence confocal microscopy are included. Additionally, the 
culture of mammalian cells is discussed. Standard operating procedures for the confocal 
microscope and the culture of mammalian cells are presented. This section is used to 
inform the reader about the fundamental details of the experiments.   
In Chapter 3, a new methodology was developed utilizing two-photon spectroscopy to 
determine the DNA-binding mode (groove binding vs intercalation). This work was 
published in the Journal of the American Chemical Society. The objective of this work 
was to demonstrate a new approach to evaluate the DNA-binding interactions of DNA-
targeted drugs and fluorescent nuclear dyes. The key results indicate that the changes in 
the TPA cross-sections are able to differentiate between the DNA-binding modes. 
Furthermore, our approach demonstrated higher sensitivity at both low DNA and drug 
concentrations by more than an order of magnitude as compared to CD, indicating that 
the methodology can be used at biologically relevant conditions. The importance of this 
work is that the methodology can be employed to understand how small organic 
molecules interact with DNA, which is important for drug research and development.  
In Chapter 4, we investigated a series of newly synthesized fluorescent dyes that 
possess a crescent shaped donor-acceptor-donor motif. This study has led to the 
emergence of structure-property relationships in regards to the DNA-binding mechanism. 
The findings reveal that the structure of these fluorophores can be designed to either 
intercalate or groove bind with DNA by structurally modifying the electron accepting 
3 
 
properties of the central heterocyclic core. Our new approach utilizing TPA was 
employed to diagnose the DNA-binding mode. These fluorophores offer several 
advantages over commercially available dyes as they exhibit low cytotoxicity and high 
photostability as well as require low energy excitation wavelengths. The steady state 
properties and the fluorescence dynamics were investigated. The dyes were found to 
possess high turn on/off sensitivity upon binding with DNA. The results indicate that the 
optical properties of the dyes can be finely tuned by varying the conjugation length and 
electron accepting properties of the heterocyclic core. A series of bio-imaging 
experiments were conducted in live HeLa cells to evaluate the performance of the dyes. 
This work has been submitted to Nature Chemistry. The work in Chapters 3 and 4 was 
done in collaboration with Prof. James Wilson at the University of Miami.  
The work presented in Chapter 5 examined kinase activity by implementing a custom 
fluorescent-based chemosensor peptide. The Sox-labeled peptide offers several 
advantages over traditional kinase assays as it is highly sensitive and allows for 
continuous real-time analysis as well as high-throughput applications. In collaboration 
with Prof. Barbara Imperiali at MIT, the kinase activity was examined by TPA and time-
correlated single-photon counting (TCSPC). In addition, bio-imaging studies were carried 
out in live HeLa cells to study the kinase activity at physiological conditions. This is the 
first example that has employed a kinase assay in live cells with continuous real-time 
analysis. Fluorescence lifetime imaging microscopy (FLIM) was utilized to examine the 
kinase activity. Kinase activity is important for cellular communication and signaling. As 
a result, many disorders, such as cancer, are associated with abnormal kinase activity. 
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Therapeutics aimed at targeting kinase activity are of considerable interest. This project is 
still ongoing and will be resumed by new graduate student, 
Chapter 6 presents a series of silsesquioxane-based network microporous polymers 
that were synthesized by a new route via the Piers-Rubinsztajn reaction. The reactions 
were carried out in mild conditions in hydrocarbon solvents in the presence of a Lewis 
acid catalyst. The materials were characterized by Fourier–transform infrared 
spectroscopy (FTIR), thermal gravimetric analysis (TGA), and X-ray diffraction (XRD). 
Porosity and surface area analyses were done by Brunauer–Emmett–Teller (BET) 
method. These materials were found to possess high surface areas (>700 m
2
/g), high 
thermal stability (>300 
o
C), and amorphous structures. The materials have the potential to 
be tailored so that multiple functionalities can be introduced into the system. Some 
potential applications of these materials include gas storage and sieving as well as 
absorbent materials. This work was published in the Journal of the Ceramic Society of 
Japan.  
In Chapter 7, the “Grand Challenge” of silicon chemistry was explored. The 
dissolution of silica has been reported in past decades. However, this is the first report of 
direct, base catalyzed depolymerization of silica by the reaction with hindered diols to 
yield spirocyclic alkoxysilanes or spirosiloxanes that can be distilled with high purity. 
We developed a renewable process to produce spirosiloxanes from biogenic silica 
sources, such as rice hull ash. This process offers several advantages over conventional 
methods used in industry. For example, the process is not energy intensive, does not 
produce a toxic, polluting byproduct, and does not require expensive capital equipment. 
These spirosiloxanes can be used as a precursor for many silicon-based materials, such as 
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fumed silica or sol-gel processing. The impact of this work is that this new process may 
significantly reduce the cost of many silicon containing products. This work was 
published in Angewandte Chemie. The work completed in Chapters 6 and 7 was done in 
collaboration with Prof. Richard Laine in the Materials Science and Engineering 
Department located at the University of Michigan.  
In Chapter 8, the impact of the work presented in the dissertation will be discussed. 
This chapter is significant as it summarizes the work to the general audience. The main 
focus of this chapter is to relate the research to the “big picture”. Although the work only 
addresses a small portion of the big picture, the research has contributed to each field in 
some aspect. Perhaps, the research can be applied to future research, which may lead to 
significant contributions to the big picture. Future work with regards to each project will 
be discussed in significant detail. The work here paves the way for future research. The 
work will be carried out by future students and/or researchers. This chapter is important 
because it provides the foundation and background for others to continue future research.  
 
1.2 Introduction and the Impact of Cancer  
Cancer also known malignant neoplasm or malignant tumor is a disease that involves 
abnormal cell growth that can spread to other regions within the body, which results in 
death if the spread is not controlled. Cancer is the second most cause of death after heart 
disease, accounting for 23% of deaths in the US.
1
 It has been reported that 90 – 95% of 
cancer is due to external factors and 5 – 10 % is due to internal factors.2 It is estimated 
that over 1.6 million new cases and approximately 600,000 deaths were a result of cancer 
in 2015
2
 as well as over 14.5 million people are currently living with cancer as of 2014.
3
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Furthermore, it has been reported that over 100 different known cancers exist today.
4
 
Cancer cells cause defects in cellular and biological regulatory processes that govern cell 
homeostasis and proliferation. The complexity of cancer provokes a number a questions 
that requires further investigation. In general, most cancers acquire the same set of 
functional capabilities as shown in Figure 1.1.
5
 As a consequence, chemotherapeutic and 
cytotoxic drugs are widely used for the treatment of cancer although their effectiveness is 
compromised by several disadvantages.
6
 Hence, new methodologies and technologies 
have been of considerable interest to better understand the complexity of cancer.  
  
 
Figure 1.1. Acquired functional capabilities of cancer.
 
  
In general, cancer therapy involves exposing cells to anti-cancer agents that can 
increase cancer cell apoptosis more efficiently than healthy cells. These therapies are 
designed to target specific molecular and cellular processes directly related to cancer. It 
7 
 
has been reported that cancerous cells proliferate more rapidly than normal cells.
5,6
 Thus, 
many therapies have been targeted at cell proliferation. Therapeutics targeted directly at 
deoxyribonucleic acid (DNA) are of considerable interest because DNA is essential for 
cell proliferation. More specifically, DNA-targeted drugs have been investigated as 
therapeutics aimed at cancer. These drugs work by inhibiting or preventing the growth 
and spread of cancer by interfering with processes directly related to DNA.
7
 Unlike 
chemotherapy which requires the use of radiation, DNA-targeted drugs do not require 
elaborate instruments and does not expose cells to radiation. Remarkably, anti-cancer 
agents that target DNA are some of the most effective agents for cancer treatment.
7
 
However, some are considered to be very toxic.
8
 The efficacy of small organic molecules 
targeted at DNA is more dependent on their effect on the DNA structure rather than the 
sequence selectivity.
7
 The binding mechanism of DNA-targeted drugs correlate to the 
biological activity or effectiveness of the drug, which is an important parameter in the 
screening process.
9
 The simplest form of designing DNA-targeted drugs is by blocking 
access of proteins and/or enzymes to DNA.
10
 This results in the inhibition of DNA-
related processes leading to cell apoptosis. Consequently, there have been efforts in 
understanding on how drugs interact with DNA as well as design strategies to control the 
DNA-binding mechanism, which is necessary for the development of more selective and 
less toxic DNA-targeted therapies. 
There have been significant advances in the development of DNA-targeted drugs over 
the last century. The modern era of cancer therapy was a consequence of chemical 
warfare from World War I and II.
11
 Research during World War II led to further 
discoveries of alkylating agents for cancer therapy.
12
 Nitrogen mustards were the first 
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alkylating agents used for cancer therapy, which work by covalently binding or cross-
linking with DNA to prevent DNA replication. However, these agents are extremely toxic 
and carcinogenic. Later, antibiotics were revolutionized in the 20
th
 century. Antibiotics 
are generally used to treat bacterial infections. Interestingly, it was discovered that 
antibiotics can also be utilized to treat cancer.
12
 Antitumor antibiotics, such as 
doxorubicin, were found to have to high selectivity for cancerous cells.
13
 These drugs act 
by interfering with enzyme access to DNA. This was important as it encouraged 
researchers to consider processes relevant to DNA, including transcription and 
replication.
7
 This has led to the development of code-reading drugs that target specific 
DNA sequences. These drugs act by targeting the minor or major groove of DNA,
14
 
which inhibits or activates enzyme interactions with DNA. Another class of drugs acts by 
intercalating with DNA, which are known as enzyme inactivators. Topoisomerase I and II 
are the most widely targeted enzymes since they are required for DNA transcription and 
replication. By hindering or inactivating these processes, the formation and spread of 
cancerous cells can be inhibited.  
 
 
 
9 
 
 
Figure 1.2. Timeline and classes of DNA-targeted drugs and the types of interactions 
with DNA.
 
 
Several FDA clinically approved DNA-targeted drugs have been used to treat cancer, 
such as topotecan
15
 and actinomycin D.
16
 Although DNA-targeted drugs exhibit toxicity 
towards healthy cells, these drugs can be aimed more selectively towards cancerous cells. 
As a result, DNA-related pathways can be directly targeted. Hence, understanding the 
interactions of small organic molecules with DNA is critical for developing DNA-
targeted drugs that exhibit high specificity and low cytotoxicity. In order to examine 
DNA-binding interactions at biologically relevant conditions, sensitive methodologies 
and design strategies are of considerable interest.  
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1.3 An Overview on the Functions and Importance of DNA in Cellular and 
Biological Processes 
DNA plays an important role in several biological and cellular processes, which is 
vital to cell survival and proliferation. DNA is essentially the blueprint of biological life. 
DNA can interact reversibly with a wide range of complexes including water, proteins, 
small organic molecules, and ions.
17
 Its discovery has revolutionized science and modern 
medicine in addition to its impact on society ranging from criminal justice to inheritance 
information. DNA is made up of chemical building blocks called nucleotides that are 
composed of a phosphate group, sugar group, and nitrogen containing nucleobase. There 
are four types of nitrogen bases, which include adenine (A), thymine (T), guanine (G), 
and cytosine (C) as detailed in Figure 1.3. The nucleobases are covalently bonded 
between the sugars of one nucleotide to the phosphate group of another nucleotide to 
form a DNA sequence. According to the base pair rules, the bases of DNA interact with 
other bases through hydrogen-bonding interactions to form double stranded DNA 
(dsDNA). The sequence for nucleotide interaction is important as adenine interacts with 
thymine and guanine interacts with cytosine. The backbone of DNA is composed of 
negatively charged phosphodiester bonds, which is resistant to cleavage.
18
 The order of 
the nucleobase sequence is critical for instructions towards cellular and biological 
expression. DNA serves a biological storage center for genetic information, which is 
considered one of its main functions.
19
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Figure 1.3. Structure of DNA.   
 
DNA has two main functions, which includes replication and transcription. These 
processes begin when a signal is received. This generally occurs when a regulatory 
protein binds to a specific region of DNA.
21
 DNA replication is the process where two 
identical DNA strands are produced from a strand of DNA. DNA replication plays an 
important step in cell growth, division, and proliferation.
22
 This occurs in all living 
organisms and is essential for biological inheritance. In order to achieve DNA replication, 
DNA polymerases are required. These enzymes are responsible for carrying out the DNA 
replication process.,
23
 which occurs at specific regions of DNA or origins of replications. 
Topoisomerase enzymes act by unwinding DNA, preparing the DNA strand for 
replication. DNA helicases separate the annealed DNA strand to produce the replication 
fork, which is the structure of DNA that forms for replication. Single-stranded binding 
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proteins stabilize the unwound DNA. A short strand of RNA called a primer is produced 
from the primase. This primer acts a starting point for DNA synthesis on the leading 
strand. DNA polymerase continuously synthesizes the new strand of DNA in the 5'→3' 
direction, which is known as the leading strand. It is important to note that DNA is 
always synthesized in the 5'→3' direction.24 It should be emphasized that DNA synthesis 
of the leading strand is a continuous process. On the lagging strand, DNA synthesis 
occurs in the opposite direction of the leading strand. RNA primers are produced by 
primase enzymes and bind at various locations on the lagging strand. Due to the 
complexity of DNA synthesis on the lagging strand, DNA is synthesize in short, 
separated complimentary fragments called Okazaki fragments.
25
 Contrarily to the leading 
strand, DNA synthesis on the lagging strand is discontinuous. Once the base pairs are 
matched up with complimentary base pairs, nuclease enzymes remove the primase 
enzymes. DNA ligases join the Okazaki fragments to form the other strand of DNA. 
Additionally, ligases seal up the DNA sequence forming two strands of DNA. As a result 
of DNA synthesis, two new DNA molecules consisting of one old stand and one new 
stand are produced. This process is described as semi-conservative.
26
 The DNA 
replication process is detailed in Figure 1.4.  
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Figure 1.4. Summary of DNA replication.  
 
DNA plays a critical role in transcription, which is required for gene expression and 
protein synthesis. A summary of transcription is shown in Figure 1.5. In eukaryotic cells, 
DNA does not leave the nucleus so the information must be copied. Thus, transcription 
occurs in the cell nucleus. Transcription is initiated when RNA polymerase binds with 
DNA, separating the two strands of DNA. This is achieved by breaking the hydrogen-
bonding interactions between the complementary nucleobases. It is important to note that 
transcription factors mediate the binding of RNA polymerase. Elongation occurs when 
the RNA polymerase begins synthesizing the RNA nucleobases with the complimentary 
DNA base pairs. In addition, the phosphate backbone is formed from RNA polymerase, 
producing an RNA strand. It should be emphasized that adenosine is replaced with uracil 
for RNA synthesis. Once the synthesis of the RNA strand is complete, transcription is 
terminated when the termination sequence of bases (stop codon) is encountered. This is 
completed by recognition of a termination sequence to give mRNA.
27
 The sequences of 
14 
 
mRNA nucleotides are arranged in codons consisting of three base pairs. These codons 
are responsible for specific amino acids that are required for protein synthesis.
29
 mRNA 
then undergoes translation where the codons are correlated to a specific amino acids to 
form proteins for gene expression. From Figure 1.6, it is clear that DNA plays an 
important role in protein synthesis, which is required for cell proliferation.  
 
 
Figure 1.5. Summary of transcription.  
 
 
Figure 1.6. Importance of DNA for protein synthesis and gene expression.
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Small organic molecules can resemble the binding strength and specificity of 
signaling regulatory proteins. These molecules can activate DNA replication and/or 
transcription, which leads to a larger production of proteins and/or induce DNA 
replication. In contrast, small organic molecules can also inhibit DNA-related processes, 
restricting DNA replication and protein synthesis that result in cell apoptosis. In most 
cases, DNA-targeted drugs are designed to inhibit DNA-related processes, which leads to 
cell apoptosis for antibiotic and antitumor applications.
30
 Small organic molecules can 
interact with DNA through groove binding, intercalation, and/or cross-linking (covalent 
bonding).
31
 A complex formation occurs when small organic molecules bind or interact 
with DNA, which results in a change in the functional properties and thermal stability of 
DNA.
32
 The binding interactions of small organic molecules with DNA often change the 
DNA properties, which has an important impact on physiological functions.
33
 Therefore, 
it is critical to understand the DNA-binding mechanism to elucidate the functional 
properties of DNA-binding molecules, which has application for drug research and 
development.  
 
1.4 The Binding Interactions of Small Organic Molecules with DNA: Intercalation 
and Groove Binding 
In this work, we have focused on understanding how small organic molecules 
intercalate or groove bind with DNA non-covalently as shown in Figure 1.7. Both 
intercalators and groove binders can be viewed as “lock-and-key” or “induced-fit” 
models similar to enzyme-substrate binding.
34
 Contrarily to DNA cross-linking agents, 
these non-covalent binding interactions are reversible. DNA-targeted drugs that interact 
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with DNA non-covalently are preferred over molecules that bind covalently with DNA 
because they are considered less toxic and dangerous. Intercalation was first recognized 
by Leonard Lerman where he studied aminoacridines binding with DNA.
35
 Lerman noted 
a physical distortion in the helical axis of DNA, which has become the hallmark of 
intercalation. Intercalating molecules generally have planar aromatic rings incorporated 
into the structure that bind with the DNA by inserting between the DNA nucleobases to 
form a binding pocket or intercalation cavity. Lengthening, unwinding, and distortion of 
the DNA helical axis are most prominent upon intercalation.
36
 In order for intercalation to 
occur, three essential steps are required. First, DNA must undergo a conformation change 
to form the intercalation site where the base-pairs separate. As a consequence, the DNA 
strand is unwound and the spacing of the phosphate groups is increased.
37
 This results in 
the reduction of the local charge density.
38
 Once the intercalation pocket is formed, there 
is a transfer from the intercalator in solution to the binding site, which can be thought as a 
hydrophobic transfer process since the binding molecule will be buried in the DNA 
structure. As a result, further counter ions are released.
39
 Finally, intercalation requires 
important driving factors, such as π-stacking and stabilizing electrostatic interactions, 
where the binding molecule seeks optimal overlap with the DNA nucleobases.
40
 Each of 
these steps required for intercalation contributes to the overall free energy. It is important 
to note that the hydrophobic transfer of the binding molecule from a hydrophilic 
microenvironment is one of the most critical driving forces for intercalation.
33 
Most 
intercalators prefer to bind at GC regions of DNA or do not have a defined preference, 
meaning that they bind at both AT and GC regions of DNA.
33
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Figure 1.7. Cartoon representation of intercalation and groove binding.  
 
Small organic molecules can groove bind with DNA at either the minor or major 
groove of DNA as illustrated in Figure 1.8. The minor and major grooves are a result of 
the DNA helical structure. In regards to the glycosidic bonds, they are in the same 
location within the base pairs such that they are not parallel or perpendicular relative to 
one another. In other words, the major groove is located where the backbone of DNA is 
far apart whereas the minor groove occurs when the backbone is close together. Groove 
binding is characterized by little to no perturbation in the DNA structure. In general, 
groove binding molecules contain unfused-aromatic structures with terminal basic 
functions.
42
 Additionally, groove binding molecules are, in most cases, crescent or V-
shaped that give conformational flexibility, which allows the molecule to fit into the 
DNA groove as well as functional groups that interact with the nucleobases through 
hydrogen bonding and/or van der Waals interactions with minimal steric hinderance.
33
 
Groove depth, groove width, electrostatic potential, and floor functionality are structural 
features found to be critical for groove binding recognition.
43
 In general, groove binding 
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is a two-step process contrarily to intercalation. The first step takes place when the 
binding molecule undergoes a hydrophobic transfer from solution to the groove of DNA. 
Next, the binding molecule forms non-covalent interactions with DNA nucleobases. As 
noted, groove binding does not require the DNA helical axis to unwind for binding. 
Typically, groove binders prefer to bind at AT sequences because GC sequences contain 
a -NH2 group that sterically inhibits the binding.
44
 Additionally, binding at AT-rich 
sequences provides better van der Waals interactions between the binding agent and 
groove walls since the AT regions are narrower than GC regions.
45
 However, this is not 
always the case as some small organic molecules bind at GC-rich sequences, such as 
topotecan.
46,47
 Fluorescence quenching is generally observed when a fluorescent nuclear 
dye groove binds at GC-rich regions due to the photoinduced electron transfer (PET) 
between the dye and nucleobase.
48
 It is important to note that the binding constants of an 
intercalator and groove binder are on the order of 10
4
 – 106 and 105 – 109 M-1, 
respectively.
33
  
 
  
Figure 1.8. Minor versus major groove of DNA.  
 
It has been reported that groove binding is mainly entropically driven whereas 
intercalation is primarily enthalpically driven.
51
 Groove binders have a higher affinity for 
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DNA as compared intercalators. Intercalation is coupled to the unstacking of the 
nucleobases to form the binding site. As a consequence, intercalation results in distortion 
of the helical axis upon binding, which requires energy. The cost of energy for disrupting 
the nucleobase stacks is 0.5 – 2.0 kcal mol-1, which is the difference in the average 
binding free energy between an interacalor and groove binder.
52
 In regards to 
intercalation, favorable enthalpy arises from the intermolecular interactions required for 
binding, such as hydrogen-bonding interactions, between the binding molecule and DNA 
base-pairs. On the other hand, there is usually a entropic penalty when a bimolecular 
complex is formed due to the loss of rotational and translational degrees of freedom.
53,54
 
There are entropic contributions when a binding molecule electrostatically interacts with 
DNA regardless of the binding mode.
55
 The work done by Chaires et al. noted that 
groove binders are entropically driven while intercalation is primarily enthalpically 
driven.
51
 However, the origin of this phenomenon remains unclear.   
 
1.5 Methodologies to Characterize the DNA-Binding Interactions of Small Organic 
Molecules  
Several techniques have been employed to investigate the DNA-binding interactions 
of small organic molecules. However, many of these techniques used to evaluate the 
DNA-binding interactions do not provide sufficient information and offer limitations. For 
example, NMR can provide detailed localized information about the binding molecule. 
However, a major issue with NMR is that it requires large quantities of materials for 
screening. In addition, screening requires isotropic enrichment of the sample as well as 
long acquisition time.
56
 Another method that has been used to examine the DNA-binding 
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interactions of external molecules is mass spectrometry, such as chemical ionization,
57
 
electrospray ionization (EI-MS),
58
 and matrix assisted laser desorption ionization 
(MALDI-TOF).
59
 A major concern with mass spectrometry is the inability to distinguish 
between specific and non-specific binding. Mass spectrometry does not provide 
information about the binding site of the binding agent and DNA complex structure.
60
 
Optical techniques can provide indirect information about the DNA-binding mode. 
Fluorescence and absorption spectra changes can be used to monitor these interactions; 
however, they do not provide sufficient information about the binding mechanism. Such 
methods can provide information about the binding constant.  
Fluorescence displacements assays have been used to examine the DNA-binding 
mechanism of small organic molecules as illustrated in Figure 1.9. Additionally, these 
assays have been employed to examine DNA binding affinity, sequence selectivity, and 
binding stoichiometry.
61
 The advantages of this technique is that it is non-destructive, 
non-demanding, and can be applied for high-throughput screening. However, there are 
also several issues with this methodology. For instance, displacements assays are 
generally used for only intercalating molecules. Thus, this method is not practical when 
investigating groove binding molecules. In addition, the results may be deceptive if the 
binding molecule exhibits multiple binding modes. Another issue with this technique is 
that it is commonly used with hairpin or single-stranded DNA. Because of this, high 
quality DNA is required in which the concentration must be known. The issue is that the 
concentration of single stranded DNA can be underestimated by up to 25% by using the 
standard coefficient of DNA.
61
 A final problem with this approach occurs when 
investigating the DNA-binding interactions of a molecule, which has a similar emission 
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spectrum as the displacement dye. This makes it difficult to monitor the change in 
fluorescence since there is overlap between the fluorescent binding molecule and 
displacement dye.  
 
 
Figure 1.9. General procedure for fluorescent displacement dye assay.  
 
Circular dichroism (CD) spectroscopy has been extensively used to study the 
functions and interactions of DNA complexes.
62,63
 CD is a differential absorption 
technique that measures the difference in the left- and right-handed circularly polarized 
light. In general, small organic molecules are achiral, meaning that they do not display 
CD signal. Optical activity arises when there are parallel molecular magnetic and 
electronic transition dipole moments that can couple with the electric field of a circularly 
polarized light source.
64
 An induced circular dichroism (ICD) signal is observed when an 
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achiral molecule binds to chiral DNA due to a nondegenerate coupling of the 
chromophore with the DNA-base transitions.
64 
 The magnitude and direction of the ICD 
signal is dependent on DNA sequence, binding mechanism, and orientation of the 
transition dipole of the binding molecule.
65
 Therefore, interpretation of the CD spectra is 
complicated as there are several factors that must be considered. In general, a strong 
positive ICD signal is observed when the dipole is polarized perpendicular to the long 
axis of the pocket, which is a characteristic feature of a groove binding molecule. The 
strong ICD signal for a groove binder is likely due to the molecule interacting with the 
DNA base pairs (on average 4 – 6 base pairs) while undergoing a conformation change to 
follow or fit the groove of DNA.
65
 Contrarily, an intercalator has a weak negative ICD 
signal when the transition dipole of the binding molecule is polarized along the long axis 
of the binding pocket or parallel to the nuclecobases.
66
 Intercalators will often display 
weak ICD signals because the binding molecule does not come in contact with as many 
base pairs and does not twist as compared to groove binders.
65
 A major drawback of CD 
is that there remains ambiguity when evaluating the DNA-binding mode. In particular, 
the direction of the transition dipole must be known to provide sufficient information 
regarding the orientation of the binding molecule.
67
 Another issue is that the signal 
indicative of an intercalating binding mode may not be observed because a stronger, more 
intense signal due to other interactions, such as aggregation, can overwhelm the 
intercalating signal.  
Linear dichroism (LD) is another common technique that has been utilized to 
examine the DNA-binding interactions of small organic molecules. LD is a differential 
absorption technique that measures the difference in the parallel or perpendicular 
23 
 
polarized light with respect to the macroscopic orientation axis. A representation of the 
common absorption methods used to investigate the DNA-binding interactions is 
presented in Figure 1.10. In order to conduct LD, the DNA strands must be oriented 
properly in a flow cell. Thus, the binding molecule will also be oriented in the same 
direction, which will exhibit a LD signal. The direction or sign of the LD signal is 
directly related to the orientation of the transition dipole of the binding molecule relative 
to the direction of the flow. The transition dipole of a groove binder will align 
approximately parallel with the flow. On the other hand, the transition dipole of an 
intercalator will be oriented perpendicular with the flow.
66
 As a result, LD signals in the 
opposite direction will arise. Groove binders will exhibit a positive signal whereas 
intercalators will display a negative signal. However, there are several drawbacks with 
LD. First, a specialized flow cell is required to perform the experiment since standard 
cuvettes cannot be used. Another issue is that only long DNA strands can be employed. 
This is problematic when investigating the binding interactions of short and well-defined 
DNA sequences. As a consequence, detailed information about the binding interactions 
cannot be elucidated with short DNA sequences. Similar to CD, the direction of the 
transition dipole moment of the binding molecule must be known in order to determine 
the DNA-binding mode by LD.  
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Figure 1.10. Information about the DNA-binding modes of small organic molecules by 
absorption, LD, and CD spectroscopy.
 
 
It has been reported that only a combination of select methods provides sufficient 
information about the binding mode.
68,69
 The only method that provides detailed 
information about the DNA-binding mode is X-ray diffraction analysis of crystalline 
structures.
33
 However, the growth of single crystals is difficult to achieve. As noted 
above, there are several limitations with the current techniques used to investigate the 
DNA-binding mode. Designing and developing drugs that target and bind to DNA with 
high specificity and selectivity remains a challenge. Therefore, highly sensitive 
methodologies that provide sufficient information about the DNA-binding interactions 
are of considerable interest.  
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1.6 Utilization of Two-Photon and Time-Resolved Spectroscopies to Examine 
Biological-Based Systems  
Two-photon spectroscopy has been previously employed to investigate biological-
based systems, which can provide information inaccessible with other conventional 
techniques. The two photon absorption (TPA) process is a third-order process with a 
quadratic dependence on the intensity of the incident radiation. TPA occurs when two-
photons are simultaneously absorbed to promote the electron from the ground state to the 
excited state. The TPA process will be discussed in Chapter 2. Two-photon excited 
fluorescence (TPEF) has been widely used to examine the fundamentals of the excited 
state as well as correlating structure-function relationships in organic molecules.
70
 Two-
photon spectroscopy has been increasingly used as a tool for investigating environmental 
changes, charge transfer character, and application towards fluorescence imaging.
71
 TPA 
materials have been utilized for several applications including microscopy,
72
 
photodynamic therapy,
73
 and optical limiting.
74
 Therefore, materials that possess TPA 
properties are invaluable tools to investigate biological systems.   
In our group, we have previously investigated several biological systems by 
employing our ultrafast nonlinear spectroscopic techniques. Peptide aggregation has been 
reported to be associated with neurodegenerative diseases, such as Alzheimers and 
Parkinson’s disease. Yang et al. investigated the conformational changes associated with 
the aggregation of amyloid-beta peptides by employing nonlinear ultrafast spectroscopy. 
This was achieved by examining the aggregation process of TAMRA-labeled Aβ1-42 
peptide.
75
 Furthermore, Clark et al. investigated the photophysical properties of a series 
of newly synthesized green fluorescent proteins (GFP).
76
 The GFP was then covalently 
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bonded to form a GFP-labeled Aβ1-42 peptide in which the aggregation process was 
monitored by TPA. TPA demonstrated superior sensitivity at low peptide concentration 
compared to CD. As a result, TPA can provide detailed information about the 
aggregation process at biologically relevant conditions, which is critical for developing 
therapeutics. Mclean et al. investigated the binding of calmodulin with calcium.
77
 
Calmodulin is a signaling protein that is responsive to calcium ion fluxes. Hence, 
calmodulin regulates many cellular processes and is critical in nearly all biological 
processes.
78,79
 TPA provides detailed information regarding the conformation change of 
the calmodulin protein upon binding with calcium and the local environment of the 
fluorophore. Evidently, understanding these processes is critical for drug research and 
development. Our research group has demonstrated that TPA and ultrafast time-resolved 
spectroscopy can provide valuable information about biological-based systems with high 
sensitivity. Therefore, we are interested in applying ultrafast nonlinear spectroscopy to 
probe other biological systems, such as the DNA-binding interactions of small organic 
molecules. The work done may provide information that can be applied towards the 
design and development of therapeutics.  
The dissertation work follows the outline of employing a combined approach of 
steady-state spectroscopy along with ultrafast nonlinear spectroscopy to investigate 
biological-based systems. The DNA-binding interactions of DNA-targeted drugs and 
fluorescent nuclear dyes were examined. A new methodology was developed to diagnose 
the DNA-binding mode of small organic molecules. Additionally, a series of newly 
synthesized fluorescent nuclear dyes were studied. By understanding the structure-
property relationships, the results indicate that these fluorophores possess promising 
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properties as biological markers, which is important in monitoring DNA-related 
processes. Additionally, this study has led to the emergence of structure-property 
relationships of DNA-binding molecules that adopt a crescent or V-shaped donor-
acceptor-donor motif. These fluorophores can be designed to either intercalate or groove 
bind with DNA by structurally modifying the electron accepting properties of the central 
heterocyclic core. 
In addition to understanding DNA-binding interactions, it has been reported that 
abnormal kinase activity is associated with several diseases, such as cancer.
80
 Kinase 
activity was investigated by implementing a custom fluorophore labeled peptide. These 
findings are the first example to monitor kinase activity in live cells with continuous real-
time analysis. The potential impact of this work lies in the ability to further understand 
these systems. This will provide detailed information about the biological processes, 
which is critical in designing and developing therapeutics. Additionally, this will allow 
drugs and therapeutics to be screen in live cells with continuous real-time analysis. In 
fact, several anti-cancer therapies have been aimed at either inhibiting or activating these 
processes. A major advantage of employing nonlinear ultrafast spectroscopy is the high 
sensitivity at low concentrations, suggesting it can be utilized at biologically relevant 
conditions. Additionally, TPA can provide both qualitative and quantitative information 
about the system, which is important for bio-imaging applications.  
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Chapter 2 
Experimental Instrumentation and Techniques  
 
 
In this chapter, the experimental setups and procedures used in the dissertation are 
discussed in detail. Common spectroscopic techniques were employed to investigate the 
materials and biological-based systems including UV-Vis absorption, steady-state 
fluorescence, and circular dichroism. Steady-state spectroscopy was used as an initial 
examination and diagnostic of the systems. Ultrafast nonlinear spectroscopy was further 
utilized to gain a deeper understanding of the materials and biological-based interactions 
including two-photon absorption (TPA), fluorescence upconversion, and time-correlated 
single-photon counting (TCSPC). TPA was implemented as a new methodology to 
determine the DNA-binding modes of small organic molecules. Fluorescence 
upconversion and TCSPC were employed to examine the excited state dynamics of the 
DNA-binding molecules. The culture and imaging of mammalian cells will discuss in 
significant detail. This was a major contribution to our research group because it will 
allow future researchers to correlate their ultrafast nonlinear techniques towards bio-
imaging applications in live cells.  
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2.1 An Overview and Introduction of Ultraviolet–Visible Spectroscopy and Single-
Photon Excited Fluorescence 
Steady-state spectroscopy is commonly used to optically characterize materials, 
which include absorption and fluorescence.
1–3
 In steady-state spectroscopy, the samples 
are continuously irradiated with a beam of light. In other words, the excited states are 
continuously formed and eliminated in which a steady-state is reached. Steady-state 
spectroscopy provides information in regards to the initial investigation of the system 
and/or material prior to a further examination by ultrafast nonlinear spectroscopy.   
Absorption remains one of the most common spectroscopic techniques because of its 
accuracy and simplicity. The absorption of energy occurs between the closely spaced 
rotational vibrational energy levels of the excited state. The absorbance spectrum can be 
used as a quantitative tool to determine the concentration of a material as well as a 
qualitative guide to identify the “fingerprint” of a material.4–6 The absorbance is the 
logarithm of the ratio of incident to transmitted radiant energy or light through a given 
material or system.
7
 The absorbance is measured using UV-Vis absorption spectroscopy, 
which is governed by Beer-Lambert’s law8 as given by 
                                               𝐴 = log (
𝐼𝑜
𝐼
) =  𝜀 ∙ [𝑐] ∙ 𝑙                                                 (2.1) 
where A is the absorbance, I is the intensity of light absorbed, ε is the molar extinction 
coefficient, [c] is the concentration, and l is the path length. It is important to note that 
absorbance is dimensionless. The wavelength of light absorbed can be translated to the 
amount of energy required to excite the molecule from the ground state to the excited 
state. In general, the absorption in the UV range results in a π→σ* whereas the absorption 
in the visible to near IR range is due to the π→ π*.9,10 Shifts in the absorption spectrum 
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can provide information with respect to environmental changes in the system. 
Additionally, changes in the absorption spectrum can provide details about sample and/or 
material degradation.  
In terms of collecting an absorption spectrum experimentally, an Agilent Model 8341 
spectrophotometer equipped with deuterium and tungsten lamps was employed, allowing 
for the absorption spectrum to be collected over a wide range (200 – 1100 nm). Quartz 
cuvettes supplied by Starna were utilized in all experiments with a path length of 1 cm. 
The solvent was used as a blank to avoid potential artifacts.   
Another steady-state process is the emission of a molecule. The fluorescence process 
is governed by three processes including excitation (absorption), vibrational relaxation, 
and emission.
11–14
 When a molecule is excited by the absorption of photons, the electron 
relaxes back to the ground state, resulting in fluorescence or the release of photons 
(radiative decay), which is generally lower in energy (longer wavelength). The emission 
of most molecules is typically inefficient due to other competing mechanisms, such as 
non-radiative decay where the energy released is in the form of phonons or more 
commonly known as heat. The fluorescence of a molecule can be quantified by the 
quantum yield, which is determined by the ratio of number of photons emitted by the 
number of photons absorbed with a maximum value of 1 (or 100%). The quantum yield 
can be calculated with the use of an integrating sphere
8 
or the comparative method.
15
 
Without the use of an integrating sphere, the comparative method cannot determine the 
absolute quantum yield, but can provide an efficient means to calculate the quantum 
yield.
16,17
 A standard is required to calculate the quantum yield by the comparative 
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method. The quantum yield of a given sample can be calculated using the following 
equation
18
 
                                               𝛷𝑥 = 𝛷𝑆𝑡𝑑 
𝐺𝑟𝑎𝑑𝑥
𝐺𝑟𝑎𝑑𝑠𝑡𝑑
𝜂𝑥
2
𝜂𝑠𝑡𝑑
2                                                (2.2) 
where Φ is the quantum yield, η is the refractive index of the solvent, and Grad is the 
slope obtained from plotting the integrated fluorescence versus absorbance at different 
concentrations. When measuring the quantum yield, it is important to keep the optical 
density below 0.10 to avoid reabsorption and internal filter effects.  
In terms of measuring the fluorescence spectrum experimentally, a Fluoromax-2 
fluorimeter equipped with a Xenon light source was used to collect the emission and 
excitation spectra. A photomultiplier tube (PMT) with diffraction grating was utilized to 
collect the counts or emission at a single wavelength. Quartz cells manufactured by 
Starna were used for all experiments with 1 cm path lengths. The emission was collected 
90
o
 from the excitation source.  
 
2.2 An Overview of Circular Dichroism Spectroscopy to Investigate the DNA-
Binding Interactions of Small Organic Molecules 
Circular dichroism has been used to investigate the chirality of molecules,
19
 
secondary structures of peptides,
20
 and DNA-binding interactions of various 
molecules.
21–24
 When polarize light passes through a material or system, the rate of 
absorption of left and right circularly polarized light may differ. CD is the differential 
absorption of left and right circularly polarized light as given by 
                                                     ∆𝐴 = (𝐴𝐿 − 𝐴𝑅) ∙ [𝑐] ∙ 𝑙                                            (2.3) 
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where ∆A is the difference in the absorption between the left (AL) and right (AR) polarized 
light, [c] is the concentration, and l is the path length. CD is commonly represented as 
ellipticity, which is the angle whose tangent is the ratio of the minor to the major axis of 
the ellipse. This can be expressed by  
                                                          𝜃 = 3298.2 ∙ ∆𝜀                                                   (2.4) 
where θ is the ellipticity and ∆ε is the change in the molar extinction coefficient. The 
units of ellipticity are deg∙cm2∙dmol-1.  
Optical activity arises when there are parallel molecular magnetic and electronic 
transition dipole moments that can couple with the electric field of a circularly polarized 
light source.
21,25,26
 An induced circular dichroism (ICD) signal is observed when an 
achiral molecule binds to chiral DNA due to a nondegenerate coupling of the binding 
molecule with the DNA-base transitions.
24
 In general, a strong positive ICD signal is 
observed when the dipole is polarized perpendicular to the long axis of the pocket, which 
is a characteristic feature of a groove binding molecule. Contrarily, an intercalator has a 
weak negative ICD signal when the transition dipole of the binding molecule is polarized 
along the long axis of the binding pocket or parallel to the nuclecobases.
27,28
 
The use of CD can be ambiguous when determining the DNA-binding mode of small 
organic molecules. It has been reported that the common methodologies to evaluate the 
DNA-binding mode must be made with caution because a combination of select methods 
only provides sufficient information to determine the DNA-binding mode.
29,30
 The dipole 
moment of the binding molecule must be known in order to determine the DNA-binding 
mode with CD. This is a major issue when examining the DNA-binding mode with solely 
the use of CD.  
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2.3 An Introduction and Overview of Two-Photon Absorption Spectroscopy  
Two-photon absorption (TPA) has been widely used to examine the fundamentals of 
the excited state as well as correlating structure-function relationships in organic 
molecules.
31–34
 As a result, two-photon spectroscopy has been increasingly utilized as a 
tool for investigating environmental changes, charge transfer character, and application 
towards fluorescence imaging.
35–38
 Two-photon excited fluorescence (TPEF) has been 
employed in confocal microcopy, which offers several advantages over traditional one-
photon excited fluorescence. TPEF demonstrates superior spatial resolution because the 
TPA process is quadratically power dependent. Additionally, the excitation wavelength is 
in the near-infrared (IR), leading to reduced photodamage and autofluorescence. The 
excitation for TPEF is confined to a small volume in a focal plane, which results in 
reduced photobleaching as well as deeper tissue penetration capabilities for imaging 
applications.
39–43
  
 Maria Göppert-Mayer theoretically proposed the idea of two-photon absorption in 
the 1930’s.44 This was experimentally confirmed decades later with the invention of the 
laser. Pulsed lasers can deliver a high density of photon with a high peak power, which is 
necessary for TPA since it requires a high density of photons to enable simultaneous 
absorption of two photons. With the use of pulsed lasers, the TPA cross-section can be 
determined. TPA cross-sections have units of cm
4∙s∙photon-1, which is also reported as 
Göppert-Mayer (GM) with 1 GM = 10
-50
 cm
4∙s∙photon-1.  
The TPA cross-section was determined by employing the TPEF method.
45
 The 
fluorescence intensity is monitored as a function of power, which allows for the 
calculation of the TPA cross-section. This method is more accurate and easily 
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accomplished as compared to the z-scan method. Intrinsically, TPEF is similar to one-
photon excited fluorescence (OPEF) with the exception that TPEF requires the 
simultaneous absorption of two-photons with half the energy as compared to OPEF.
46
 
The Jabolonski diagram of OPEF and TPEF is shown in Figure 2.1.  
 
Figure 2.1. Jabolonski diagram representing one-photon absorption (OPA), two-photon 
absorption (TPA), and the emission process.  
 
 
 
In this work, the TPA cross-sections were measured utilizing the TPEF method as 
described above. Two-photon spectroscopy was performed using a Kapteyn Murnane 
Laboratories diode-pumped mode-locked Ti:sapphire laser with pulses of ~30 fs. The 
laser head (Millennia) was supplied by Spectra Physics. Typical output power from the 
cavity was 200 – 250 mW. All emission scans were recorded at 800 nm excitation, 
scanning from 350 – 750 nm. An Ocean Optics spectrometer was used to monitor the 
wavelength. The two prisms located within the cavity were utilized to adjust the mode-
lock and beam quality. The input power from the laser was varied by utilizing a variable 
neutral density filter. The fluorescence was collected perpendicular to the incident beam. 
A focal-length plano-convex lens was used to direct the fluorescence into a 
monochromator whose output was coupled to a photomultiplier tube. The photon-
counting unit was manufactured by Hamamatsu, which was used to convert the photons 
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into counts. The multi-meter was used to convert the input mV to mW by obtaining a 
Keithley plot. Coumarin 307 ((φδ)800 nm = 15 GM) dissolved in methanol was used as a 
standard.
45
 The TPA set-up is shown in Figure 2.2. 
 
Figure 2.2. TPA set-up in our laboratory.  
 
The equation used to calculate the TPA cross-section will be derived. The TPEF 
signal can be used to calculate the TPA cross-section with the following mathematical 
equation as given by 
                                                𝐹(𝑡) =  
1
2
𝜂𝛿[𝑐]𝑛
𝑔𝑝
𝜋𝑓𝜆𝜏
𝜙〈𝑃(𝑡)〉2                                     (2.5) 
where F(t) is the TPEF photons collected per second, η is fluorescence quantum yield, δ 
is the TPA cross-section of the sample, [c] is the concentration, n is the refractive index 
of the solvent, gp is the shape factor of the pulsed laser (0.664 for Gaussian shape), f is the 
frequency of the laser (75 x 10
6
 pulses/sec in our case), λ is the excitation wavelength, τ is 
the pulse durations, ϕ is the collection efficiency, and 〈𝑃(𝑡)〉 is the input intensity.  
Equation 2.5 can be simplified by using a standard to calculate the TPA cross-section 
of a given sample. The standard is used to determine the collection efficiency. 
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Additionally, the values associated with the laser parameters are not needed when 
comparing against a known standard. As a consequence, the equation to calculate the 
TPA cross-section can be derived accordingly. By taking the logarithm of Equation 2.5, 
the equation can be simplified as  
                               log[𝐹(𝑡)] = 2 log[〈𝑃(𝑡)〉] + log [
1
2
𝜂𝛿[𝑐]𝑛
𝑔𝑝
𝜋𝑓𝜆𝜏
𝜙]                            (2.6) 
Therefore, the logarithm plot of the fluorescence intensity versus the power should give a 
slope of 2 since Equation 2.6 can be transcribed into the form a y = mx + b. The slope of 
2 confirms a two-photon excitation process rather than a one-photon excitation process.  
Since the sample and standard both exhibit a slope of 2, the following equation is 
true: 
                                                     𝑚𝑠𝑡𝑑𝑥𝑠𝑡𝑑 = 𝑚𝑠𝑎𝑚𝑝𝑥𝑠𝑎𝑚𝑝                                          (2.7) 
The values or variables are substituted into Equation 2.5 to give the following: 
                                     2 log[〈𝑃(𝑡)〉]𝑠𝑎𝑚𝑝 = 2 log[〈𝑃(𝑡)〉]𝑠𝑡𝑑                                       (2.8)              
    log[𝐹(𝑡)𝑠𝑎𝑚𝑝] − 𝑏𝑠𝑎𝑚𝑝 =  log[𝐹(𝑡)𝑠𝑡𝑑] − 𝑏𝑠𝑡𝑑; 𝑏 = 𝑙𝑜𝑔 [
1
2
𝜂𝛿[𝑐]𝑛
𝑔𝑝
𝜋𝑓𝜆𝜏
𝜙]            (2.9)                   
By substituting in the values, a relationship between the standard and sample can be 
established. It is important to note the b in Equation 2.9 can be ascribed to the y-intercept. 
Equation 2.9 is further manipulated to give the following: 
                                   log[𝐹(𝑡)𝑠𝑎𝑚𝑝] −  log[𝐹(𝑡)𝑠𝑡𝑑] = 𝑏𝑠𝑎𝑚𝑝 − 𝑏𝑠𝑡𝑑                       (2.10) 
                                                  log [
𝐹(𝑡)𝑠𝑎𝑚𝑝
𝐹(𝑡)𝑠𝑡𝑑
] = 𝑏𝑠𝑎𝑚𝑝 − 𝑏𝑠𝑡𝑑                                    (2.11) 
                                                        
𝐹(𝑡)𝑠𝑎𝑚𝑝
𝐹(𝑡)𝑠𝑡𝑑
= 10(𝑏𝑠𝑎𝑚𝑝−𝑏𝑠𝑡𝑑)                                     (2.12) 
Equation 2.12 simplifies to F(t) =  b with b = 
1
2
𝜂𝛿[𝑐]𝑛
𝑔𝑝
𝜋𝑓𝜆𝜏
𝜙 when the logarithm power 
is equal to 0. This can be substituted into Equation 2.12 to give the following: 
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1
2
𝜂𝑠𝑎𝑚𝑝𝛿𝑠𝑎𝑚𝑝[𝑐]𝑠𝑎𝑚𝑝𝑛𝑠𝑎𝑚𝑝 ∙
𝑔𝑝
𝜋𝑓𝜆𝜏
𝜙
1
2
𝜂𝑠𝑡𝑑𝛿𝑠𝑡𝑑[𝑐]𝑠𝑡𝑑𝑛𝑠𝑡𝑑 ∙
𝑔𝑝
𝜋𝑓𝜆𝜏
𝜙
= 10(𝑏𝑠𝑎𝑚𝑝−𝑏𝑠𝑡𝑑)                          (2.13) 
                                      
 𝜂𝑠𝑎𝑚𝑝𝛿𝑠𝑎𝑚𝑝[𝑐]𝑠𝑎𝑚𝑝𝑛𝑠𝑎𝑚𝑝 
𝜂𝑠𝑡𝑑𝛿𝑠𝑡𝑑[𝑐]𝑠𝑡𝑑𝑛𝑠𝑡𝑑 
= 10(𝑏𝑠𝑎𝑚𝑝−𝑏𝑠𝑡𝑑)                               (2.14) 
                                    𝛿𝑠𝑎𝑚𝑝 =
 10(𝑏𝑠𝑎𝑚𝑝−𝑏𝑠𝑡𝑑)∙𝛿𝑠𝑡𝑑𝜂𝑠𝑡𝑑[𝑐]𝑠𝑡𝑑𝑛𝑠𝑡𝑑 
𝜂𝑠𝑎𝑚𝑝[𝑐]𝑠𝑎𝑚𝑝𝑛𝑠𝑎𝑚𝑝 
                                   (2.15) 
Equation 2.13 is simplified to give Equation 2.15 as the final expression to calculate the 
TPA cross-section of a given sample. The quantum yield, concentration, and refractive 
index of the solvent can be easily determined. The y-intercept or b value is determined by 
plotting the log-log plot of the fluorescence intensity-power. The log-log plot may not 
have an exact slope of 2 due to artifacts in the measurement, such as the residual light 
from the environment. As consequence, the slope needs to be corrected to give a slope of 
2. This was done by manually subtracting counts from the fluorescence intensity. 
Furthermore, the TPA action cross-section can be determined by multiplying the TPA 
cross-section by the quantum yield. The action cross-section provides information about 
the two-photon excited fluorescence brightness, which is an important property for bio-
imaging applications.  
 
2.4 An Introduction and Overview of Time-Resolved Fluorescence Upconversion 
In order to investigate the fluorescence dynamics of a molecule or system, 
fluorescence upconversion can be employed. Fluorescence upconversion has resolution 
on the femtosecond to picosecond time scale, which allows for the examination of 
electronic processes in the excited state. This technique can be used to gain detailed 
information relative to charge-transfer and energy migration.
47–49
 Additionally, time-
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resolved spectroscopy is widely a used technique to study to the function and structure of 
macromolecules, including peptides and proteins.
33,50–53 
Polarization measurements can be obtained by a Berek compensator. The polarization 
of the excitation source can be altered as either parallel (I//) or perpendicular (I⊥). 
Fluorescence anisotropy can provide detailed information about the system, such as the 
directionality
11,54
 of a material
 
as well as about the shape, size, and dynamics of 
biological molecules.
55–60
 The fluorescence anisotropy can be calculated as given by
61
 
                                                           𝑟(𝑡) =
𝐼//−𝐺∙𝐼⊥
𝐼//+2𝐺∙𝐼⊥
                                                  (2.16) 
where r(t) is the anisotropy and G is the correction factor. Anisotropy is a dimensionless 
quantity that relates the ratio of the difference in the polarized intensity with the overall 
intensity.
11
 The maximum initial anisotropy value that can be achieved with a one-photon 
process is 0.40. In other words, no depolarization from the excitation to the emission 
between the dipoles is noted. The initial anisotropy can be calculated by the following
62
: 
                                                           𝑟𝑜 =
2
5
(
2𝑐𝑜𝑠2𝜃−1
2
)                                               (2.17) 
Where ro is the initial anisotropy and θ is the angle between the absorption and emission 
transition dipoles. The initial anisotropy will change as the excitation wavelength is 
varied because anisotropy measurements are wavelength dependent.   
The fluorescence upconversion setup used in our laboratory is shown in Figure 2.3. A 
Millennia was used to produce a 532 nm light source. The light source was directed into a 
Tsunami manufactured by Spectra Physics containing a Ti:sapphire crystal to produce a 
mode-locked 800 nm light source with pulses of ~120 fs and repetition rate of 82 MHz. A 
FOG-100 system supplied by CDP, Inc. was used for the fluorescence upconversion 
measurements. The 800 nm light source is directed to a dichromic mirror. The residual 
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800 nm is passed to the variable delay line to produce a gate pulse, allowing for time-
resolved measurements with a resolution of ~200 fs. The 800 nm light source is up-
converted to 400 nm through second harmonic generation with the use of a beta-barium 
borate (BBO) crystal to produce the excitation source. A rotating cell holder with an 
optical path of 1 mm containing two quartz lens with a Teflon spacer was used to reduce 
photo-degradation.  
 
Figure 2.3. Fluorescence upconversion set-up in our laboratory.  
 
The fluorescence was collected by focusing the emission on a second BBO crystal in 
which there is overlap between the emission and gate pulse that has passed through the 
delay line. A sum frequency radiation is generated, which combines the emission and 
gate pulse at 300 – 400 nm.63 This signal is further focused and directed into a 
monochromator where it is detected by a photomultiplier tube (PMT). From the delay 
line, one step is equivalent to 6.25 femtoseconds with a range of approximately 1 
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nanosecond.
64
 This allows for the time-resolved investigation of fluorescence dynamics 
in the femtosecond to picosecond time regime. It is important to check for photo-
degradation by measuring the absorption spectrum before and after the experiment since 
this can cause artifacts in the data.  
 
2.5 An Introduction and Overview of Time-Correlating Single-Photon Counting  
Time-correlated single-photon counting (TCSPC) can be employed to examine the 
fluorescence decay on the nanosecond timescale. The principles described in 
fluorescence upconversion are applicable. Unlike fluorescence upconversion, TCSPC 
does not depend on a delay line for time-resolved measurements. Instead, TCSPC is an 
electronic process based on the repetitive collection of single photons over many different 
excitations.
65
 This technique requires a high repetitive light source to accumulate a 
sufficient number of photons.
66
 In order for time-resolved measurements, a time 
reference is necessary to sort the detected photons into bins.
67
 This is achieved by taking 
the difference between the emission and reference pulse detection times. The reference 
pulse signal is converted to an electrical process or growing voltage by using a time-to-
amplitude converter (TAC).
68,69
 This signal is then abrupt once the emission pulse is 
detected, which stops the growing voltage. The difference in the signal and emission 
pulses results in a signal that is guided to a multichannel analyzer or analog to digital 
converter (ADC). A quantitative value is assigned and recorded, which is sorted into the 
appropriate bin. This process or cycle is repeated until the distribution of photons relative 
to their bin assignment produces the fluorescence lifetime.  
47 
 
The TCSPC set-up is presented in Figure 2.4. It is important to note that the 
electronic components required for TCSPC must have sufficient processing speed in 
order to measure the fluorescence decay accurately. Therefore, the system is designed to 
minimize late response by measuring a single photon per excitation cycle, which allows 
for a dead time between the detection of photons. The quality of the detectors and ADC 
are critical for the time-resolution. Thus, it is important to use equipment that has 
sufficient processing speed. A Kapteyn Murnane Laboratories diode-pumped mode-
locked Ti:sapphire laser with pulses of ~30 fs and repetition rate of 90 MHz was used as 
discussed earlier. The laser is tunable from 780 – 830 nm, which can produce an 
excitation wavelength of 390 – 415 nm through second harmonic generation. Single-
photon excitation can be achieved by directing the pulsed laser through a BBO to 
generate a 400 nm excitation source. Two-photon excitation can be obtained by removing 
the BBO. The intensity of the excitation source can be altered with the use of a neutral 
density filter. The SYNC reference signal is produced by reflecting a small portion of the 
800 nm beam towards a silicon photodiode with a glass slide. It is important to use an 
oscilloscope to monitor the amplitude of the reflected beam. The position of the 
photodiode must be adjusted until an amplitude of 1 W is achieved. A polarizer is placed 
after the second harmonic generation of the 400 nm excitation beam and emission of the 
sample. The polarizer can be adjusted to the magic angle of 54.7
o
 with respect to the 
vertical polarization of the excitation beam, which allows for fluorescence decay 
measurements with distinct polarization.
70
 In addition, the polarizers can be adjusted for 
anisotropy measurements. 
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Figure 2.4. TCSPC setup in our laboratory.  
 
The fluorescence of the sample is collected perpendicular to the excitation beam. A 
focusing lens is used to direct the emission towards a monochromator where the detected 
emission wavelength is specified. A PMT is used to detect the emission and transmit the 
signal into the computer with an interface card supplied by Time Harp. PicoQuant 
software was utilized to display and analyze the data collected from the experiment. The 
instrument response function (IRF) was collected by using a scattering medium, such as 
milk or mixing gold colloidal particles with NaCl.
55
 The IRF was reported to have a value 
of approximately 300 ps. The average excitation power used was less than 10 mW at 400 
nm.   
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2.6 An Introduction and Overview of Confocal Microscopy to Image Live Cells  
Fluorescence microscopy has a broad range of applications due to the sensitivity as 
well as its ability to provide information about biological-related processes.
41,71–85
 
Additionally, fluorescence microscopy is nondestructive and noninvasive, thus 
fluorescence microscopy can be applied to live specimens.
86
 As a result, cellular and 
biochemical processes can be investigated at biologically relevant conditions. 
Fluorescence microscopy techniques that exhibit high spatial and temporal resolution 
have been employed to examine biological processes. In this work, confocal (single-
photon and multi-photon) and fluorescence lifetime imaging microscopy (FLIM) were 
utilized. Confocal microscopy is an optical imaging technique that provides high spatial 
resolution and contrast by using a spatial pinhole at the confocal plane to avoid and 
minimize out-of-focus light.
87
 Additionally, confocal microscopy can be used to 
reconstruct 3-D structures from the collected images.
88
 Confocal microscopy offers 
several advantages over traditional wide-field microscopes as the excitation source is 
focused on a specific position of specimen rather than the entire specimen.
89
 On the other 
hand, the emission close to the focal plane can be detected while eliminating out-of-focus 
signal with the use of confocal microscopy.
90
 The images obtained from scanning the 
specimen are called optical sections, which refers to the noninvasive method to collect 
the image using focused light rather than sectioning the sample by physical means.
91
 A 
representation of wide-field vs pointing scanning of specimens is depicted in Figure 2.5. 
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Figure 2.5. Representation of wide-field vs point scanning of a specimen.   
 
A diagram representation of confocal microscopy is shown in Figure 2.6. A tunable 
excitation source produced from a light source passes through an aperture then a beam 
splitter.
88
 The excitation light is then focused at the focal plane where the specimen is 
located. The beam splitter acts a dichromatic mirror for the emission wavelength and 
transparent for the excitation wavelength. However, the dichromatic mirror can behave 
vice versa if the position of the excitation source and detector are switched. The specimen 
is excited then the emission is directed back towards the dichromatic mirror, which 
directs the emission towards another aperture. The fluorescence that arrives at the 
detector comes predominately from a narrow focus plane to improve z-resolution. This 
allows for superior resolution as compared to conventional microscopy. To increase 
resolution, multi-photon excitation can be used to excite the sample.
92
 It is important to 
note that multi-photon confocal microscopy does not require a pinhole aperture.  
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Figure 2.6. Diagram representation of confocal microscopy. 
 
Fluorescence lifetime imaging microscopy (FLIM) is an imaging technique that is 
based on the differences in the fluorescence lifetime or exponential fluorescence decay 
rate. The fluorescence lifetime of the fluorophore is used to yield the image rather than 
the intensity. In other words, the images are shown in pseudo-color that correlates to a 
given lifetime. FLIM produces images with the intensity in each pixel determined by the 
fluorescence lifetime. As a result, fluorophores with similar emission wavelengths, but 
varying fluorescence lifetimes can be differentiated. An advantage of FLIM is that the 
fluorescence image produced is dependent on the environment of the fluorophore instead 
of its concentration.
84
 Thus, molecular effects can be examined independently of the 
concentration of the fluorophore. FLIM can provide information that is inaccessible with 
steady-state fluorescence microscopy techniques. In this work, FLIM requires the use of a 
pulsed-laser as the excitation source and is based on time-correlated single-photon 
counting (TCSPC) or a time-domain method as given in Figure 2.7. The FLIM images 
are produced from well-defined planes rather than out-of-focus fluorescence to reduce 
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unwanted fluorescence. FLIM based on TCSPC exhibits high time resolution as well as 
high photon efficiency and lifetime accuracy.
93,94
  
 
 
Figure 2.7. Principle of FLIM based on TCSPC.
 
 
 
The imaging experiments were carried out on Leica Inverted SP5X Confocal 
Microscope System equipped with a 10X – 100X objective. The 100X objectives was 
used with oil immersion, which provides a medium (high refractive index) to increase 
resolution. It is important to use the oil immersion correctly as it will result in spherical 
aberration if used incorrectly. Avalanche diode detectors were used to increase sensitivity 
and resolution when capturing and collecting images. A 405 nm diode (UV excitation), 
multi-line argon laser (470-670 nm), and Spectra Physics Mai-Tai two-photon tunable 
(640-1040 nm) laser were used as the excitation wavelength source. The power of the 
laser was adjusted to 5 – 10 % to reduce cell apoptosis. It is important to minimize 
exposure times especially when using the multi-photon excitation source. Picoquant 
SMD fluorescent lifetime imaging module (FLIM) is integrated into the Leica software. 
An Acousto Optical Beam Splitter (AOBS) was utilized to replace beam splitters and 
fluorescent filters in the light path. The microscope is equipped with five photomultiplier 
tubes (PMT) to allow the detection of emission, which is tunable to a specific or desired 
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wavelength. A motorized X, Y, Z stage allows for precise control of the position of the 
sample.  
When operating the confocal microscope located in the Microscopy and Imaging 
Analysis (MIL) Core at the University of Michigan, it is important to turn on the 
equipment in the proper order. The equipment is labeled 1 – 7, which should be turned on 
in the following series (1 through 7).  If multi-photon is utilized, turn on the equipment 
labeled 8 and 9 as well. Click on the LASF icon on the computer to start the software. 
When a window asking to initialize the stage appears, click no. Once the software has 
loaded, click laser and turn on the necessary excitation source (405 diode, argon laser, 
multi-photon, white light) under configuration. Select the desired magnification objective 
lens (10x – 100x). Note that 40x and higher requires oil immersion whereas the other 
objective lens do not. Place the sample on the stage located on the microscope. The x and 
y direction of the stage can be adjusted using the hand wheel. Focus the cells under bright 
field mode. Additionally, the cells can be focused under the bright field using UV 
excitation fluorescence. On equipment #1, open the shutter and turn on the 405 nm diode 
to excite the sample. Select the background by pressing the GFP or BRG button, which 
turns the background green or red, respectively allowing for better contrast. Click the z 
button on the hand wheel to adjust and focus in the z-direction. Once focused, turn on the 
selected excitation source for single photon and adjust the power to 5 – 10 % and open 
the shutter. Click pinhole and airy 1 before the imaging experiments. The pinhole 
controls the amount of light that is directed into the detector. Select detector 1 and adjust 
the collected emission wavelength range. In my case, HyD1 was used for the imaging 
experiments. It is important to turn off the other detectors that are not in use. The color of 
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the fluorescence can also be adjusted by clicking properties. Adjust the resolution to 1024 
x 1024 pixels and the number of scans to 6. Click the live button to visualize and observe 
the cells. The z-direction or focus can be adjusted to improve the image quality. The gain 
and intensity can also be adjusted to optimize fluorescence and image quality. Once you 
are ready to capture the image, click the capture bottom. The image will be captured. Be 
sure to save the file into your folder as well as the image by clicking “export as” and 
saving as a TIF file. A distance key can also be added to the imaged if desired. This can 
be achieved by clicking the scale button located on the right computer monitor. Right 
click with the mouse and click capture image, which will allow the scale to be visualized 
in the image. The fluorescence and background contrast can be adjusted by moving the 
contrast scale located on the right computer monitor. If the images are fuzzy or blurry, 
the objectives may have to be cleaned with methanol. It is important to not saturate the 
intensity of the image. This can be done by clicking the button that changes the scanning 
abilities in the software located on the right computer monitor (icon on the top left hand 
corner). If the cell or any part of the screen is blue, this indicates the intensity is too high. 
You do not want blue or high intensity spots in the images. With regards to the multi-
photon imaging experiments, the wavelength can be adjusted. Be sure the pulse icon is on 
before starting. Turn on the gate (right column to 1), gain to 30%, power to 10%, and 
open the shutter. In order to acquire images via FLIM, the second computer next to the 
computer monitors needs to be powered on. Additionally, the Pico Quant instruments 
need to be turned on. The sample will be excited with the pulsed laser (two-photon 
excitation). The two monitors on the top row control the FLIM software. It is important 
to click the SymPho Time (Pico Harp) software then start a new workspace to begin. In 
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the Leica software, open the FLIM wizard set-up on the top left hand margin. This will 
allow you to setup the parameters. Once it is setup, you can select to either collect the 
fluorescence lifetime for a given time or until a certain amount of counts are reached per 
pixel. It is critical to keep the photons per second below 1000 counts/sec as it will 
saturate the image. This can be achieved by reducing the laser power and/or gain. Click 
collect image and wait for the collection to complete. Once the image is collected, use the 
Pico Harp software to fit the fluorescence lifetime. It important to fit the exponential 
decay with bi- or tri-exponential fit. This will correlate the fluorescence lifetime to an 
image color. The pseudo-color within the image will correspond to the fluorescence 
lifetime. The FLIM images can be viewed by clicking the tau icon. The time resolution 
on the FLIM is on the order of picoseconds to nanoseconds. After the imaging 
experiments, the shut-down procedure is important. Turn off the laser(s) and switch the 
objective back to 10X in the Leica Software. If oil immersion is used, clean the 
objectives with the lens paper before switching the objective back to 10X. When 
powering down, follow the instructions on the wall located behind the computer. It is 
important to turn off the numbered equipment in the proper order to avoid damage. Be 
sure to give the laser(s) 10 min to cool down prior to turning off the remaining 
equipment. This is listed on the instructions. If FLIM is used, shut down the computer 
and the Pico Quant instruments. The microscope located in the MIL core is shown in 
Figure 2.8. 
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Figure 2.8. Inverted confocal microscope located in the MIL Core at the University of 
Michigan. 
 
2.7 Summary and Standard Operating Procedures to Culture Mammalian Cells 
The examination of biological-based systems plays an important role in drug research 
develop and development. In vivo experiments are conducted in the entire or whole 
animal/plant. In contrast, in vitro studies are performed in solution or in cells cultured 
with medium. In order to examine systems at physiologically relevant conditions, 
experiments can be conducted in vitro, which offers several advantages. Living 
organisms have extremely convoluted functional systems that consist of many complex 
structures and compounds. Because of this complexity, there is a significant barrier when 
examining systems at biologically relevant conditions. The main advantage of in vitro 
experiments is that it simplifies the system, thus, bypassing the complex barrier. Another 
advantage is that the studies can be used to examine human cell lines without exposing 
humans to potential carcinogenic and/or toxic compounds. An additional advantage is 
that human cell lines can be used directly.
95
 In other words, no translation from animal to 
human is necessary. Finally, in vitro studies can be tuned towards automation processes, 
which is essential for high through-put screening for pharmaceutical testing.
36,96–103
  
In order to culture mammalian cells while avoiding contamination, it is critical to 
practice aseptic technique. It is critical to use protective wear (goggles, gloves, lab coat) 
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at all times when handling cells.
104
 Before working in the laminar flow hood, wash hands 
with soap and warm water. A laminar flow hood equipped with a high-efficiency 
particulate arrestance (HEPA) filter is required to prevent contamination from airborne 
particles and aerosols.
105
 It is important to locate the hood away from windows, doors, 
and other equipment with no foot traffic as well as keeping the hood uncluttered as it can 
hinder the flow of air. When handling cells, it necessary to turn the UV lamp for at least 
30 min to sterilize the surface. Once completed, the laminar flow should be established 
for at least 20 min prior to working in the hood. It is critical to clean the hood with 70% 
ethanol before and after usage. Be sure to spray all containers entering the hood with 70% 
ethanol before placing it in the hood. All cell culture containers (pipettes, flasks, petri 
dishes, centrifuge tubes, etc.) should be purchased sterilized by gamma-irradiation. 
Always spray your hands with 70% ethanol while wearing gloves before placing them in 
the hood. It should be emphasized to never pour solutions and always pipette the solution 
as pouring can cause contamination. If for some reason you have to place the cap of a 
container down, never place it facing down.
106
 After you are done working in the laminar 
flow hood, wipe the surface down with ethanol and turn on the UV light. The equipment 
required for culturing cells is shown in Figure 2.9. 
 
    
Figure 2.9. (A) Laminar flow hood and (B) CO2 incubation oven in our laboratory. 
 
A B 
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The cells were cultured with Dulbecco's Modified Eagle Medium (DMEM) with 10% 
fetal bovine serum (FBS), 100 units of penicillin, and 100 μg/ml streptomycin. DMEM 
was purchased with phenol red, which allows for easy monitoring of the pH of the 
medium. The cells should be grown in medium with a pH of 7.0 – 7.4.105 FBS provides 
the essential growth factors for proper cell growth. Penicillin and streptomycin are used 
as antibiotics to prevent bacterial contamination. The cells must be grown at conditions of 
37 
o
C with 5% CO2 and high humidity. CO2 is necessary to prevent the medium from 
becoming too basic as CO2 (slightly acidic) is absorbed into the medium.
106
 This is 
important to maintain the pH of the medium. The temperature must be kept at 37 
o
C for 
optimal cell growth. The incubation oven should be cleaned with ethanol prior to use. 
The water dish located inside the incubation oven should be replaced every other week. 
Be sure to clean the metal dish with ethanol before use. It is critical to use sterilize water 
and place the water dish under the UV lamp for at least 1 h prior to placing the dish back 
in the hood. The water dish is a major site for contamination so it is crucial to keep it 
clean and replace the water frequently.
104
   
It is important to preserve the cells using a liquid nitrogen freezer (-120 to -130 
o
C). 
The cells should be placed into working medium (DMEM with 10% FBS) and 5% 
DMSO with about 10
5
 cells/mL.
105
 The cells should be placed in a cryogenic tube and 
frozen at 1 
o
C/min until -80 
o
C then placed at -120 
o
C. In order to thaw the cells, the cells 
must be removed from the liquid nitrogen freezer then immediately placed in a 37 
o
C 
water bath for 1 – 2 min. It is important to move as quickly as possible as DMSO is toxic 
and results in cell apoptosis. Once the cells are thawed, place the solution into 10 mL of 
working medium in a 15 mL centrifuge tube then centrifuge at 125 x g for 5 min. The 
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cells will be located at the bottom of the centrifuge tube as a beige color. Aspirate the 
medium then place 10 mL of new working medium into the centrifuge tube. Resuspend 
the cells by gently mixing the cells using the 15 mL pipette. Place the cells in a T-flask 
(75 cm
2
). These flasks are coated with poly-lysine to facilitate and promote cell 
adherence. Poly-lysine is positively charged, which promotes adherence of the cells since 
the cell membrane is negatively charged. Gently rock the flask back and forth to 
eventually distribute the cells. Do not rock the flask in a stirring motion as it can cause 
the cells to aggregate. Incubate the cells in the CO2 oven with the proper conditions as 
discussed above. It is important to replenish the medium every 1 – 3 days. With the use 
of phenol red, the pH can be monitored by the color of medium: yellow pH 6.0 – 6.5, 
orange 6.6 – 6.9, orange/pink 7.0 – 7.4, pink/purple 7.5 – 8.0.107 The medium should be 
changed immediately if it is orange to yellow in color. The cells will take approximately 
4 – 7 days to reach 70 – 90 % confluency during the first passage. A microscope is 
required to observe the cells during this period. It is important to be gentle with the cells 
as it is the most sensitive period of the cells. 
Once the cells have reached 70 – 80 % confluency, passaging (splitting or 
subculturing) of the cells is necessary. Remove the medium and wash the cells with 
sterile PBS containing no ions. Remove the PBS then add 2 – 3 mL of 0.25% (w/v) 
Trypsin-0.53 mM EDTA solution to cover the cells.
108
 Trypsin is a serine protease that is 
used to hydrolyze the proteins (peptide bonds) keeping the cells adhered to the surface, 
thus detaching the cells from the surface.  Place the cells into the CO2 oven for 2 – 5 min 
to increase the Trypsin activity or until the cells start to dislodge from the surface. Longer 
exposure time is required for cells that are difficult to remove from the surface of the 
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flask. Add 6 – 8 mL of working medium to neutralize the Trypsin solution. It is important 
to not expose the cells to the Trypsin solution too long as it is very toxic. Gently mix the 
cells into the medium using the pipette. Subculture ratios of 1:2 to 1:10 are 
recommended.
105,106
 The cells will reach 70 – 90 % confluency in 3 – 5 days at a 1:10 
split. Cells should be discarded after 30 – 50 splits as the genetics can alter. After 
working in the hood, the flasks and pipettes should be placed in a bleach bath (10 – 20 % 
bleach) for at least 1 d prior to disposal. Medium or water that came in contact with the 
cells should be disposed in a container containing concentrated bleach. This container can 
be poured down the sink after sitting for at least 30 minutes. 
 
Figure 2.10. Standard operating procedure to stain cells with fluorescent nuclear dyes.  
 
The fluorescent nuclear dyes were imaged in vitro by fluorescence confocal 
microscopy. This was accomplished by incubating the cells with 1 – 5 μM of dye in 
DMEM for 30 – 60 min. The cells were washed with PBS (3X) to remove excess dye. 
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Live cell imaging solution was used as the physiological medium for the imaging 
experiments, which also provides image clarity with high signal-to-noise ratio. This 
solution offers several advantages over standard buffer, such as PBS or HEPES. Cells 
apoptosis begins after 30 min in common buffers whereas the live imaging solution 
provides high cell viability for up to 4 h when exposed to ambient conditions for 
extended periods of time. It is important to monitor cell viability if the dye exhibits high 
cytotoxicity. This can be done by employing a cell counting unit or hemocytometer along 
with trypan blue, which is a stain that is used to label non-living cells. The dye works by 
staining the cells blue since the cell wall has been disrupted. Live cells will not stain blue 
as the dye cannot penetrate the cell wall. It is important that at least 70 – 80 % of the cells 
are viable when performing imaging experiments. The protocol is summarized in Figure 
2.10. 
   
Figure 2.11. (A) Simplied directions to use BioPORTER peptide delivery kit. (B) 
Summary of how the BioPORTER reagent works.  
 
A B 
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Transfection experiments are required for the delivery of macromolecules, such as 
DNA, peptides, and proteins into live cells. The transfection kit used in this work was 
supplied by BioPORTER.
109
 The kit uses a lipid-based reagent for protein and peptide 
delivery, which allows for a quick delivery into to the cell. The delivered peptides retain 
their structure and function while minimizing adverse effects on the cell. The protocol for 
the transfection of peptides and/proteins is easy to follow. 250 μL of methanol or 
chloroform was added to the vial containing the BioPORTER reagent. It is important to 
use sterile solvent or sterile filter the solvent by using a 0.22 μm filter. The solution was 
vortexed for 10 – 20 sec. 2.5 μL of BioPORTER reagent solution was added to centrifuge 
tube. The solvent was allowed to evaporate in the laminar flow hood for 2 h to produce a 
thin film of transfection reagent. If larger amounts of transfection reagent are used, longer 
evaporation time is required. 10 – 25 μL of the protein or peptide (100 μg/ml) was added 
to the centrifuge tube containing the BioPORTER reagent. The solution was mixed using 
a pipette and allowed to incubate at room temperature for 3 – 5 min. The solution was 
then diluted with 250 of μL DMEM (serum-free, antibiotic-free). It is important to not 
include FBS or antibiotics during the transfection process as it can hinder the transfection 
efficiency. The solution was then added to the cells and incubated in the CO2 oven at 37 
o
C for 4 h. The cells were washed with PBS to remove excess dye-transfected complex 
prior to imaging. The BioPORTER kit is detailed in Figure 2.11.  
In this work, the cells were imaged live in optical imaging wells. The cells were not 
fixed because it can alter cells and/or tissue as well as the fluorescence dynamics cannot 
be observed with continuous real-time analysis. The optical imaging wells were supplied 
by MatTek Corporation. 35 mm imaging wells coated with poly-lysine with a glass 
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thickness of No. 1.5 were used for all imaging experiments. The cells were plated by a 
1:5 dilution (1.25 – 1.5 mL) 24 h prior to conducting the imaging experiments. It is 
critical to plate or seed the cells with the proper density. If the cells are too dense, it can 
cause variation in the transfection process. It is important to note that the transfection kits 
are generally toxic, resulting in cell apoptosis. Therefore, it is critical to use the proper 
cell density (60 – 70 % confluent).  
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Chapter 3 
Two-Photon Spectroscopy as a New Sensitive Method for Determining the DNA 
Binding Mode of Fluorescent Nuclear Dyes 
 
 
 
3.1 Original Publication Information 
A majority of this chapter was published as the following document:  
Doan, P.; Pitter, D.; Kocher, A.; Wilson, J. N.; Goodson III, T. “Two-Photon 
Spectroscopy as a New Sensitive Method for Determining the DNA Binding 
Mode of Fluorescent Nuclear Dyes” J. Am. Chem. Soc. 2015, 137, 9198. 
Modifications were made to the original document to adapt the context to this form. 
The original manuscript and supporting information have been combined.  
 
3.2 Abstract 
A new optical strategy to determine the binding modes (intercalation vs groove 
binding) of small fluorescent organic molecules with calf thymus DNA was developed 
using two-photon absorption (TPA) spectroscopy. Two-photon excited emission was 
utilized to investigate newly synthesized donor-acceptor-donor π-system chromophores, 
which bind to DNA. The results show that TPA cross-sections are able to differentiate the 
fine details between the DNA binding modes. Groove binding molecules exhibit an 
enhanced TPA cross-section due to the DNA electric field induced enhancement of the 
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transition dipole moment while intercalative binding molecules exhibit a decrease in the 
TPA cross-section. Remarkably, the TPA cross-section of 1 is significantly enhanced 
(13.6-fold) upon binding with DNA. The sensitivity of our TPA methodology is 
compared to circular dichroism (CD) spectroscopy. TPA demonstrates superior 
sensitivity by more than an order of magnitude at low DNA concentrations. This 
methodology can be utilized to probe DNA interactions with other external molecules 
such as proteins, enzymes, and drugs. 
 
3.3 Introduction 
Fluorescent molecular nuclear dyes have been widely used in cellular biology with 
potential applications in forensic, diagnostic and bioanalytical analysis.
1
 Fluorophores 
that display enhanced fluorescence upon binding with DNA have been utilized in 
fluorescence microscopy as well as quantifying nucleic acids in gel electrophoresis and 
flow cytometry.
2
 The binding interactions of external molecules with DNA often results 
in a significant change in their properties, which has an important impact on 
physiological functions.
3
 Thus, the binding mode is a crucial parameter for drugs targeted 
at DNA. DNA binding molecules interact with DNA through intercalation or groove 
binding as represented in Figure 3.1, respectively. Common effects of DNA intercalative 
drugs inhibit cell growth, cell transformation and cell death, which have applications as 
antitumor, antibacterial, and anti-parasitic agents.
4
 Another class of drugs interact with 
DNA through a groove binding mechanism. Several groove binding drugs act by 
interfering with cellular processes,
 
which target enzyme and protein access to DNA.
5
 The 
mechanism of binding is key to the performance of both DNA-targeted therapies and 
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fluorescent probes. While basic design principles are proposed, the binding modes of 
many dyes cannot be unambiguously assigned based either on their structure, or through 
the use of many well-established spectroscopic techniques. Therefore, distinguishing 
between an intercalator and groove binder is critical for the design of DNA-targeted 
drugs and fluorescent probes.  
 
 
Figure 3.1. (A) Intercalative and (B) groove binding modes. Orientation of the S0 → S1 
transition dipole is shown in green. The DNA electric field is shown in red.  
 
Qualitative methods have been employed to elucidate the binding modes of external 
molecules to DNA.
3
 However, a combination of select methods must be used to 
determine the DNA binding mode with certainty.
6 
New methodologies with high 
sensitivity are of interest to investigate the DNA binding modes. Nonlinear spectroscopy 
methods, such as TPA provide a powerful tool to examine the photophysical properties of 
fluorescent organic molecules in biological systems.
7
 Hence, TPA can be used with high 
sensitivity to understand the changes in the chromophore DNA binding environment, 
charge transfer character, and excited-dipoles.
8 
We present the first results of two-photon 
A B 
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spectroscopy to diagnose the DNA binding modes of small fluorescent molecules with 
calf thymus dsDNA (ctDNA). The change in the TPA cross-section was investigated to 
assess the binding mode based on the DNA electric field induced perturbation of the 
dye’s transition dipole. A series of dyes (Figure 3.2) were investigated to demonstrate our 
methodology. These fluorophores illustrate a general scaffold for DNA binding dyes, 
which include linear, crescent, or planar structural motifs. 
 
 
Figure 3.2. Chemical structures of 4,6-bis(4-(4-methylpiperazin-1-yl)phenyl) pyrimidine 
(1), 4,6-bis(4-(4-methylpiperazin-1-yl)phenyl) pyrimidin-2-ol (2), acridine orange (3), 
Hoechst 33258 (4), thioflavin t (5), and topotecan (6). 
 
Reaction of 4,6-bis(4-fluorophenyl)pyrimidine
9
 with N-methylpiperazine by 
nucleophilic aromatic substitution afforded 1 with an overall yield of 41%. The reaction 
is shown in scheme 3.1. The Biginelli reaction of 4-(4-methyl-1-piperazinyl) 
benzaldehyde, 4-(4-methyl-1-piperazinyl) acetophenone and urea yielded 2.
10 
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Scheme 3.1. Synthesis of 1.  
 
 
It has been reported that the TPA cross-section of fluorophores can change in 
different environmental conditions. It has been shown that the local electric fields have an 
influence on the TPA cross-section.
11 
The TPA cross-sections of triphenylamines with N-
methyl benzimidazolium moiety terminated branched dyes have been investigated, and it 
was reported that the TPA cross-section enhances about 10-fold upon groove binding 
with DNA.
12,40
 We also present a TPA cross-section enhancement for the characterization 
of groove binding molecules similar to Dumat et al.
12
 However, we attribute the TPA 
cross-section change due to the DNA electric field influence on the dipole of the binding 
molecule. Based on the orientation of the binding agent relative to the DNA helical axis, 
the change in the TPA cross-section is analyzed to determine the DNA binding mode. A 
groove binding molecule will have a dipole oriented more parallel to the DNA electric 
field resulting in an enhanced TPA cross-section upon binding. Contrarily, an 
intercalating agent will have a dipole aligned more perpendicular to the DNA electric 
field leading to a decreased TPA cross-section upon binding. A groove binding molecule 
will exhibit an increased induced dipole while an intercalating molecule will have a 
decreased induced dipole due to the DNA electric field perturbation. It is important to 
note that the TPA cross-sections are an ensemble average for the given system. This 
allows for the investigation of DNA-dye interactions at various DNA-to-dye ratios. 
Notably, this was observed for the intercalating dyes. 
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3.3 Experimental 
Materials. All chemicals and solvents were obtained from commercial suppliers and 
used without further purification, unless otherwise indicated. Calf thymus DNA (ctDNA), 
[poly(dA-dT)]2, [poly(dG-dC)]2, and topotecan were purchased from Sigma Aldrich and 
used as received.  
Sample Preparation. Stock solutions of the dye (500 μM) were prepared by 
dissolving in DMSO then sonicated for 15 min. Once prepared, the samples were stored 
in the absence of light at 25 
o
C. Samples were prepared in PBS (1X) by diluting the stock 
solution of dye. A stock solution of DNA (1000 μM) was prepared by dissolving the 
DNA in PBS (1X) for 24 h at 4 
o
C with occasional stirring prior to use. The DNA base 
pairs concentration of the polynucleotides were determined using molar extinction 
coefficients: ε260 = 13,500 M
-1 
cm
-1
 for ctDNA,
13
 ε262 = 6600 M
-1 
cm
-1
 for [poly(dA-
dT)]2,
14
 and ε254 = 8400  M
-1 
cm
-1
 for [poly(dG-dC)]2.
15
 Once prepared, the nucleic acids 
were stored at 4 
o
C. Measurements were performed with [dye] = 5 μM. Topotecan-DNA 
complexes were prepared 72 hours and stored at 25 
o
C
 
before optical measurements.  
Quantum Yield Measurements. The fluorescence quantum yields were measured 
using the Williams comparative method. The optical density was measured below 0.10 to 
avoid reabsorption and internal filter effects. The absorption and fluorescence were 
measured for four samples with decreasing concentrations. The quantum yield was 
calculated using the following equation  
                                               𝛷𝑥 = 𝛷𝑆𝑡𝑑 
𝐺𝑟𝑎𝑑𝑥
𝐺𝑟𝑎𝑑𝑠𝑡𝑑
𝜂𝑥
2
𝜂𝑠𝑡𝑑
2                              (2.16) 
where is 𝛷 the quantum yield, 𝜂 is the refractive index of the solvent, and 𝐺𝑟𝑎𝑑 is the 
slope obtained from plotting the fluorescence versus absorbance. The quantum yields 
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were measured for 1 and 2 using Coumarin 307 (𝛷 = 0.56)16 dissolved in methanol as 
the standard; 3 using Coumarin 153  (𝛷 = 0.54)17 dissolved in methanol as the standard; 
4, 5, and 6 using Coumarin 30 (𝛷 = 0.35)18 dissolved in methanol as the standard. The 
quantum yields were measured at the maximum absorption for each complex. Extra 
precaution was taken when measuring the quantum yields as it can significantly influence 
the TPA cross-section.   
Steady-State Measurements. Absorption spectra were measured on an Agilent 8341 
spectrophotometer. Emission spectra were collected on a Fluoromax-2 fluorimeter with 
slits set at 3 nm and an integration time of 0.100 s. CD spectra were measured on an Aviv 
model 202 circular dichroism spectrometer using a wavelength step of 1 nm and a 
bandwidth of 1.0 nm. The CD scans were averaged with n = 3. Quartz cells with 10 mm 
path lengths were used for all measurements. All optical measurements were carried out 
at 25 
o
C.  
Two-Photon Absorption (TPA). Two-photon spectroscopy was performed using a 
Kapteyn Murnane Laboratories diode-pumped mode-locked Ti:sapphire laser with pulses 
of ~30 fs. All emission scans were recorded at 800 nm excitation, scanning from 350 – 
750 nm. TPA cross-sections were measured utilizing the two-photon excited fluorescence 
(TPEF) method.
19
 The input power from the laser was varied using a variable neutral 
density filter. The fluorescence was collected perpendicular to the incident beam. A 
focal-length plano-convex lens was used to direct the fluorescence into a monochromator 
whose output was coupled to a photomultiplier tube. A counting unit was used to convert 
the photons into counts. Coumarin 307 dissolved in methanol was used as a standard 
((φδ)800 nm = 15 GM).
19 
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Disadvantages of TPA. There are several drawbacks when using TPA. First, the 
quantum yield is required to calculate the TPA cross-section by the TPEF method. 
Inaccurate quantum yield measurements can significantly influence the TPA cross-
section, therefore affecting the results. In order to measure the TPA cross-section 
accurately, the quantum yield must be measured with precaution. It is important to use 
proper technique and keep the optical density below 0.10 to avoid reabsorption and 
internal filter effects. The quantum yield and TPA measurements were conducted with 
three trials and averaged to give a TPA cross-section value. Another disadvantage of TPA 
is that it is a destructive technique since a high density of photons is required for two-
photon excitation. It is important to monitor the degradation of the sample by measuring 
the absorption and fluorescence before and after the experiment. Sample degradation can 
be reduced by minimizing the output power used to excite the sample. Finally, the TPEF 
technique cannot be used if the sample does not display two-photon excited fluorescence. 
In this case, a nonlinear transmission method, such as Z-scan would have to be employed 
to measure the TPA cross-section. Measurements using the TPEF technique are more 
accurate and precise than nonlinear transmission techniques. When using a nonlinear 
transmission technique, there will be more variation in the TPA data. Such variations can 
be reduced by minimizing false nonlinear optical processes including thermal lensing as 
well as stimulated emission and scattering.
20 
Synthesis. 4,6-Bis(4-fluorophenyl)pyrimidine
21
 (450 mg, 1.68 mmol), Cs2CO3 (1 g, 
3.0 mmol), N-methylpiperazine (3.0 mL, 27.0 mmol) and 1.0 mL of DMSO were placed 
in a 15 mL pressure tube with a stir bar, then heated at 90 °C for 96 h.  The progress of 
the reaction was monitored every 12 h by TLC until the 4,6-bis(4-
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fluorophenyl)pyrimidine and mono-substituted product were completely consumed.  The 
cooled, crude reaction mixture was poured into 100 mL of water, extracted with 3 x 50 
mL of EtOAc and 1 x 50 mL of CH2Cl2.  The organic fractions were combined with the 
solvents removed under reduced pressure; as the volume reduced, a yellow precipitate 
was observed.  This was collected by filtration to yield 298 mg of 1 (41% yield).  mp 468 
- 472 °C (decomp.); IR νmax (cm
-1
): 2967.25, 2930.95, 2840.30, 27966.66, 1606.34, 
1570.55, 1499.84, 1223.38, 816.92, 792.64;
 1
H NMR (500 MHz, DMSO-d6, TFA ):  
2.896 (s, 6H), 3.151 (broad s, 8H), 3.542 (broad s, 4H), 4.053 (broad s, 4H), 7.129-7.147 
(d, 4H, J = 9 Hz), 8.262-8.280 (d, 4H, J = 9 Hz), 8.382 (s, 1H), 9.085 (s, 1H), 10.539 
(broad s, 2H); 
13
C NMR (500 MHz, DMSO-d6, TFA):  42.52, 45.01, 52.47, 110.22, 
115.46, 117.73, 127.26, 128.95, 151.89, 163.18; HR-ESI (Q-TOF) m/z: calcd for 
C15H21N2O2
+
 [M+H]
+
 calcd  429.2761, found 429.2754. 
 
 
Figure 3.3. 
1
H-NMR of 1.  
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Figure 3.4. 
13
C-NMR of 1. 
 
3.5 Results and Discussion 
To demonstrate our methodology, acridine orange (3) and Hoechst 33258 (4) were 
used as standards. It is important to note that 3 has been reported as a DNA intercalator
24
 
and 4 has been reported as a DNA groove binder.
25
 The steady-state absorption and 
emission are shown in Figure 3.5. The fluorescence quantum yield of the dyes is 
summarized in Table 3.1. A red-shift in the absorption spectra was noted as DNA 
concentration increased, which is due to the dye binding with DNA. The fluorescence 
increased 2.1 fold upon binding with DNA at 624 μM for 3. The TPA cross-sections were 
measured utilizing the two-photon excited fluorescence (TPEF) method.
26 
For 3 (Figure 
3.6), a decrease in the TPA cross-section was observed as the DNA concentration was 
increased. This can be rationalized by the orientation of 3 upon intercalating to DNA. The 
dipole of 3 is oriented more perpendicular to the DNA electric field (parallel to the bases) 
leading to a reduction in the induced dipole. The decreasing trend is evident of a DNA 
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intercalative binding mode resulting in lengthening and unwinding of the DNA helix.
6
 
Important driving factors for intercalation include π-stacking, dispersive interaction, 
dipole-dipole interaction, and electrostatic factors with the aromatic nucleobases in 
DNA.
27
 The TPA cross-section was also measured in the presence of [poly(dG-dC)]2. 
The results confirm that the decreasing TPA cross-section trend is directly related to 3 
intercalating at GC base pairs. It was previously reported that 3 intercalates at GC-rich 
sequences,
28
 which corresponds with our results. Interestingly, the TPA cross-section 
increased from 0.11 to 0.13 GM when the DNA concentration was increase to 4 μM. This 
observation can be explained by the dye-dye interaction when DNA is introduced to the 
system, which was also observed at 7 μM of DNA using CD.29 The dyes form ordered 
aggregates at the surface of DNA resulting in an enhanced dipole, which influences the 
TPA cross-section.  
 
Table 3.1. Fluorescence quantum yield of dyes at various DNA concentrations. 
DNA (μM) 1 2 3 4 5 
0 0.009 0.003 0.29 0.012 0.29 
2 0.029 0.008 0.31 0.018 0.24 
4 0.034 0.017 0.30 0.045 0.24 
7 0.048 0.033 0.47 0.082 0.23 
14 0.087 0.052 0.41 0.14 0.23 
32 0.19 0.11 0.42 0.30 0.21 
63 0.28 0.18 0.51 0.41 0.22 
125 0.37 0.25 0.66 0.46 0.22 
250 0.44 0.30 0.73 0.47 0.22 
624 0.47 0.36 0.66 0.45 0.21 
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Figure 3.5. (A) Absorption and (B) emission spectra of 3. Measurements were conducted 
at different DNA (base pairs) concentrations with units of μM (0, purple; 2, navy; 4, dark 
yellow; 7, yellow; 14, magenta; 32, cyan; 63, blue; 125, green; 250, red; 624, black). 
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Figure 3.6. (A) TPA cross-section of 3 (5 μM) plotted as a function of DNA (base pairs) 
concentration. Inset graph: Enlargement at low DNA concentration. Results are the mean 
with ± SD (n = 3). (B) TPA cross-section plotted in the presence of [poly(dG-dC)]2. The 
red line is to guide the eye. 
 
 
As shown in Figure 3.7, the absorption and emission displayed shifts as the DNA 
concentration increased for 4, which is due to the dye binding with DNA Presented in 
Figure 3.8, an increasing TPA cross-section trend was observed for 4 with increasing 
DNA concentrations. A TPA cross-section enhancement of 6.9-fold was observed upon 
binding with DNA. The dipole of 4 is oriented more parallel to the DNA electric field 
A B 
A B 
0 5 10 15 20 25 30 35
0.08
0.10
0.12
0.14

 (
G
M
)
[DNA] (M)  
83 
 
when bound resulting in an enhanced TPA cross-section. The increasing trend indicates a 
DNA groove binding mode, which is characterized by little to no perturbation of the 
DNA structure.
30 
Groove binding molecules require conformational flexibility that allows 
the molecule to fit into the groove and functional groups that interact with the 
nucleobases with minimal steric hinderance.
3
 Moreover, the TPA cross-section of 4 was 
measured in the presence of [poly(dA-dT)]2. A TPA cross-section enhancement of 7.4 
fold was observed upon binding at AT base pairs. The findings confirm the TPA cross-
section enhancement is directly related to 4 groove binding at AT-rich sequences. 4 was 
reported to groove bind along the AT sequences while occupying four base pairs
31
 
through van der Waals and hydrogen bonding interactions.
32 
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Figure 3.7. (A) Absorption and (B) emission spectra of 4. Measurements were conducted 
at different DNA (base pairs) concentrations with units of μM (0, purple; 2, navy; 4, dark 
yellow; 7, yellow; 14, magenta; 32, cyan; 63, blue; 125, green; 250, red; 624, black). 
A B 
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Figure 3.8. (A) TPA cross-section of 4 (5 μM) plotted as a function of DNA (base pairs) 
concentration. Inset graph: Enlargement at low DNA concentration. Results are the mean 
with ± SD (n = 3). (B) TPA cross-section plotted in the presence of [poly(dA-dT)]2. The 
red line is to guide the eye. 
 
CD measurements were applied to compare with the TPA analysis. Positive and 
negative induced circular dichroism (ICD) signals were observed near 480 nm and 465 
nm, respectively for 3. The CD spectra are shown in Figure 3.9. The positive band is due 
to the interaction between the transition dipoles of two or more ordered dyes and reduces 
when DNA concentrations are increased.
29
 The negative ICD signal near 465 nm is 
attributed to the intercalated dye.
33
 Contrarily, a strong positive ICD signal was observed 
at approximately 360 nm for the interaction of 4 with DNA (see Supporting Information). 
The positive band is attributed to 4 groove binding with DNA
34
 as presented in Figure 
3.9B.  
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Figure 3.9. CD spectra of (A) 3 and (B) 4 at different DNA concentrations. 
Measurements were conducted at different DNA (base pairs) concentrations with units of 
μM (0, purple; 2, navy; 4, dark yellow; 7, yellow; 14, magenta; 32, cyan; 63, blue; 125, 
green; 250, red; 624, black). 
 
TPA was employed to study the binding mode of thioflavin t (5). It was previously 
reported that 5 intercalates with dsDNA.
35
 5 undergoes a twisted internal charge-transfer 
(TICT), which is responsible for the quenched fluorescence in the absence of DNA. 
When bound with DNA, the internal rotation of the dye is restricted due to steric 
hindrance resulting in enhanced fluorescence.
36
 Presented in Figure 3.10, the decreasing 
trend is indicative of an intercalative binding mode. This suggests the dipole of 5 is 
oriented more perpendicular with the DNA electric field upon binding. 5 had a TPA 
cross-section of 40.0 GM in the absence of DNA. The TPA cross-section decreased to 
11.4 GM at 624 μM of DNA. The decrease in the TPA cross-section can be attributed to 
the DNA electric field induced perturbation of the dye’s transition dipole rather than the 
conformational change of the dye upon intercalation since 1, 2, and 4 undergo a 
conformational change upon groove binding. Similar to 3, the TPA cross-section 
increased at low DNA concentrations. The TPA cross-section increased to 53.7 GM at 4 
μM of DNA, which can be attributed to the formation of dimers that bind at the DNA 
A B 
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grooves under excess dye conditions.
37
 Furthermore, CD was used to compare with the 
TPA experiments. However, an ICD signal was not detected at our experimental 
conditions. This demonstrates TPA is more sensitive at low dye concentrations as 
compared to CD. Bathochromic shifts of 8 and 48 nm were observed in the absorption 
and emission spectra, respectively at 624 μM of DNA indicating the dye is bound with 
DNA as presented in Figure 3.11.  
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Figure 3.10. (A) TPA cross-section of 5 (5 μM) plotted as a function of DNA (base 
pairs) concentration. Inset graph: Enlargement at low DNA concentration. Results are the 
mean with ± SD (n = 3). The red line is to guide the eye. (B) CD spectra of 5 at different 
DNA concentrations. Measurements were conducted at different DNA (base pairs) 
concentrations with units of μM (0, purple; 2, navy; 4, dark yellow; 7, yellow; 14, 
magenta; 32, cyan; 63, blue; 125, green; 250, red; 624, black). 
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Figure 3.11. (A) Absorption and (B) emission spectra of 5 at different DNA 
concentrations. Measurements were conducted at different DNA (base pairs) 
concentrations with units of μM (0, purple; 2, navy; 4, dark yellow; 7, yellow; 14, 
magenta; 32, cyan; 63, blue; 125, green; 250, red; 624, black). 
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The binding mode of topotecan (6), a clinically approved anti-cancer drug, was 
investigated using TPA. There has been controversy regarding the binding mode of 6. 
The binding mechanism is of interest because therapeutic importance can be improved. 
Yang et al. reported an intercalating binding mode in the absence of topoisomerase I.
38
 
However, Streltsov et al.
39
 and Joshi et al.
40
 concluded 6 binds to DNA through a groove 
binding mechanism. Our TPA analysis suggests 6 groove binds with DNA as shown in 
Figure 3.13. The TPA cross-section enhancement can be attributed to 6 groove binding at 
GC-rich sequences.
38,40 
Quenching in the steady-emission was noted as presented in 
Figure 3.12. This can be ascribed to the photoinduced electron transfer (PET) between 
the drug and DNA nucleobases.
31
 A TPA cross-section enhancement of 1.5-fold was 
observed upon binding with DNA. This can be attributed to the orientation of the binding 
agent relative to the DNA helical axis. 6 was reported to be oriented nearly 55
o 
to the 
DNA helical axis, which is approximate to a groove binder (<55
o
), but less than a 
classical intercalator (62-76
o
).
38,40
 Comparatively, 4 had a TPA cross-section 
enhancement of 6.9-fold with a 45
o
 angle of orientation.
41
 The difference in the TPA 
cross-section enhancement at low and high DNA concentrations can be attributed to the 
DNA electric field induced enhancement of the transition dipole. The low TPA cross-
section enhancement suggests the binding angle of topotecan is between an intercalator 
and groove binder. A larger TPA cross-section enhancement is expected if the dipole of 
the binding molecule is oriented more parallel with the DNA electric field. Interestingly, 
an ICD signal was not detected at our experimental conditions of 5 μM. This indicates 
that our approach is more sensitives at both low DNA and drug concentration.  
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Figure 3.12. (A) Absorption and (B) emission spectra of 6. Measurements were 
conducted at different DNA (base pairs) concentrations with units of μM (0, purple; 2, 
navy; 4, dark yellow; 7, yellow; 14, magenta; 32, cyan; 63, blue; 125, green; 250, red; 
624, black). 
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Figure 3.13. (A) TPA cross-section of 6 (5 μM) plotted as a function of DNA (base 
pairs) concentration. Inset graph: Enlargement at low DNA concentration. Results are the 
mean with ± SD (n = 3). The red line is to guide the eye. (B) CD spectra of 6 at different 
DNA concentrations. Measurements were conducted at different DNA (base pairs) 
concentrations with units of μM (0, purple; 2, navy; 4, dark yellow; 7, yellow; 14, 
magenta; 32, cyan; 63, blue; 125, green; 250, red; 624, black). 
 
The binding mode of 1 was investigated. Shown in Figure 3.14, a red-shift was 
observed in the absorption spectra whereas the fluorescence increased with increasing 
DNA concentrations suggesting that the dye is binding with DNA. Furthermore, the 
binding mode was studied utilizing TPA and CD. The TPA cross-section of the unbound 
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dye was 2.1 GM. Shown in Figure 3.15, the TPA cross-section increased to 28.7 GM at 
624 μM of DNA. A significant TPA cross-section enhancement of 13.6-fold was 
observed upon binding with DNA, which was the largest enhancement noted. The TPA 
cross-section enhancement suggests 1 undergoes a groove binding mechanism in the 
presence of DNA. The crescent shape of 1 allows the molecule to groove bind at AT-rich 
sequences. Furthermore, CD was used to investigate the system. 1 exhibits a positive ICD 
signal near 370 nm in the presence of DNA, which is consistent of a groove binding 
mode (Figure 5B). The positive band corresponds to the S0 → S1 transition, which 
suggests the transition dipole of 1 is oriented along the groove.
42
 Interestingly, a weak 
negative band is observed near 325 nm at 32 μM of DNA or greater. The bisignate ICD 
signal is attributed to the formation of dimers at the surface or in the groove of DNA.
43
 In 
agreement with CD, the TPA cross-section enhancement indicates the transition dipole of 
1 is oriented more parallel to the DNA electric field.  
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Figure 3.14. (A) Absorption and (B) emission spectra of 1. Measurements were 
conducted at different DNA (base pairs) concentrations with units of μM (0, purple; 2, 
navy; 4, dark yellow; 7, yellow; 14, magenta; 32, cyan; 63, blue; 125, green; 250, red; 
624, black). 
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Figure 3.15. (A) TPA cross-section of 1 (5 μM) plotted as a function of DNA (base 
pairs) concentration. Inset graph: Enlargement at low DNA concentration. Results are the 
mean with ± SD (n = 3). The red line is to guide the eye. (B) CD spectra at different DNA 
concentrations. 1→10 represents DNA (base pairs) concentrations 0, 2, 4, 7, 14, 32, 63, 
125, 250, 624 μM, respectively. 
 
The binding mode of 2 was examined. The steady-state absorption and emission 
spectra are shown in Figure 3.16. As expected, a red-shift in the absorption and emission 
spectra was noted as the DNA concentration increased indicating the dye is binding with 
DNA. Moreover, TPA and CD were used to investigate the binding interactions. 
Presented in Figure 3.17A, the TPA cross-section is plotted as a function of DNA 
concentration. The TPA cross-section increased from 3.4 to 14.0 GM from 0 to 624 μM 
of DNA. A TPA cross-section enhancement of 4.1-fold was observed. Comparing with 1, 
this suggests a larger TPA cross-section enhancement is observed when a less electron 
withdrawing central core is incorporated into the donor-acceptor-donor π-system. In 
addition, the hydroxyl substituent from 2 may interact with the DNA nucleobases and 
surrounding water molecules resulting in a lower TPA cross-section enhancement.
44
 The 
increasing trend suggests 2 interacts with DNA though a groove binding mechanism. 
Moreover, CD was used to examine the binding mode of 2 (Figure 3.17B). A positive 
ICD signal was recorded in the presence of DNA near 400 nm, which corresponds to the 
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S0 → S1 transition. The negative band at approximately 350 nm corresponds to the S0 → 
S2 transition. 2 was previously reported to groove bind with DNA using linear dichroism 
(LD),
10
 which agrees with the TPA analysis. Additionally, it was shown that 2 interacts 
with DNA through hydrogen bonding interactions at the AT base pairs, occupying three 
base pairs. However, the fluorescence is nearly quenched from GC sequences, which is 
most likely due to PET from guanine to the excited chromophore.
45 
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Figure 3.16. (A) Absorption and (B) emission spectra of 2. Measurements were 
conducted at different DNA (base pairs) concentrations with units of μM (0, purple; 2, 
navy; 4, dark yellow; 7, yellow; 14, magenta; 32, cyan; 63, blue; 125, green; 250, red; 
624, black). 
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Figure 3.17. (A) TPA cross-section of 2 (5 μM) plotted as a function of DNA (base 
pairs) concentration.  Inset graph: Enlargement at low DNA concentration. Results are 
the mean with ± SD (n = 3). The red line is to guide the eye. (B) CD spectra at different 
DNA concentrations. 1→10 represents DNA (base pairs) concentrations 0, 2, 4, 7, 14, 32, 
63, 125, 250, 624 μM, respectively. 
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A direct comparison of TPA and CD demonstrates superior sensitivity compared to 
CD. It is important to note an ICD signal was not observed for 5 and 6, however a change 
was detected utilizing TPA. This indicates our method has superior sensitivity at low dye 
and DNA concentrations. Moreover, an ICD signal was not observed at DNA 
concentrations less than 7 μM for 1 – 3. However, an ICD signal was detected at 4 μM of 
DNA for 4. TPA detected a significant environmental change in the presence of 2 μM of 
DNA for all compounds, which demonstrates the methodology has potential use at 
biologically relevant concentrations while avoiding problems with background absorption 
of common buffers.
46
 For example, the TPA cross-section increased from 2.1 to 6.2 GM 
when DNA concentrations were increased to 2 μM for 1. The findings are significant as it 
suggests two-photon spectroscopy can provide detail information at dilute concentrations 
of DNA and differentiate between the DNA binding modes of external molecules, which 
are inaccessible with single-photon excited fluorescence. Furthermore, two-photon 
excitation microscopy (TPEM) can be used for cellular studies. Since the TPA process is 
quadratically intensity dependent, TPEM can provide superior spatial resolution with 
reduced photobleaching and photodamage as well as autofluorescence for bioimaging at 
low concentrations.  
 
3.6 Conclusion 
In summary, we developed a new highly sensitive methodology to diagnose the DNA 
binding mode of external molecules. This report is the first example that applied TPA 
cross-section changes to determine the DNA binding mode of fluorescent nuclear dyes 
and DNA-targeted drugs. The TPA cross-sections of intercalating and groove binding 
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dyes are influenced by the electric field of the DNA backbone upon binding. An 
increasing trend is indicative of a groove binding mode while a decreasing trend suggests 
an intercalative binding mode. Moreover, a comparison of our TPA studies with CD 
demonstrates TPA exhibits superior sensitivity at DNA concentrations of 4 μM and lower 
by more than an order of magnitude. This work may facilitate the biological studies of 
DNA interactions with other external molecules as well as applications for bioimaging.  
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Chapter 4 
A New Design Strategy to Tailor the DNA-Binding Mechanism of Small Organic 
Molecules and Drugs 
 
 
4.1 Original Publication Information 
A majority of this chapter was published as the following document:  
Doan, P.; Pitter, D.; Kocher, A.; Wilson, J. N.; Goodson III, T. “A New Design 
Strategy to Tailor the DNA-Binding Mechanism of Small Organic Molecules and 
Drugs” 
Modifications were made to the original document to adapt the context to this form. 
The manuscript has been submitted to Nature Chemistry.  
 
4.2 Abstract 
The classical model for DNA groove binding molecules states that groove binding 
molecules should adopt a crescent shape that closely matches the helical groove of DNA. 
We present a new design strategy that does no obey this classical model. The DNA-
binding mechanism was investigated by synthesizing and examining a series of novel 
fluorescent nuclear dyes as fluorescent probes for the detection of nucleic acids. This 
study has led to the emergence of structure-property relationships of DNA-binding 
molecules that possess a crescent or V-shaped donor-acceptor-donor motif. The findings 
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reveal that the structure of these fluorophores can be designed to either intercalate or 
groove bind with calf thymus dsDNA by structurally modifying the electron accepting 
properties of the central heterocyclic accepting core. This is the first example that has 
demonstrated an induced change in the DNA-binding mode for crescent shaped DNA-
binding molecules. Moreover, the results indicate that increasing conjugation length 
between the electron donating arms and electron accepting core does not induce a change 
in the DNA-binding mode. This suggests that the electron accepting properties of the 
central heterocyclic core is the key factor in the DNA-binding mechanism. The 
fluorophores were characterized by steady-state and ultrafast nonlinear spectroscopies as 
well as electronic structure calculations. The fluorophores are nearly quenched in 
buffered aqueous solution, however, display a high degree of turn on/off sensitivity upon 
DNA binding with a fluorescence enhancement of up to 74-fold as well as a Stokes shift 
of up to 9320 cm
-1
. Furthermore, these fluorophores exhibit a two-photon absorption 
(TPA) cross-section enhancement of up to 13.6-fold upon binding with DNA. Bio-
imaging experiments were carried out in live HeLa cells to evaluate the performance of 
these fluorophores utilizing two-photon excited fluorescence confocal microscopy. This 
report represents a new strategy for the design and development of therapeutics aimed at 
DNA. 
 
4.3 Introduction  
Fluorophores are valuable in many fields including, nanoscience, biochemistry, and 
energy conversion.
1
 Fluorescent nuclear dyes have become important tools in cellular 
biology as well as for the detection and characterization of nucleic acids. Additionally, 
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fluorescent nuclear dyes have been widely employed in flow cytometry,
2 
cellular 
imaging, and the quantification of nucleic acids in gel electrophoresis.
3 
Fluorophores that 
can be used for DNA quantification offer several advantages. For example, fluorescent 
detection of DNA is approximately 100 to 1000 times more sensitive than traditional 
absorption techniques.
4 
Moreover, fluorescent nuclear dyes are not generally affected by 
contaminates, such as proteins and enzymes. Fluorophores that display enhanced 
fluorescence upon binding with DNA are of considerable interest. However, there 
remains limitations with several commercially available fluorescent dyes used for 
imaging and detection purposes including Hoechst 33242 and 4',6-diamidino-2-
phenylindole (DAPI). These limitations include insufficient photostability, high energy 
excitation wavelengths, and poor water solubility that lead to the formation of non-
fluorescent aggregates.
2,5,6,7 
Furthermore, there are drawbacks with fluorescent nuclear 
dyes that possess low cell permeability and high toxicity.
8,9
 
Small organic DNA-binding molecules can interact with DNA predominately through 
an intercalating or groove binding mechanism.
10
 In general, intercalating molecules have 
planar aromatic rings incorporated into the structure that bind with DNA by inserting 
between the DNA nucleobases to form a binding pocket. Lengthening, unwinding, and 
distortion of the DNA helical axis are most prominent upon intercalation,
11
 which 
requires important driving factors, such as π-stacking, dipole-dipole interaction, 
electrostatic factors, and dispersive interaction with the aromatic nucleobases in DNA.
12 
On the other hand, groove binding is characterized by little to no perturbation in the DNA 
structure. Groove binding molecules generally contain unfused-aromatic structures with 
terminal basic functions.
13 
Additionally, groove binding molecules require 
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conformational flexibility that allows the molecule to fit into the DNA groove and 
functional groups that interact with the nucleobases through H-bonding and/or van der 
Waals interactions with minimal steric hinderance.
10
 Groove depth, groove width, 
electrostatic potential, and floor functionality are structural features found to be critical 
for groove binding recognition.
14
 The DNA-binding interactions of small organic 
molecules can provide valuable information towards the development of highly sensitive 
probes for DNA detection as well as the means for the design of therapeutics targeted at 
DNA. For example, common effects of DNA intercalative drugs inhibit cell growth, cell 
transformation, and cell death, which have applications as antitumor, antibacterial, and 
anti-parasitic agents
15
 while common effects of groove binding drugs interfere with 
cellular processes by targeting enzyme and protein access to DNA.
16
 Hence, structure-
property relationships are of considerable interest to guide in the design of small organic 
molecules in which the DNA-binding mechanism can be modified and tailored. These 
relationships will contribute to the development of therapeutics aimed at DNA.  
Several common methods have been employed to examine the DNA-binding 
interactions of small organic molecules including circular dichroism. However, these 
techniques cannot provide information accessible with ultrafast nonlinear spectroscopy. 
Therefore, ultrafast nonlinear spectroscopy has been widely utilized to investigate 
structure-property relationships of organic molecules.
17–19
 Additionally, two-photon 
excited fluorescence (TPEF) has been used to study the fundamentals of the excited state 
as well as correlating structure-function relationships.
20–24
 As a result, two-photon 
spectroscopy has been increasingly utilized as a tool for investigating environmental 
changes, charge transfer character, and application towards fluorescence imaging.
25
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Furthermore, ultrafast time-resolved spectroscopy has been employed to study the 
photophysical properties of fluorescent organic molecules in biological systems.
26–29
 
Thus, ultrafast nonlinear spectroscopy provides a power tool to develop structure-
property relationships of small organic DNA-binding molecules.  
In this article, we report the first design strategy for DNA-binding molecules that 
possess a crescent or V-shaped donor-acceptor-donor motif in which the DNA-binding 
mode can be tailored. According to the classical model for DNA binding, molecules that 
adopt a crescent or curved scaffold can groove bind with DNA because the complex can 
closely fit or match the groove of the DNA helix.
30
 The combined approach utilizing 
ultrafast nonlinear and steady-state spectroscopies along with electronic structure 
calculations were employed to examine the structure-property relationships of these 
fluorophores. Herein, the results reveal that an induced change in the DNA-binding mode 
can be achieved by modifying the electron accepting properties of the central heterocyclic 
core of the fluorophore. Altering conjugation length between the electron donating arms 
and electron accepting core did not induce a change in the DNA-binding mode, 
suggesting that the central heterocyclic core plays an important role in the DNA-binding 
mechanism. The impact of this work is significant as the design strategy can be applied 
towards the development of therapeutics targeted at DNA. 
  
4.4 Experimental 
Materials. Chemicals and solvents were obtained from commercial suppliers and 
used without further purification, unless otherwise indicated. HeLa cells (CCL-2) were 
purchased from ATCC and used as received. Fetal bovine serum (FBS), 
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penicillin/streptomycin (10,000 U/ml), and Live Cell Imaging Solution were provided by 
Life Technologies. Dulbecco's Modified Eagle Medium (DMEM) was supplied by 
Corning. Calf thymus dsDNA was purchased from Sigma Aldrich. A stock solution of 
calf thymus dsDNA (1 mM) was prepared by dissolving DNA in PBS (1X) for 24 h at 4 
o
C with occasional stirring prior to use. A stock solution of fluorophore (500 μM) was 
constructed in DMSO. Samples were prepared in PBS (1X) by diluting the stock solution. 
Measurements for the DNA system were performed with [fluorophore] = 5 μM and 
[DNA] = 100 μM, unless otherwise indicated. 
Synthesis. 1 and 5 were synthesized previously.
31
 Reaction of 4,6-bis(4-
fluorophenyl)pyrimidine
32,33
 with N-methylpiperazine by nucleophilic aromatic 
substitution afforded 4 with an experimental yield of 41%.
34 
2, 3, 6, and 7 were 
synthesized elsewhere.
35 
 
Synthesis of [2-[2,6-bis[(1E)-2-(4-methylpiperazin-1-yl)phenyl]ethenyl]-4-H-pyran-
4-ylidene]-propanedinitrile (8): 0.17 g (1.0 mmol) of 2-(2,6-dimethyl-4H-pyran-4-
ylidene)-propanedinitrile, 0.45 g (2.2 mmol) of 4-(4-methyl-1-piperazinyl)-benzaldehyde, 
2.40 g (19.0 mmol) of TMS-Cl, and 10 ml of anhydrous dimethylformamide were mixed 
in a 25 mL pressure tube with a magnetic stir bar. After heating at 90 ºC for 48 h, the 
reaction was cooled to room temperature and poured into a chilled solution of 1 M 
NaOH; the resulting dark red precipitate was isolated by suction filtration and rinsed with 
water.  The filtrate was crystallized twice from methanol and dried in an oven to yield 
0.23 g (42%) of 8 as a deep red powder.   m.p: 296-298 
oC; IR νmax (cm
-1
): 2791.64, 
2204.35, 1635.96, 1595.66, 1537.87, 1487.56, 1331.44, 1188.29, 1138.23, 828.66; 
1
H 
NMR (500 MHz, DMSO-d6),  (ppm): 2.22 (3H, s), 2.43 (broad s, 8H), 3.29 (broad s, 
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8H), 6.73 (2H), 6.98-7.00 (d, 4H, J = 10 Hz), 7.11-7.14 (d, 2H, J = 15.0 Hz), 7.65-7.68 
(d, 2H, J = 15.0 Hz), 7.67-7.69 (d, 4H, J = 8.6 Hz); 
13
C NMR (125 MHz, DMSO-d6, 
TFA),  (ppm): 42.51, 44.95, 52.46, 55.34, 106.46, 115.07, 116.61, 117.40, 126.56, 
130.17, 138.05, 151.08, 156.52, 159.96; HR-ESI (Q-TOF) m/z: calc’d for C34H37N6O
+ 
(M+H
+
): 545.7105, found: 545.3012. 
Absorption and Fluorescence. Absorption spectra were measured on an Agilent 
8341 spectrophotometer. Emission spectra were collected on a Fluoromax-2 fluorimeter 
with slits set at 4 nm and an integration time of 0.100 s. Fluorescence quantum yields 
were obtained for 1 and 3 using Coumarin 153 dissolved in methanol; 2 using Rhodamine 
B dissolved in water; 4 and 6 using cresyl violet dissolved in methanol; 5 and 8 using 
Rhodamine 6G dissolved in water; 7 using Coumarin 30 dissolved in methanol as the 
fluorescence standards.  
Circular Dichroism (CD). CD spectra were recorded on an Aviv model 202 circular 
dichroism spectrometer using a wavelength step of 1.0 nm and a bandwidth of 1.0 nm. 
CD scans were averaged with n = 3. Quartz cells with 10 mm path lengths were used for 
all measurements. All optical measurements were carried out at 25 
o
C under N2.  
Two-Photon Absorption (TPA). Two-photon spectroscopy was performed using a 
Kapteyn Murnane Laboratories diode-pumped mode-locked Ti:sapphire laser with pulses 
of ~30 fs. All emission scans were recorded at 800 nm excitation. TPA cross-sections 
were measured utilizing the two-photon excited fluorescence (TPEF) method.
36
 A 
variable neutral density filter was used to control the input power from the laser. The 
fluorescence was collected perpendicular to the incident beam. A focal-length plano-
convex lens was utilized to direct the fluorescence into a monochromator whose output 
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was coupled to a photomultiplier tube. A counting unit was utilized to convert the 
photons into counts. Coumarin 307 dissolved in methanol was used as a standard ((φδ)800 
nm = 15 GM).
36
 
Fluorescence Lifetime Measurements. The time-correlated single-photon counting 
(TCSPC) system has been described in detail elsewhere.
37 
A Kapteyn Murnane 
Laboratories (KML) mode-locked Ti:sapphire laser system (90 MHz) delivering ∼30 fs 
output pulses at 800 nm was used as the excitation source.  Second harmonic generation 
in a β-barium borate (BBO) crystal was used to convert the 800 nm pulsed light to 400 
nm excitation pulses. The fluorescence was collected at the maximum emission to a right 
angle excitation and detected by a photomultiplier tube (PMT) module coupled to a 
monochromator. A time to amplitude converter (TAC) was used to create time resolution. 
TimeHarp 200 (PicoQuant) software was implemented for the TCSPC measurements. 
Fluorescence anisotropy measurements were carried out by recording the fluorescence 
with a polarizer oriented parallel or perpendicular with respect to the excitation source. 
 
The fluorescence upconversion setup used for time-resolved measurements has been 
reported previously.
38
 A Tsunami Ti:sapphire laser operated at 800 nm with 120 fs pulses 
and a repetition rate of 82 MHz was utilized to produce an excitation wavelength of 400 
nm using a BBO crystal. The gate pulse was directed to a delay line while the excitation 
light was upconverted to excite the samples using a FOG-100 system. Fluorescence 
anisotropy measurements were collected by changing the polarization of the excitation 
source utilizing a Berek compensator. All samples were placed in a 1 mm thick rotating 
sample cuvette.  
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Electronic Structure Calculations. The electronic structure calculations were 
carried out utilizing General Atomic and Molecular Electronic Structure System 
(GAMESS) software.
39,40
 The configuration interaction singles (CIS) approach was 
implemented in the calculations. The CIS method utilizes the restricted Hartree-Fock 
(RHF) theory generating singly excited determinants of configuration of interaction 
expansions. The CIS approach offers several advantages of calculating the excited states 
as well as the optimization of the selected state. The first exited state was optimized. 6-
31G was used as the basis set. Hückel was employed as the initial molecular orbital 
guess. The calculations were performed on the free fluorophore in the absence of DNA. 
Avogadro was used to optimize the configuration of the molecule.
41
 The molecular 
orbitals were visualized using Gabedit Software.
42
 
Cell Culture and Fluorescence Microscopy. HeLa cells were cultured in DMEM 
(with phenol red) supplemented with 10% dialyzed FBS serum, 100 units of penicillin, 
and 100 μg/ml streptomycin in a humid incubator at 37 °C and 5% CO2. Prior to imaging, 
the cells were seeded in a 35 mm glass bottom dish supplied by MatTek. The cells were 
incubated for 24 h or until a monolayer was visible at 60 – 70% confluency. The working 
medium was removed and 2 μM of fluorophore in DMEM (serum-free) was added to the 
imaging dish and incubated for 1 h. The medium was removed and the cells were washed 
with PBS to remove excess fluorophore. Live Cell Imaging Solution was used as the 
physiological medium during the imaging experiments.  
The imaging experiments were carried out on a Leica Inverted SP5X Confocal 
Microscope System equipped with a 10X – 100X objective. Avalanche diode detectors 
were used when capturing and collecting images. A 405 nm diode (UV excitation), multi-
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line argon laser (470 – 670 nm), and Spectra Physics Mai-Tai two-photon tunable laser 
(640 – 1040 nm) were used as the excitation wavelength source. The excitation power 
was adjusted to 5 – 10 % to reduce cell apoptosis. An Acousto Optical Beam Splitter 
(AOBS) was utilized to replace the beam splitters and fluorescent filters in the light path. 
The microscope was equipped with five photomultiplier tubes (PMT). A motorized X, Y, 
Z stage allows for precise control of the position of the sample. 
 
 
4.5 Results  
Design. The fluorophores (Figure 4.1) were designed with three key elements: (i) 
Recognition units were incorporated into the pendant arms of the fluorophores. Because 
DNA is a polyanionic molecule, cationic recognition arms are necessary for the 
fluorophore to electrostatically interact with the DNA backbone, which plays an 
important role in the formation of DNA-drug complexes.
43
 N-methylpiperazine was 
selected because protonation of the pendant arms is achieved at physiological 
conditions.
44
 (ii) The pedant aryl arms were designed to control the optical switching of 
fluorescence. Quenching is noted when the pendant arms are allowed free rotation in the 
absence of DNA, resulting in an ultrafast non-radiative deactivation. The pendant arms of 
the fluorophores are restricted of rotation when bound with DNA, which leads to a planar 
conformation. As a consequence, a large fluorescence enhancement originates from the 
loss of rotation of the pendant arms due to the constrictive DNA environment as well as a 
reduction in the non-radiative deactivation pathways upon binding with DNA. (iii) The 
donor-acceptor-donor π-system motif is responsible for the optical properties.45 The 
incorporation of heterocyclic cores with varying electron accepting properties into the 
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conjugated π-system leads to an enhancement in the photophysical properties, which 
allows for a variety of molecular designs. 
 
Figure 4.1. Chemical structures of the fluorescent nuclear dyes. The fluorophores adopt a 
donor-acceptor-donor motif with varying conjugation length between the electron donor 
arms and electron acceptor core. 
 
UV-Vis Absorption. The steady-state absorption spectra of the fluorophores in the 
absence of DNA are presented in Figure 4.2a. As expected, the fluorophores (1, 4, 5) with 
shorter conjugation length displayed the shortest wavelength absorption maxima while 
the fluorophores (3, 7, 8) with increased conjugation length on both pendant arms 
exhibited the longest wavelength absorption maxima. The fluorophores displayed a single 
absorption band, which can be attributed to the π – π* transition. In the case of the 
fluorophores with a difluoroboron β-diketonate or dicyanomethylene pyran heterocyclic 
core (5 – 8),  a second less intense absorption band at a higher energy wavelength was 
noted, which can be ascribed to the n – π* transition. Interestingly, 7 had the broadest 
absorption band with a bathochromic shift of 63 nm compared to 5. The broad absorption 
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band is similar to the case where the closely spaced vibrational energy levels are due to 
the increase in conjugation length and electron accepting abilities of the heterocyclic 
core.
46
 
A direct comparison of the fluorophores with (3, 7, 8) and without (1, 4, 5) increased 
conjugation length on the pendant arms will allow us to assess the effect of the electron 
accepting abilities of the heterocyclic central core relative to the absorption spectra in the 
absence of DNA. The fluorophores (1, 4, 5) without increased conjugation length on both 
pendant arms will be discussed first. As expected, the addition of an electron donating 
hydroxyl substituent to the pyrimidine core (1) resulted in a bathochromic shift of 39 nm 
compared to 4. The shift can be ascribed to both the electron accepting properties of the 
core as well as the increase in conjugation length. Comparing with 4, a bathochromic 
shift of 124 nm was achieved by replacing the pyrimidine core with a difluoroboron β-
diketonate core as demonstrated with 5. The fluorophores with increased conjugation 
length on both pendant arms were also investigated (3, 7, 8). 3 exhibited a maximum 
absorption band near 435 nm. 8 displayed a bathochromic shift of 20 nm compared to 3 
while 7 exhibited a bathochromic shift of 80 nm relative to 8. The pyrimindinol core 
displayed the weakest electron accepting properties followed by the dicyanomethylene 
pyran core. The difluoroboron β-diketonate core possessed the strongest electron 
accepting properties.
47
  
The absorption spectra of the fluorophores were also examined in the presence of 
DNA (Figure 4.2b). Bathochromic shifts of 2 – 4 nm were observed in the absorption 
maxima upon DNA binding for the fluorophores (1, 4, 5) without increased conjugation 
length on both pendant arms, which was the smallest shift noted. Interestingly, the 
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fluorophores (3, 7, 8) with increased conjugation length on both pendant arms exhibited 
the largest bathochromic shifts of 12 – 20 nm upon complexing with calf thymus dsDNA. 
It remains unclear on why this phenomenon is observed. Thus, it is reasonable to suggest 
that the difference in the absorption shift upon binding with DNA can be directly related 
to the conjugation length. The fluorophores with increased conjugation length on the 
pendant arms exhibit more conformational isomers compared to the fluorophores without 
increased conjugation length. A larger bathochromic shift is observed since the 
fluorophores with increased conjugation length on both pendant arms resulted in a larger 
reduction of conformational isomers upon complexing with DNA. The bathochromic 
shift can also be ascribed to the change in the environment of the fluorophore when 
bound with DNA.
48
 Upon complexing with DNA, the fluorophore displaces water 
molecules, leading to a more hydrophobic environment that prevents fluorescence 
quenching and provides steric protection.
49,50 
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Figure 4.2. Steady-state spectra of the fluorophores. Normalized absorption spectra of 
the fluorescent nuclear dyes in the (a) absence and (b) presence of DNA. Normalized 
emission spectra of the fluorescent nuclear dyes in the (c) absence and (d) presence of 
DNA. 
 
Steady-State Fluorescence. The emission spectra of the fluorophores were 
investigated in the absence of DNA (Figure 4.2c). The fluorophores displayed weak 
fluorescence in buffered aqueous solution with the fluorescence quantum yield ranging 
on the order of 10
-4
 to 10
-2
. In particular, the fluorophores with increased conjugation 
length on both pendants arms exhibited the lowest quantum yields. Similar to the 
absorption spectrum, shifts in the emission band were also noted by varying the 
conjugation length and electron accepting properties of the heterocyclic core. By 
comparing 1, 4, and 5, the difluoroboron β-diketonate core possesses the most electron 
a b 
c d 
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accepting abilities, leading to the most bathochromically shifted maximum emission band 
near 549 nm as noted for 5. It has been reported that the vacant p-orbital from the boron 
atom overlaps with the conjugated moiety, which leads to a decrease in the lowest 
unoccupied molecular orbital (LUMO), resulting in a bathochromic shift in both the 
absorption and emission spectra.
51,52 
A similar trend was also observed by comparing 3, 
7, and 8. The results indicate that the optical properties of the fluorophores can be finely 
tuned by varying the electron accepting properties of the central heterocyclic core as well 
as the conjugation length. The modifications in the optical properties can be directly 
attributed to the change in the highest occupied molecular orbital (HOMO) and/or 
LUMO. By comparing the fluorophores that possess the same electron donating pendant 
arms, the incorporation of a stronger electron accepting core decreases the LUMO 
energy, resulting in a bathochromic shift.
31
 Likewise, increasing conjugation length on 
the pendant arms led to an increase in the energy of the HOMO. As a consequence, a 
bathochromic shift was observed because the molecule exhibits delocalization.
53
  
Presented in Figure 4.2d, the emission spectra of the fluorophores were examined in 
the presence of DNA. With the exception of 8, the fluorophores displayed a fluorescence 
fold increase of up to 74-fold as well as narrowing of the emission band upon binding 
with DNA. The broader emission band can be attributed to a large distribution of 
conformational isomers of the free fluorophore in solution.
48
 In particular, the emission 
band of 3 is broad compared to the remaining complexes. It is important to note that the 
small peak near 515 nm arises from the Raman scattering of solvent. The broadening of 
the emission band is ascribed to several equilibrated excited state rotational 
conformational isomers of the unbound fluorophore.
48
 In the presence of DNA, the broad 
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emission band was not observed. Narrowing of the emission band implies that the 
fluorophore adopts a more planar conformation upon binding with DNA, which restricts 
free rotation of the pendant arms. As a consequence, there is a reduction of 
conformational isomers as well as a fluorescent enhancement, which was shown in a 
previous report.
31
  
 
Table 4.1. Summary of steady-state properties of the fluorophores in the absence of 
DNA. Measurements were conducted with [fluorophore] = 5 μM in PBS. 
Compound λmax, abs (nm) 
λmax, em 
(nm) 
Stokes 
Shift 
(cm
-1
) 
ε (M-1 cm-1) Φ 
1 387 523 6720 36,500 0.005 
2 415 598 7370 37,400 0.012 
3 435 619 6680 36,600 7 x 10
-4
 
4 348 514 9320 39,900 0.006 
5 472 549 2970 29,000 0.009
 
6 508 647 4230 43,000 0.005 
7 535 696 4320 27,200 2 x 10
-4
 
8 455 661 6850 42,500 0.002 
 
 
Table 4.2. Summary of steady-state properties of the fluorophores in the presence of 
DNA. Measurements were conducted with [fluorophore] = 5 μM and [DNA] = 100 μM in 
PBS. 
Compound 
λmax, abs 
(nm) 
λmax, em 
(nm) 
Stokes 
Shift 
(cm
-1
) 
ε (M-1 
cm
-1
) 
Φ 
Fluorescence 
Fold 
Increase 
1 389 501 5790 32,700 0.14 73.8 
2 423 586 6490 30,100 0.15 31.2 
3 448 620 6140 26,300 0.02 61.1 
4 352 476 7400 29,600 0.10 29.0 
5 474 555 3180 23,800 0.06 28.5 
6 521 642 3590 44,600 0.18 39.3 
7 555 682 3310 32,900 0.007 33.7 
8 467 659 5260 29,200 0.004 1.3 
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Trends in the Stokes shift were observed when the electron accepting properties of 
the central core and conjugation length on the pendant arms were varied. In the case of 
the fluorophores with the difluoroboron β-diketonate heterocyclic core, they displayed 
the smallest Stokes shift. Notably, 5 had the lowest Stokes shift of 2970 and 3180 cm
-1 
in 
the absence and presence of DNA, respectively. On the other hand, 4 exhibited the largest 
Stokes shift of 9320 and 7400 cm
-1
 in the absence and presence of DNA, respectively. 
The Stokes shift decreased as the electron accepting properties of the central core 
increased for the bound fluorophore regardless of conjugation length. Interestingly, the 
Stokes shift increased when conjugation length was extended to a single pedant arm. For 
example, 1 displayed a Stokes shift of 5790   cm
-1
 in the presence of DNA. Increasing 
conjugation length to a single pendant arm resulted in an enhanced Stokes shift of 6490 
cm
-1
 as observed with 2. This trend was also observed in the case of the fluorophores with 
a difluoroboron β-diketonate heterocyclic core.  
Circular Dichroism (CD) Spectroscopy. CD has been used to study the function 
and interactions of DNA complexes in buffered aqueous solution.
54–57 Optical activity 
arises when there are parallel molecular magnetic and electronic transition dipole 
moments that can couple with the electric field of a circularly polarized light source.
54,55 
An induced circular dichroism (ICD) signal is noted when a achiral molecule binds to 
chiral DNA due to a nondegenerate coupling of the chromophore with the DNA-base 
transitions.
55
 In general, a strong positive ICD signal is observed when the dipole of the 
fluorophore is polarized perpendicular to the long axis of the pocket, which is a 
characteristic feature of a groove binding molecule. On the contrary, an intercalator has a 
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weak negative ICD signal when the transition dipole of the fluorophore is polarized along 
the long axis of the binding pocket or parallel to the nuclecobases.
58,59
  
CD was employed to gain an insight on the DNA-binding mechanism of the 
fluorophores. The CD spectra in the presence of DNA are presented in Figure 4.3 With 
the exception of 8, an ICD signal was detected, which confirms DNA-dye binding 
interactions. A positive ICD signal was observed for 1 – 4, which suggests that the 
fluorophores are groove binding with DNA. Additionally, this indicates that the transition 
dipole of the fluorophore is oriented along the groove.
60
 Interestingly, a bisignate ICD 
signal was observed for 1 – 7, which is due to the interactions between the fluorophore 
that reflect excitonic coupling in dimers or aggregates formed at the groove or surface of 
DNA.
59
 1 and 4 were previously found to groove bind with DNA, which corresponds 
with the results.
34
 The heterocyclic core allows the fluorophore to interact with the DNA 
nucleobases required for groove binding. The pyrimidine core can act as an H-bonding 
donor site whereas the hydroxyl substituent on the pyrimidine core can act as an H-
bonding donor/acceptor site for 1 – 3. In a previous report, 1 was found to groove bind at 
AT-rich sequences. However, the fluorescence is nearly quenched from GC sequences, 
which is likely due to the photoinduced electron transfer (PET) from guanine to the 
excited chromophore.
61
 
The CD spectra were investigated in case of the fluorophores with a difluoroboron β-
diketonate core (5 – 7). 5 was previously reported to intercalate with DNA utilizing linear 
dichroism (LD).
31
 Unexpectedly, 5 exhibited a strong positive ICD band near 475 nm, 
which suggests that the fluorophore is groove binding with DNA. However, when a 
positive ICD signal arises from an intercalator, this indicates that the transition dipole is 
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oriented along the long axis of DNA whereas a negative ICD signal is observed when the 
transition dipole is aligned perpendicular with the long axis.
62
 Based on the CD results, it 
is reasonable to suggest that the transition dipole of 5 – 7 is oriented parallel with the 
long axis of DNA. However, it is difficult to determine the DNA-binding mode based 
solely on CD.  
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Figure 4.3. CD spectra. Evidence of DNA-binding interactions for (a) 1, (b) 2, (c) 3, (d) 
4, (e) 5, (f) 6, (g) 7. (h) An ICD signal was not detected for 8, which indicates that the 
molecule is neither intercalating nor groove binding with DNA. Measurements were 
conducted at [fluorophore] = 5 μM and [DNA] = 100 μM. 
 
 
Two-Photon Absorption (TPA). Summarized in Table 4.3, the TPA cross-sections 
(δ) of the unbound fluorophores were examined. The TPA cross-section increased as 
conjugation length increased in the case of the fluorophores with the same central core. 
a b c 
d e f 
g h 
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For example, the TPA cross-section of 1 was 3.4 GM. Increasing conjugation length to a 
single pendant arm resulted in a TPA cross-section of 6.1 GM as detailed with 2 while 
increasing conjugation length to both pendant arms led to a TPA cross-section of 66.8 
GM as shown with 3. A similar trend was also noted for 5 – 7. Interestingly, there was a 
significant enhancement in the TPA cross-section when a stronger electron accepting 
core was incorporated into the structure in the case of the fluorophores with increased 
conjugation length on a single pendant arm. For instance, 2 had a TPA cross-section of 
6.1 GM. A dramatic increase in the TPA cross-section was found by replacing the 
hydroxypyrimidine core with a difluoroboron β-diketonate core as demonstrated with 6, 
which displayed a TPA cross-section of 37.5 GM. The findings suggest that the electron 
accepting properties of the core and conjugation length play an important role in the TPA 
cross-sections of the unbound fluorophore. 
 
Table 4.3. TPA cross-section (δ) of fluorescent nuclear dyes in the absence of DNA. The 
TPA cross-sections were measured with an excitation wavelength of 800 nm in PBS.  
Compound Φ δ (GM)
 
1 0.005 3.4 
2
 
0.012 6.1 
3
 
7 x 10
-4
 66.8 
4 0.006 2.1 
5 0.009
 1.4 
6 0.005 37.5 
7
 
2 x 10
-4
 50.6 
8
 
0.002 87.6 
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Figure 4.4. TPA cross-section (δ) plotted as a function of DNA concentration. The TPA 
cross-section was measured for (a) 1, (b) 4, (c) 5, (d) 6 with [fluorophore] = 5 μM at 
increasing DNA concentrations to determine the DNA-binding mode. The red line is to 
guide the eye 
 
TPA was employed to assess the DNA-binding mode as described in a previous 
report where an overall increasing or decreasing trend in the TPA cross-section indicates 
a groove binding or intercalating binding mode, respectively.
34
 The TPA cross-sections 
were plotted as a function of DNA concentration as given in Figure 4.4. 1
 
and 4 were 
previously found to display an increasing TPA cross-section trend,
 
suggesting a groove 
binding mode.
34 
The increasing TPA cross-section trend suggests that the dipole of the 
fluorophore is oriented more parallel with the DNA electric field, which is indicative of a 
groove binder. It is reasonable to suggest that these fluorophores are binding at the minor 
groove because it has been reported that large molecules tend to bind at the major groove 
while small molecules bind at the minor groove of DNA.
63 
Interestingly, the TPA cross-
 
a b 
c d 
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section enhancement of 4 is significantly greater than 1. 1 exhibited a TPA cross-section 
enhancement of 4.1-fold whereas 4 displayed a TPA cross-section enhancement of 13.6-
fold upon binding with DNA. Since the structures are nearly identical, this can be 
attributed to the hydroxyl substituent on the heterocyclic core of 1. It has been shown that 
intermolecular interactions can influence the TPA cross-section.
64–66
 Additionally, it has 
been reported that H-bonding interactions and aggregation can reduce the TPA cross-
section of V-shaped hydroxypyrimidine complexes.
67
 Hence, the difference in the TPA 
cross-section enhancement upon binding with DNA is directly related to the hydroxyl 
substituent on 1 interacting with the DNA nucleobases and/or surrounding water 
molecules.
 
5 was previously shown to intercalate with DNA utilizing LD.
31
 It has been reported 
that CD cannot determine the binding mode of an intercalator unambiguously without the 
orientation of the transition dipole moment being known.
10
 In order to determine the 
DNA-binding mode unambiguously, TPA was employed. Our TPA results indicate that 
both 5 and 6 intercalate with DNA as observed with the decreasing TPA cross-section 
trend. For example, 6 had a TPA cross-section of 37.5 GM in the absence of DNA. The 
TPA cross-section decreased to 8.6 GM at 624 μM of DNA. The overall decreasing TPA 
cross-section trend suggests that the transition dipole of both 5 and 6 is oriented more 
perpendicular to the DNA electric field, which is indicative of an intercalating binding 
mode. Interestingly, the TPA cross-section of 5 increased from 1.4 to 3.5 GM when the 
DNA concentration was increased from 0 to 2.1 μM. This can be directly attributed to the 
fluorophore stacking or aggregating at the surface of DNA at high dye-to-DNA ratios.
68 
This provides an example in which CD cannot determine the binding mode of an 
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intercalator unambiguously. Based on our findings, we can conclude that 5 and 6 
intercalate with DNA, which does not necessarily agree with the CD interpretation. 
 
Time-Resolved Fluorescence. The fluorescence lifetime of the fluorophores in the 
absence of DNA was investigated to gain a better understanding on the excited-state 
dynamics as presented in Figure 4.5. Since the fluorophores exhibit a single emission 
band, the fluorescence dynamics of the fluorophores were measured at the maximum 
emission band. The fluorophores displayed a two-component decay, suggesting that 
multiple excited states exist. The fluorescence lifetimes are summarized in Table 4. The 
multi-exponential decay indicates that there are two deactivation pathways, which 
includes the emission from the locally excited (LE) state and the intramolecular charge 
transfer between the fluorescent LE state to the non-fluorescent twisted intramolecular 
charge transfer (TICT) state (LE → TICT transition) by twisting of the molecular 
moieties.
69
 The short component is likely due to an intramolecular charge transfer from 
the fluorescent LE to the non-fluorescent TICT state. When the pendant arms are allowed 
free rotation, the rate of the LE → TICT transition process may compete with other 
radiative and non-radiative processes.
70
 By hindering this process or restricting the 
pendant arms, the LE → TICT transition is suppressed, leading to an enhanced emission 
and a longer decay rate. Interestingly, the short component of fluorophores is near 2 ps 
with the exception of 8. Because of this, it is also reasonable to suggest that the fast 
component may also be attributed to the photoisomerization of the fluorophore. It has 
been reported that photoisomerization of cis-stilbene is 1 ps in n-hexane.
71
 This indicates 
that the photoisomerization activation barrier is minimal. The longer component is not 
likely due to solvent or vibrational relaxation, but to the excited-state population 
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dynamics of the free fluorophore. In other words, this is attributed to the population 
decay of the charge transferred state coupled with the triplet state.
72 
The predominant 
long component can be attributed to the LE state or the deactivation of the LE state to the 
ground state.  
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Figure 4.5. Fluorescence lifetime dynamics. Fluorescence upconversion of (a) 1, (b) 2, 
(c) 3, (d) 4, (e) 5, (f) 6, (g) 7, (h) 8 in the absence of DNA.  
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Table 4.4. Summary of fluorescence lifetime data in the absence of DNA. The 
fluorescence lifetime values were fitted to the equation y(t) = A1e
−t/τ1 + A2e
−t/τ2. 
 
Compound A1 τ1 (ps) A2 τ2 (ps) 
1 0.55 2.0  0.45 22.3  
2 0.38 1.7  0.62 45.1  
3 0.71 1.4 0.29 16.4  
4 0.62 2.3 0.38 30.6  
5 0.50 1.1  0.50 10.6  
6 0.32 2.4  0.68 43.3  
7 0.58 0.8  0.42 7.4  
8 0.56 4.0  0.44 27.3  
 
The fluorescence decay dynamics were investigated to analyze the effect of 
conjugation length. Increasing π-conjugation length to one pendant arm led to a longer-
lived fluorescence lifetime as observed with 2 and 6.  For example, 2 exhibited a long 
component of 45.1 ps, which was the longest lifetime noted. The longer-lived 
fluorescence lifetime can be directly ascribed to the asymmetrical configuration of the 
fluorophore. The fluorophores have two charge transfer excited states that are different in 
energy due to the asymmetric pathway. Thus, there is an increase in the ICT character 
due to the asymmetric structural configuration. It has been previously reported that the 
fluorescence lifetime increases as the ICT character is increased, which corresponds with 
our results.
69 
The shortest lifetimes were observed for the fluorophores with increased π-
conjugation length on both pendant arms. These observations are consistent in the case of 
the fluorophores that possess a pyrimidinol or difluoroboron β-diketonate core. 3 
exhibited a long component of 16.4 ps while 7 had a long component of 7.4 ps. The low 
quantum yield and fast decay of 3 and 7 can be directly related to the increase in 
conjugation length on both pendant arms. Increasing conjugation length results in the 
delocalization of the excited state. Photoinduced alterations in the dipole occur when the 
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π-conjugated system connecting the donor and acceptor moieties is lengthened.73 The 
insertion of double bonds between the donor and acceptor moieties leads to a decrease in 
the overall aromaticity of the system, resulting in a reduced band gap.
74
 Additionally, this 
leads to an increase in the rigidification of the fluorophore. As a consequence, a faster 
fluorescence lifetime is observed.  
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Figure 4.6. Fluorescence lifetime dynamics of fluorescent nuclear dyes in the presence of 
DNA.   
 
Table 4.5. Summary of fluorescence lifetime data in the presence of DNA. The 
fluorescence lifetime values were fitted to the equation y(t) = A1e
−t/τ1. 
 
 
TCSPC was employed because of the increase in the fluorescence lifetime of the 
DNA bound fluorophore (Figure 4.6). A single-component decay in the nanosecond time 
Compound τ (ns) 
1 2.59 
2 2.37 
3 0.60 
4 3.40 
5 2.28 
6 2.14 
7 0.34 
8 0.46 
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range was noted with the exception of the fluorophores with increased conjugation length 
on both pendant arms. The fluorescence lifetime in the presence of DNA is summarized 
in Table 4.5. In order to assess the effect of conjugation length, the pyrimidinol (1 – 3) 
and difluoroboron β-diketonate (5 – 7) fluorophores were studied. In both cases, the 
fluorophores without increased conjugation length exhibited the longest lifetimes. The 
fluorophores with increased conjugation length on a single pendant arm displayed a slight 
decrease in the fluorescence lifetime. Interestingly, a sub-nanosecond decay was 
observed for the fluorophores with increased conjugation length on both pendant arms. 
For instance, 1 exhibited a fluorescence lifetime of 2.59 ns while 2 displayed a single-
component lifetime of 2.37 ns. Increasing conjugation length on both pendant arms 
resulted in a lifetime decay of 0.60 ns as shown with 3.  
The fluorescence dynamics of the DNA bound fluorophore were examined to analyze 
the effect of varying the electron accepting properties of the central heterocyclic core. 
The fluorophores (1, 4, 5) without increased conjugation length exhibited fluorescence 
lifetimes greater than 2 ns. 5 had a slightly faster decay than 1 with a fluorescence 
lifetime of 2.28 ns, suggesting that the incorporation of a more electronegative core leads 
to a faster decay. 4 exhibited a single exponential decay of 3.40 ns, which was the longest 
lifetime observed. Interestingly, 4 had a lower quantum yield (Φ = 0.10) as compared to 1 
(Φ = 0.14), but the lifetime was predominantly longer. As discussed above, the addition 
of the hydroxyl substituent to the pyrimidine core contributes to the significant change in 
the fluorescence lifetime by interacting with the DNA nucleobases and/or surrounding 
water molecules. The fluorophores (3, 7, 8) with increased conjugation length on both 
pendant arms displayed a fluorescence lifetime in the sub-nanosecond time scale. 
125 
 
Similarly, a stronger electron accepting core resulted in a faster fluorescence lifetime as 
noted above. The low quantum yield and short lifetime can be attributed to the 
fluorophore not tightly binding with DNA. As a consequence, the pendant arms are not as 
restricted. Furthermore, the fluorophore is exposed to more surrounding water molecules, 
which can interact with the bound fluorophore. 8 was not compared since the results 
indicate that the fluorophore does not bind with DNA. The findings suggest that 
incorporating a stronger electron accepting core results in a faster decay for the DNA 
bound fluorophore regardless of conjugation length.  
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Figure 4.7. Fluorescence anisotropy in the absence of DNA for (a) 1, (b) 2, (c) 3, (d) 4, 
(e) 5, (f) 6, (g) 7, (h) 8. 
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To further understand the fluorescence dynamics of the unbound fluorophores, 
ultrafast fluorescence anisotropy decay measurements were conducted as shown in Figure 
4.7. The rotational anisotropy decay values are summarized in Table 4.6. Anisotropy 
measurements can provide detailed information about the directionality of the material. A 
higher anisotropy suggests that the material is more symmetrical and less freely 
moving.
53
 Interestingly, the anisotropy value decreased as conjugation length increased. 
This indicates that the highest symmetry and lowest direction dependence is observed for 
the fluorophores without increased conjugation length regardless of the accepting 
properties of the central heterocyclic core. This observation can also be attributed to the 
increase in rotational diffusion and/or energy transfer processes.
75
 Specifically, the 
fluorophores with increased conjugation length reorient faster after excitation. Anisotropy 
values can also provide information about the transition dipole of the fluorophore. A high 
anisotropy (near 0.40) indicates that the emission is not delocalized and is subsequent 
from localized transition dipoles,
76 
which was noted for 1 (0.39). With the exception of 8, 
the fluorophores exhibit anisotropy decay in the absence of DNA. This suggests that the 
angle between the absorption and emitting dipoles does not change during intersystem 
crossing for 8.
76
 In other words, the emission from 8 has equal intensities along the 
different axes of polarization.  
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Table 4.6. Rotational anisotropy decay. The rotational correlation decay parameters of 
the fluorophores are given in the absence and presence of DNA.   
Compound 
Absence of DNA Presence of DNA 
τ (ps) ro τ (ps) ro 
1 31.8 0.39 5194 0.19 
2 104.0 0.31 2020 0.16 
3 85.4 0.19 4880 0.17 
4 57.3 0.35 5806 0.27 
5 11.3 0.34 452 0.05 
6 24.7 0.25 1079 0.03 
7 85.4 0.12 2200 0.11 
8 N/A 0.12 2276 0.07 
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Figure 4.8. Fluorescence anisotropy in the presence of DNA for (a) 1, (b) 2, (c) 3, (d) 4, 
(e) 5, (f) 6, (g) 7, (h) 8. 
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The DNA-binding interactions of the bound fluorophores were investigated by 
polarized excitation measurements. Time-resolved anisotropy can provide important 
information about the shape, size, and dynamics of biological molecules.
77 
A change in 
the depolarization is observed when a small molecule binds to a macromolecule, such as 
DNA. The bound fluorophore exhibits different excited states that lead to different 
depolarization times. The rotational correlation times of the bound fluorophore were 
longer than the local motion of the free fluorophore under the same conditions, indicating 
a restricted tumbling motion. Both groove binding and intercalation inhibit the rapid 
tumbling motion of the binding molecule.
78
 Fluorescence anisotropy was utilized to 
investigate the fluorophores bound with DNA. The values are summarized in Table 6. 
The rotational correlation times of the bound fluorophore were longer than the local 
motion of the free fluorophore under the same conditions, indicating a restricted tumbling 
motion as presented in Figure 4.8. For example, 1 had an anisotropic decay of 31.8 ps in 
the absence of DNA while the anisotropic decay was 5.2 ns when bound with DNA. 
Interestingly, 1 – 4 displayed high residual anisotropy whereas the remaining 
fluorophores showed rapid anisotropy decay.  
The high residual anisotropy of 1 – 4 suggests that the fluorophores exhibit highly 
restricted rotation upon binding with DNA. This can be ascribed to the fluorophore 
tightly binding at the groove of DNA. The locking of the fluorophore is due to the 
protonated N-methylpiperazine recognition units electrostatically interacting with the 
negatively charged DNA helix. In addition, the heterocyclic core of the fluorophore 
undergoes intermolecular interactions with the DNA nucleobases to further stabilize the 
binding molecule. It is important to note that high residual anisotropy was not observed 
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for 5 – 7, which indicates that the fluorophores are less restricted upon binding. By 
comparing with the groove binding fluorophores, this can be directly related to the DNA-
binding mechanism of the fluorophore as they were found to intercalate with DNA by 
implementing our TPA methodology. The rapid anisotropic decay can be attributed to the 
wobbling of the fluorophore at the intercalating site, indicating a less restricted 
motion.
79,80
 Poor intermolecular interactions required for intercalation, such as π-
stacking, between the DNA nucleobases and the intercalating fluorophore can contribute 
to the wobbling of the bound fluorophore.  
Electronic Structure Calculations. GAMESS Software was implemented to 
examine the electronic structure of the fluorophores in the absence of DNA. Calculations 
were carried out in the gaseous state. Geometry optimization was performed by 
Avogadro Software. The CIS method was implemented in this work. 6-31G and Hückel 
were used as the basis set and initial molecular orbital guess, respectively. Presented in 
Table 4.7, the molecular orbitals (MO) of the free fluorophores were investigated. 
One can gain an insight on the charge transfer character by examining the electronic 
structure of a molecule. In the case of the fluorophores with the pyrimidinol core (1 – 3), 
the HOMO was mainly localized on a single pendant arm whereas the LUMO was mostly 
localized on the central heterocyclic core, which indicates that the HOMO → LUMO 
absorption transition exhibits ICT character. This was also noted for 4 and 8. 
Interestingly, the distribution of the MO differed in the case of the fluorophores with the 
difluoroboron β-diketonate core (5 – 7). The HOMO was more delocalized over the entire 
molecule while the LUMO was localized on the central heterocyclic core and/or a single 
pendant arm. This suggests that the complexes with an uneven distribution of the HOMO 
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exhibit a stronger ICT character. In other words, the fluorophores with the difluoroboron 
β-diketonate core exhibit a weaker ICT character compared to the remaining 
fluorophores. The difference in the localization of the HOMO can be directly related to 
the electron accepting properties of the central core. By structurally modifying the central 
core of the fluorophore with a stronger electron accepting moiety, the energy of the 
LUMO is decreased. Furthermore, mixing between the accepting core and donating arms 
is observed in the case of the difluoroboron β-diketonate fluorophores because there is a 
reasonable energy match between the HOMO of the moieties. As a consequence, this 
leads to delocalization throughout the molecule and a bathochromic transition
47
. In the 
case of the remaining fluorophores, the energy match is poor between the electron 
donating arms and electron accepting core. As a result of this, the HOMO is more 
localized on a single pendant arm, leading to greater ICT character.  
The electronic structure calculations were analyzed to further understand the DNA-
binding mechanism of the fluorophores. It has been reported that intercalators exhibit 
large charge delocalization and polarizability.
81
 Additionally, intercalation is 
accompanied by the interaction between the HOMO of the DNA base pairs and LUMO 
of the binding molecule, which contributes to the selectivity of the DNA-binding 
mechanism.
82
 Interestingly, the groove-binding molecules (1 – 4) displayed strong 
delocalization of the LUMO over the entire molecule whereas the LUMO was more 
localized on a single pendant arm in the case of the intercalating molecules (5 – 7). This 
suggests that the localization of the LUMO plays an important role in the DNA-binding 
mode. The localization and lower energy of the LUMO promotes intercalation because 
the binding molecule can accept electrons from the DNA base pairs.
83
 In other words, 
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there is mixing between the LUMO of the intercalating molecule and HOMO of the DNA 
base pairs, which stabilizes the complex. It is important to note that the groove binding 
molecules exhibit greater localization of the HOMO on a single pendant arm whereas the 
HOMO of the intercalating molecules is more delocalized over the entire molecule. This 
implies that the DNA-binding molecules with localization of the HOMO on a single 
pendant arm groove bind with DNA while delocalization of the HOMO results in 
intercalation, which remains unclear in our case. It has been reported that the HOMO of 
water is a large contributor to the stabilization of H-bonding interactions.
84
 Therefore, it 
is reasonable to suggest that groove binding of the fluorophores is partially governed by 
the localization of the HOMO on a single pendant arm as it stabilizes the binding 
molecule at the DNA helical groove by promoting favorable interactions, such as H-
bonding.  
 
Table 4.7. Molecular orbitals diagrams. The electronic structures of the unbound 
fluorescent nuclear dyes were calculated by GAMESS in the gaseous state.  
Chemical Structure HOMO LUMO 
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Table 4.8. Experimental TPA cross-sections (δ) and electronic properties of the unbound 
fluorophore. Electronic calculations were implemented by GAMESS to obtain the ground 
state and transition state dipoles of the fluorophores in the gaseous state.  
Compound δ (GM) Ground state dipole (D) Transition state dipole (D) 
1 3.4 0.52 8.85 
2
 6.1 0.51 10.46 
3
 66.8 0.46 11.12 
4 2.1 0.56 8.31 
5 1.1 1.92 9.77 
6 21.7 2.25 10.06 
7
 50.6 2.41 11.59 
8
 87.6 2.81 8.34 
 
The ground state and transition state dipole moments were obtained by the electronic 
structure calculations. The fluorophores with weaker electron accepting properties (1 – 4) 
had ground state dipoles ranging from 0.46 – 0.56 D. On the other hand, the fluorophores 
with stronger electron accepting properties (5 – 8) had ground state dipoles ranging from 
1.92 – 2.81 D. The transition dipole of the fluorophore increased as conjugation length 
increased. For instance, the transition dipole of 1 was 8.85 D. Increasing conjugation 
length to single pedant arm resulted in a transition dipole of 10.46 D as noted with 2 
whereas increasing conjugation length on both arms led to a transition dipole of 11.12 as 
observed with 3. A similar trend was also recorded in the case of the fluorophores with 
the difluoroboron β-diketonate heterocyclic core.  
Live Cell Imaging. To explore the utility of the fluorescent nuclear dyes, a series of 
imaging experiments were carried out using confocal fluorescence microscopy. The 
fluorophores demonstrated a dramatic increase in the fluorescence upon binding with 
DNA, which makes them suitable for bioimaging applications. Cellular uptake of the 
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fluorophore was verified by confocal microscopy. The fluorophores displayed excellent 
cellular uptake with low cytotoxicity. No cell morphology or viability changes were 
found during the experiments. Single-photon fluorescence confocal microscopy was 
utilized to image the fluorescent nuclear dyes (Figure 4. 9). 1, 2, and 4 demonstrated 
distinguishable nuclei staining with high selectivity for DNA with less pronounce 
staining of the cytoplasm. The images displayed specific staining of DNA localized in the 
cell nucleus with a high signal-to-noise ratio. 3 also exhibited high selectivity for DNA 
localized in the nucleus; however, staining of the cytoplasm was more pronounced. To 
confirm these observations, the cells were also stained with 1 μM of 3. Staining of the 
cytoplasm was also noted at the lower fluorophore concentration.  
5 – 8 showed vastly different staining trends as the fluorophore was mainly localized 
in the cytoplasm. This is likely due to the increase in the electron accepting properties of 
the heterocyclic core, causing the fluorophore to penetrate the nucleus membrane with 
lower efficiency. From the steady-state studies, 8 was not expected to label the nuclei 
with a high fluorescent enhancement. It should be emphasized that localized bright spots 
were observed in the cytoplasm, which is likely attributed to direct staining of organelles. 
It was previously reported that cationic molecules can be used as fluorescent probes for 
lysosomes, endoplasmic reticulum, cell membrane, and mitochondria.
85 
Therefore, these 
bright spots localized in the cytoplasm may constitute as labeled organelles, such as 
lysosomes
86 or mitochondria.87 
Presented in Figure 4.10, two-photon excited microscopy (TPEM) was utilized to 
image the fluorophores in live HeLa cells. TPEM offers several advantages over 
traditional one-photon fluorescence microscopy (OPEM) as it demonstrates superior 
135 
 
spatial resolution and sensitivity because the TPA process is quadratically power 
dependent. For example, the features of a single cell are remarkably pronounced by 
TPEM as compared to OPEM as illustrated in Figure 4.11. A significant portion of the 
fluorescence collected with single-photon microscopy arises from autofluorescence due 
to the higher energy excitation wavelength. Autofluorescence is less pronounced with 
TPEF since the excitation wavelength is near the IR range, which also minimizes 
photodamage. The excitation for TPEF is confined to a small volume in a focal plane, 
leading to reduced photobleaching as well as deeper tissue penetration capabilities for 
imaging applications.
88 
Thus, fluorophores that exhibit TPA properties are of interest. 1, 
2, and 4 displayed optical properties that are promising as biological markers utilizing 
TPEM. The labeled nuclei are less pronounced with single-photon confocal microscopy 
whereas the contrast and resolution is more dramatic by TPEM. Cell permeable small 
organic molecules that can target specific DNA sequences and interfere with gene 
expression are important for drug research and development.
89 
Hence, imaging of such 
processes with high spatial resolution is of considerable interest.  
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Figure 4.9. Single-photon excited fluorescence confocal microscopy images of (a) 1, (b) 
2, (c) 3, (d) 4, (e) 5, (f) 6, (g) 7, (h) 8. The cells were incubated at 2 μM of fluorophore 
for 1 h. Bar: 20 μm. 
 
 
   
    
Figure 4.10. Two-photon excited fluorescence confocal microscopy images of (a) 1, (b) 
2, (c) 3, (d) 4, (e) 5, (f) 6, (g) 7, (h) 8. The cells were incubated at 2 μM of fluorophore 
for 1 h. λex = 800 nm. Bar: 20 μm. 
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Figure 4.11. Two-photon excited fluorescence confocal microscopy images of a single 
HeLa cell. (a) One-photon and (b) two-photon excited fluorescence confocal microscopy 
images of cells stained with 1. Bar: 5 μm. 
 
4.5 Discussion   
The fluorophores displayed a high turn-on sensitivity upon binding with DNA. In the 
non-planar conformation, fluorescence quenching is predominant because electronic 
coupling of the donor pendant arms and acceptor heterocyclic core is not as effective due 
to poor overlapping between the π-orbitals.90 Upon binding with DNA, the fluorophore 
undergoes a conformational change to the planar configuration where overlapping of the 
π-orbitals is maximized, leading to enhanced fluorescence.91 The conformational change 
enhances the coupling between the transition dipole of the fluorophore and internal 
charge transfer in each pedant arm, causing enhanced fluorescence.
90 
The increase in 
fluorescence can be attributed to the inhibition of ultrafast isomerization of the 
fluorophore.
92
 This fluorescent turn-on mechanism is a key element in the molecular 
design of the fluorophores. With the exception of 8, a dramatic fluorescence fold increase 
was noted upon binding with calf thymus dsDNA. It has been reported that the charge 
transfer state of the fluorophore is stabilized in polar solvents.
31
 Thus, fluorescence 
b a 
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quenching is observed in the absence of DNA due to the free rotation in the pendant 
arms. 
The Stokes shift is a critical property for biological applications. Stokes shifts greater 
than 80 nm are of considerable interest because the reabsorption of photons is 
minimized,
1
 which have applications in quantitative determination, bioimaging, and 
fluorescence assay.
91,93
 Moreover, there are disadvantages of fluorophores with low 
Stokes shifts, such as self-quenching and measurement error by both excitation and 
scattering light.
94
 The results imply that a stronger electron accepting central core leads to 
a smaller Stokes shift regardless of the conjugation length. In addition, increasing 
conjugation length on a single pendant arm resulted in a larger Stokes shift. This is 
significant as it indicates that the Stokes shift of a fluorophore can be tailored. The 
smaller Stokes shift of 5 can be directly related to the electron accepting properties of the 
difluoroboron β-diketonate heterocyclic core. Such inclusions lead to a smaller geometry 
relaxation of the molecular framework when excited.
95 
The geometry of the S1 state is 
more similar to the geometry of the So state. Hence, the emission energy is not 
significantly lower than the excitation energy, which results in a reduced Stokes shift. On 
the contrary, 4 had the largest Stokes shift. The large Stokes shift of 4 indicates a large 
vibrational, electronic, and geometric difference in the excited state reached immediately 
after absorption.
91,96
 
The optical properties of the fluorophores were further examined by investigating the 
excited-state dynamics utilizing time-resolve spectroscopy.  Emission dynamics can be 
utilized to understand the fluorophore as the fluorescence lifetime is sensitive to the 
environment and local motion of the fluorophore.
75
 As shown in the results, the 
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fluorescence lifetime decreases as the electron accepting properties of the core is 
increased in the case of the fluorophores without increased conjugation on the pendant 
arms. It is important to note that the fluorescence lifetime did not always correlate with 
the quantum yield. For example, 5 displayed the fastest lifetime (10.6 ps) although the 
quantum yield (Φ = 0.009) was the largest while 4 exhibited a significantly longer 
lifetime (30.6 ps), but yielded a slightly lower quantum yield (Φ = 0.006). The 
incorporation of a difluoroboron β-diketonate core led to a faster fluorescence lifetime 
regardless of conjugation length. This can be rationalized due to the increase in the 
competing radiative pathways because of the stronger electron acceptor core. Since the 
fluorescence lifetime increases with increasing ICT character,
69
 the difluoroboron β-
diketonate core likely causes a weaker ICT, leading to a faster fluorescence decay. 
Interestingly, 8 did not follow the trend. It is also important to note that increasing 
conjugation length on a single pedant arm resulted in a longer-lived fluorescence lifetime 
as shown with both 2 and 6. These observations can be explained by the electronic 
structure calculations.  
 The trends in the excited-state dynamic studies can be rationalized by interpreting the 
electronic structure calculations. As noted, in the case of the fluorophores with the same 
structural motif, a decrease in the fluorescence lifetime was observed as the electron 
accepting properties of the central heterocyclic core was enhanced with the exception of 
8. This can be explained by the ICT character of the molecule, which is due to the 
relaxation of the excited state by twisting of a single bond between the donor and 
acceptor moieties. It has been reported that ICT states may lead to charge separation by 
structural reorganization, which is an irreversible process.
97
 Additionally, maximum 
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charge separation occurs between the donor and acceptor moieties of a molecule because 
of minimum overlap of the orbitals.
69
 The difference in the charge separation affects ICT 
character, which can influence the fluorescence lifetime as shown in the results. By 
comparing the fluorophores without increased conjugation length on the pendant arms, 4 
displayed the longest fluorescence lifetime while 5 exhibited the fastest fluorescence 
lifetime. Illustrated in the electronic structure calculations, the HOMO of 4 was mainly 
localized on a single pendant arm whereas the HOMO was more delocalized for 5, which 
indicates that 4 exhibits more ICT character. As a result, the fluorophore with greater ICT 
character will exhibit a longer fluorescence lifetime.  
Although the central core of 3 is a weaker electron acceptor, 8 surprisingly displayed 
the longest long-lived fluorescence decay in the case of the fluorophores that possess 
increased conjugation length on both pendant arms. Represented in the electronic 
structure calculations, 8 exhibited significant ICT character as the HOMO was localized 
on a single pendant arm, which explains the fluorescence lifetime results. 
Dicyanomethylene pyran derivatives have been extensively studied as dopants for 
organic light emitting diodes (OLED).
98–100 8 is a symmetric derivative of 4-
(dicyanomethylene)-2-methyl-6-(4-dimethylaminostyryl)-4H-pyran (DCM), which is a 
well-known laser dye. The dicyano group possesses strong electron accepting properties. 
Additionally, the pyran ring is electron deficient, which can act as an auxiliary 
acceptor.
101
 The symmetric structure of 8 indicates that it has two ICT routes. This infers 
that 8 has two excited states with similar energy levels. The low quantum yield of 8 (Φ = 
0.002) suggests that the fluorescence emission solely originates from the ICT from the 
donor to the acceptor moieties.
102 Upon excitation, the first locally excited state is 
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reached, which is non-emissive. The ICT state is then reached, which leads to enhanced 
charge separation.
103
 The electronic structure calculations correlated with the 
experimental data, which implies that both enhanced ICT character and charge separation 
lead to a longer fluorescence lifetime.   
 
While increasing conjugation length between the donor pedant arms and acceptor 
central core led to a bathochromic shift in the absorption, the TPA cross-section of the 
unbound fluorophores increased with increasing conjugation length. The increase in the 
TPA cross-section was more than an order of magnitude greater when comparing the 
fluorophores containing the same electron accepting core with and without increased 
conjugation length on both pendant arms. These implications suggest that the transition 
dipole increases with increasing conjugation length, which can be rationalized by the 
electronic structure calculations. Summarized in Table 4.6, the ground state and transition 
dipole moments were calculated. It has been reported that the TPA cross-section is 
dependent on the transition dipole moment of a molecule.
104
 In the case of the 
fluorophores that possess a pyrimidinol and difluoroboron β-diketonate core, the 
transition dipole increased with increasing conjugation length. It has been shown that, in 
general, extending π-conjugation leads to a larger TPA cross section.101 Additionally, it 
has been previously reported that molecules with a donor-π-acceptor-π-donor motif 
exhibit high TPA activity.
17,105,106
 This suggests that there is stronger electronic coupling 
between the pendant arms and central heterocyclic core for the fluorophores that possess 
increased conjugation length, which gives rise to a larger TPA cross-section.
107,108
 
Interestingly, the TPA cross-section of 8 was more than a magnitude higher than 4 
although the calculated transition dipoles were similar. However, the ground state dipole 
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of 4 and 8 were significantly different. It has been reported that TPA cross-section is 
dependent on the nature of the ground state and excited state.
109
 Therefore, the difference 
in the TPA cross-section between 4 and 8 can be attributed to the ground state and 
transition dipole moments as well as the conjugation length. Moreover, the steady-state 
absorption spectra can serve as an effective representation relative to the TPA cross-
sections. As detailed in Figure 2A, 8 demonstrated greater absorption at 400 nm 
compared to 4. The TPA cross-section measured at 800 nm is attributed to the S0 → S1 
electronic transition for 4. On the contrary, the TPA cross-section of 8 is due to the S0 → 
Sn electronic transition. This assignment seems probable because 8 exhibited a bimodal 
absorption band with the higher energy absorption band near 400 nm whereas 4 displayed 
a single absorption band. Hence, it is likely that these electronic transitions are also 
contributing to the dramatic contrast in the TPA cross-sections.  
CD spectroscopy was employed to investigate the DNA-binding interactions of the 
fluorophores. Overall, the positive ICD bands correspond well with the absorption bands, 
which can be assigned to the transition along the long axis of the molecule.
61
 
Interestingly, all the fluorophores displayed a bisignate shape in the presence of DNA 
with the exception of 8. Because of this, it is difficult to determine the DNA-binding 
mode with solely the use of CD. An major issue with CD is that the DNA-binding mode 
cannot be determined unambiguously without the inclusion of other techniques.
10
 In 
previous reports, it has been noted that the common methodologies, such as CD and LD, 
to evaluate the DNA-binding must be made with caution because a combination of 
selected methods only provides sufficient information to determine the DNA-binding 
mode.
11,110,111 In particular, the direction of the transition dipole must be known in order 
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to provide detailed information regarding the orientation of the fluorophore relative to the 
DNA structure by CD.
6
 In order to better understand the DNA-binding mechanism, our 
developed TPA methodology was implemented.  
The DNA-binding mode of the fluorophores that possess a difluoroboron β-
diketonate core could not be determined unambiguously by only CD. Therefore, TPA 
was employed to investigate the DNA-binding mechanism. TPA can provide valuable 
information that is inaccessible with steady-state spectroscopy. The TPA cross-section is 
directly proportional to the square of the transition dipole moment and change of the 
static dipole moment after excitation. Hence, TPA can detect changes in environmental 
conditions, charge transfer character, and excited-dipoles with high sensitivity.
25
 Many 
factors play an important role on the TPA cross-section, such as conjugation length, 
molecular planarity, efficiency of intramolecular charge transfer (ICT), vibronic 
coupling, properties of charge transfer network, and electron donating and accepting 
properties.
17,112
 In our previous report, it was shown that the local DNA electric field can 
influence the transition dipole of the binding molecules, which affects the TPA cross-
section of the fluorophore upon DNA binding.
34
 As shown in the results, 5 and 6 
displayed an overall decreasing TPA cross-section trend as the concentration of DNA 
was increased, indicating that the fluorophores are intercalating with DNA. This is 
critical as it illustrates a major drawback of CD to determine the DNA-binding mode of 
small organic molecules whereas our TPA approach can determine the DNA-binding 
mode unambiguously. This is important if the direction of the transition dipole of the 
fluorophore is unknown since it is required to assess the DNA-binding mode by CD. 
Another issue with CD is that the signal indicative of an intercalating binding mode may 
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not be observed because a stronger, more intense signal due to other interactions, such as 
aggregation, can overwhelm the intercalating signal.
113
 
Based on the results, it was confirmed that an induced change in the DNA-binding 
mode can be achieved by varying the electron accepting properties of the central 
heterocyclic core while conjugation length between the electron donor arms and electron 
acceptor core did not influence the DNA-binding mode. This is significant as crescent 
shaped DNA-binding molecules have been reported to groove bind with DNA because 
they can match the curvature of the DNA groove for binding.
30
 Herein, we demonstrated 
that crescent shaped molecules can bind with DNA through intercalation, which does not 
obey the classical model for groove binding. This is in strong contrast to other 
intercalative binding molecules as they generally adopt planar structural scaffolds. The 
induced change in the DNA-binding mode can be explained by the charge-transfer 
interactions between an intercalator and DNA nucleobases. Previous calculation studies 
have shown that intercalators, such as ethidium bromide, are good electron acceptors that 
exhibit large charge delocalization while DNA base pairs are good electron donors.
81
 As 
the electron accepting properties of the central heterocyclic core is increased, we observe 
an induced change in the DNA-binding mode from groove binding to intercalation by 
modifying the hydroxypyrimidine to a difluoroboron β-diketonate central core. This 
implies that intercalating molecules are not only stabilized by interactions, such as 
electrostatic and dispersion interactions, but also charge-transfer contributions.
81
 Charge-
transfer reactions can occur over short distances (on the order of Angstroms),
114
 which 
provide evidence of charge-transfer interactions between the DNA nucleobases and 
intercalating fluorophore. This is significant as it suggests that the DNA-binding mode 
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can be tailored by modifying the electron accepting properties of the central heterocyclic 
core. Based on these conclusions, one would elucidate that 8 would bind with DNA 
through intercalation. Although the electron accepting properties of the central core is 
increased for 8, the experimental data indicates that the fluorophore does not bind with 
DNA. 
The findings substantiate that 8 is neither intercalating nor groove binding with DNA. 
Narrowing of the emission band was not noted as well as a low fluorescence 
enhancement (1.3-fold) in the presence of DNA support the claim that 8 is not binding 
with DNA. Moreover, an ICD signal was not detected for 8 in the presence of DNA. This 
implies that the fluorophore is not binding with DNA, but rather electrostatically 
interacting with DNA. This was further supported by the anisotropy data as 8 exhibited a 
rotational correlational time of 2.3 ns in the presence of DNA, suggesting some sort of 
interaction between the fluorophore and DNA. The N-methylpiperazine recognition units 
can electrostatically interact with the negatively charged DNA helical axis. The results 
confirm that the dicyanomethylene pyran core is responsible for 8 not binding with DNA 
since 3 and 7 were found to bind with DNA. The required interactions for DNA-binding 
with the DNA nucleobases, such as van der Waals and/or hydrogen bonding interactions, 
is directly due to the dicyanomethylene pyran preventing these interactions. It has been 
reported that the orientation of a molecule upon binding with DNA can be directly related 
to the electrostatic and steric effects.
81
 Thus, the dicyanomethylene substituent may 
undergo steric hindrance with the DNA nucleobases, which does not allow the 
fluorophore to fit in the groove or pocket of DNA.  
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The performance of the fluorophores was evaluated by carrying out a series of bio-
imaging experiments. Several TPA active molecules are not biocompatible due to poor 
water solubility or form non-fluorescent aggregates in aqueous solution. Therefore, water 
soluble DNA-binding fluorophores that demonstrate TPA properties are consequently 
rare.
115 
Water soluble fluorophores that exhibit TPA properties with large upconversion 
fluorescence yields have attracted considerable interest in the development of fluorescent 
probes towards biological applications. The results indicate that 1 is the most suitable for 
biological applications because of the reasonable Stokes shift (5790 cm
-1
) and large 
fluorescence fold increase (74-fold) upon binding with DNA. Additionally, 1 was 
previously reported to exhibit low cytotoxicity, sufficient photostability, and possess high 
water solubility.
31
 Based on the bio-imaging experiments, 1 displayed a high signal-to-
noise ratio as well as low cytoplasm staining. The staining of the nuclei was pronounced 
and distinguishable compared to the remaining fluorophores. Consequently, 1 offers 
significant advantages over commercial fluorescent nuclear dyes. Although 4 
demonstrated the largest TPA cross-section enhancement upon binding with DNA, the 
staining contrast between the nuclei and cytoplasm was not as predominant. In addition, 
an issue with 4 is that the maximum absorption is near 352 nm in the presence of DNA. 
As a consequence, 4 requires a higher energy excitation wavelength, which is undesirable 
for bio-imaging applications requiring single-photon excitation. In particular, 1 
demonstrated promising bio-imaging properties, suggesting that it can be used as an 
invaluable tool to detect and monitor regions of DNA, which opens further applications. 
 
 
147 
 
4.6 Conclusion 
In summary, we developed a design strategy that allows tailoring of the DNA-binding 
mode by investigating a series of novel fluorescent nuclear dyes that exhibit high turn 
on/off sensitivity upon binding with DNA. Steady-state spectroscopy, nonlinear ultrafast 
spectroscopy, and electronic structure calculations were employed to examine the optical 
properties and DNA-binding interactions of the fluorophores. The findings imply that the 
optical properties can be finely tuned by varying the conjugation length as well as the 
electron accepting properties of the central heterocyclic core. Moreover, bio-imaging 
experiments were carried out to evaluate the performance of the fluorophores by confocal 
fluorescence microscopy in which 1 was found to possess excellent properties towards 
bio-imaging applications.  
By investigating the DNA-binding mechanism, a structure-property relationship was 
established for DNA-binding molecules that adopt a crescent donor-acceptor-donor 
motif. The results reveal that the DNA-binding mode can be tailored by implementing 
structural modifications to the central heterocyclic core. This was achieved by simply 
replacing the central heterocyclic core from a pyrimidine-based moiety with a 
difluoroboron β-diketonate moiety, which induced a change in the DNA-binding mode 
from groove binding to intercalation, respectively. While increasing conjugation length 
between the electron donating arms and electron accepting core of the fluorophore did 
not induce a change in the DNA-binding mode, this implies that the central heterocyclic 
core plays a critical role in the DNA-binding mechanism. This is the first report that has 
demonstrated structure-property relationships for a design strategy where the DNA-
binding mode can be tailored in the case of DNA-binding molecules that possess a 
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crescent donor-acceptor-donor motif. The impact of this work opens new strategies for 
the design and development of therapeutics targeted at DNA as their performance is 
dependent on the DNA-binding mechanism. 
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Chapter 5 
Photophysical Investigation and Imaging of Sox-Based Fluorescence Chemosensor 
Peptide for Kinase Activity with Continuous Real-Time Analysis in Live Cells 
 
 
5.1 Explanation 
The objective of this project was to examine the activity of kinase enzymes with 
continuous real-time analysis in live cells. This project was done in collaboration with 
Prof. Barbara Imperiali at Massachusetts Institute of Technology. In order to accomplish 
this task, a custom fluorescent labeled peptide was implemented that allowed kinase 
activity to be monitored. This is the first example that has demonstrated a continuous 
real-time analysis of kinase activity in live cells. This work is significant as it allows for 
the study of kinase activity at physiological conditions, which is critical for drug research 
and development. Abnormal kinase activity has been associated with several disorders, 
such as cancer and diabetes. Therefore, it is important to better understand the activity of 
kinase enzymes because they are essential in nearly all biological processes. The work 
presented in this chapter is the preliminary results. The project will be resumed by a new 
graduate student. 
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5.2 Introduction 
Signaling in biological systems is critical for many cellular and biological processes, 
which are regulated by protein phosphorylation. Such processes are complex and 
strategically orchestrated by diverse cellular species. More importantly, signaling 
cascades are important for cellular function, such as mediating cell proliferation and 
apoptosis.
1
 The transmission of signal is continued through a series of biochemical 
changes within the cell or cell membrane. A major component of cellular signaling is to 
control and maintain normal physiological equilibrium within the cell. Thus, many 
diseases are directly related to an abnormal cellular signaling process. Because of their 
complexity, understanding these processes remains a challenge in biochemistry.  
 
 
Figure 5.1. Signaling pathways of a cell.
 
 
In order to treat disorders and diseases, several biological and cellular processes have 
been examined. One process of considerable interest is targeting protein kinases, which 
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have become major targets for therapy. Kinases are enzymes that are responsible for 
phosphorylating peptides and proteins, which can modify their functions. It has been 
shown that protein phosphorylation regulates various cellular functions, such as cell 
proliferation, metabolism, motility, and apoptosis.
2
 Therefore, disruption of protein 
phosphorylation can alter cellular functions, thus leading to severe disorders. Over 500 
types of kinases are known to exist in the human genome in which 478 are typical and 40 
are atypical.
3
 Typical kinases are divided into those that phosphorylate serine, threonine 
or tyrosine residues. On the other hand, atypical kinases have been reported to exhibit 
biochemical kinase activity, but lack sequence similarities to the conventional eukaryotic 
kinases.
3
 The phosphorylation process is essential for cellular communication and 
signaling. In particular, protein substrate phosphorylation can have pronounced effects on 
many biological and cellular processes. For example, phosphorylation can lead to enzyme 
activation and deactivation as well as the development of sites for other biological 
entities.
2
 A major component of cellular signaling is to control normal physiological 
balance within the cell. Thus, many diseases are directly related to an abnormal cellular 
signaling process. Oncology drug discovery has significantly benefited from 
understanding kinase activity. In fact, kinase inhibitors are currently being studied as new 
therapeutics aimed at cancer.  
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Figure 5.2. Cartoon representation of kinase enzymes.  
 
In general, kinases consist of nearly 250 amino acids, which are composed of β-sheets 
at the N-terminus and α-helices (20 – 35 residues) at the C-terminus as illustrated in 
Figure 5.2.
3
 The phosphorylation of the peptide/protein substrate takes place at the 
phosphorylation-site or P-site. In order for the phosphorylation process to occur, ATP 
binds to the cleft between the β-sheets and α-helices in which the adenosine moiety is 
buried in the hydrophobic pocket with the phosphate moiety directed away from the 
enzyme. The protein prone to phosphorylation binds along the cleft at a specific site of 
residues. The γ-phosphate of ATP is then transferred to the amino acid undergoing 
phosphorylation (Ser, Thr, Tyr). In the active conformation, the α-helix packs against the 
N-terminal lobe and the aspartate of the DFG (Asp-Phe-Gly) motif chelates to Mg
2+
 to 
orientate ATP for phosphorylation as depicted in Figure 5.3. In the inactive 
conformation, this interaction is disrupted so that the phenylalanine of the DFG motif is 
directed towards the ATP site.
4
 The specificity of the kinase to phosphorylate a specific 
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residue is based on the depth of the catalytic cleft. Tyr-specific kinases have deeper 
catalytic clefts compared to Ser/Thr kinases. However, it is important to note that the P-
site is not always specific. For example, there have been reports where Ser/Thr kinases 
phosphorylate Tyr residues whereas the opposite is consequently rare.
5
  
 
Figure 5.3. DFG motif location on kinase enzyme. These residues are responsible for 
preparing ATP for phosphorylation.  
 
 
Peptide and protein phosphorylation is one of the most important and vital 
mechanism for cellular signaling and communication.
6
 Kinases are responsible for 
protein phosphorylation, which initiate and relay phosphorylation signals in intracellular 
pathways. This cycle is catalytic and very complex as detailed in Figure 5.4. Most 
kinases display specificity for the regions near the phosphorylation site or require 
recognition sites. The preference in recognition regions allows the kinase to fit and mold 
the region of the protein substrate. The transfer of the phosphoryl group is relatively 
simple, but is dependent on the correct orientation of the kinase, protein substrate, γ-
phosphate of ATP, and hydroxyl substituent on the residue prepared for 
phosphorylation.
4
 Interestingly, it has been reported that Mg
2+
 is required for 
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phosphorylation to stabilize the negative charge that is developed the bridging oxygen.
7
 
The transfer of the phosphoryl group is comprised of three steps: (i) orientation of the 
kinase and protein substrate; (ii) nucleophilic attack by the substrate hydroxyl substituent; 
(iii) acid catalysis for the proton transfer.
4
 The kinase activity is very complex, but was 
simplified for our purpose. In fact, many human diseases, especially cancer, are 
associated with abnormal protein phosphorylation.
8
 Hence, understanding kinase activity 
or protein phosphorylation is important for the development of therapeutic drugs. 
Additionally, kinase inhibitors are of interest for the development of cancer related 
drugs.
9
 In order to investigate protein kinase activity, sensors provide a means to 
elucidate protein-kinase interactions and allow for screening of potential therapeutics.  
 
 
Figure 5.4. (Top) Catalytic cycle of kinase phosphorylation of peptide/protein substrate 
and (bottom) simplified schematic diagram of protein kinase mechanism.
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Traditional methods have been employed to examine protein kinase activity, such as 
the use of radioactive-based assays where the phosphoryl transfer from [γ-32P]ATP to a 
substrate or protein is quantified by scintillation counting. An issue with this approach is 
that it requires handling of radioactive material and is not practical for high-throughput 
applications. Another limitation is that the method is a discontinuous assay, meaning that 
it cannot be used for real-time analysis. Furthermore, radioactive-based assays require 
significantly lower concentrations of ATP (10 – 50 μM), which reduces the activity of 
most kinases, leading to poorer resolution and sensitivity as well as the loss of kinetic 
information.
10
 Understanding kinase activity at physiological conditions is critical for 
drug research and development. The process of employing such assays are time-
consuming as require immunopurification of the kinase from cell lysates and the proper 
disposal of radioactive material.
11
 Other approaches to monitor and examine kinase 
activity are of considerable interest. 
Continuous fluorescence-based assays are desirable because they can extract 
information relative to kinase activity with continuous real-time analysis. These assays 
can be used for high-throughput screening and the detection of kinase activity in cell 
extracts as well as examining spatial and temporal localization of kinase activity in 
vitro.
12
 Many continuous assays used to examine kinase activity have been reported, such 
as the use of fluorescence-based fluorophores adjacent to the phosphorylated residue
13-15
 
that take advantage of the conformation change of the substrate upon 
phosphorylation.
16,17
 However, these assays demonstrate low fluorescence changes, 
limiting their applicability. Hence, there remains a considerable challenge for the 
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development of fluorescence-based assays that demonstrate high sensitivity to monitor 
kinase activity. 
A chelation-sensitive fluorophore 8-hydroxy-5-(N,Ndimethylsulfonamido)-2-
methylquinoline (Sox) integrated into a peptide substrate via solid-phase peptide 
synthesis (SPPS) was previously reported for the detection of divalent metals.
18
 The Sox 
fluorophore demonstrates significant fluorescence enhancement in the presence of a 
divalent metal based on chelation enhanced fluorescence (CHEF). The Sox fluorophore 
or residue was used to develop a fluorescence-based approach to monitor kinase 
phosphorylation.
12
 This versatile chemosensing strategy is utilized for the detection of 
serine, threonine, and tyrosine phosphorylation located on the N- or C-terminus of the 
kinase recognition motifs. The kinase recognition motifs can be tuned to target specific 
kinases. The Sox residue is separated from the amino acid prone to phosphorylation by a 
β-turn sequence, which generally consists of two or three residues. Upon 
phosphorylation, the turn sequence promotes a chain reversal in the peptide backbone, 
which allows the chelation between the Sox fluorophore and phosphorylated residue 
introduced by the kinase with the divalent metal resulting in fluorescence enhancement. 
The schematic representation of the Sox-labeled peptide is shown in Figure 5.5.  
 
 
Figure 5.5. Schematic representation of Sox-labeled peptide for probing kinase activity. 
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In this work, we investigated the protein kinase activity utilizing a Sox-labeled 
peptide as a chemosensor. Steady-state and ultrafast nonlinear spectroscopies were 
employed to further examined the kinase activity. Additionally, we examined the kinase 
activity in live cells by conducting a series of bio-imaging experiments. The findings 
indicate that the Sox-labeled peptide can provide valuable information at physiological 
conditions.  
 
5.3 Results and Discussion  
The first step in this project was to investigate the steady-state properties of the Sox-
peptide. We investigated the photophysical properties of the phosphorylated peptide 
(JNKP19). The absorption and emission spectra of JNKP19 in the absence and presence 
of Mg
2+
 are shown in Figure 5.6. In regards to the absorption spectra, a bathochromic 
shift approximately 50 nm was noted when Mg
2+
 was added to the system. This is due to 
energy transfer from the donor (Sox chromophore) to the acceptor (Mg
2+
), which is 
typical of a donor-acceptor system. In terms of the emission spectra, the fluorescence was 
quenched in the absence of Mg
2+
. In the presence of Mg
2+
, a significant fluorescence 
enhancement was noted, which indicates that the Sox-peptide is highly sensitive. A 
fluorescence increase of over 30-fold was noted upon the addition of Mg
2+
.  
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Figure 5.6. (A) Absorption and (B) emission spectra of JNKP19 in the absence (- - -) and 
presence (−) of 10 mM MgCl2.  
 
The fluorescence enhancement of the Sox fluorophore in the presence of a divalent 
metal, such as Mg
2+
 is due to the chelation enhanced fluorescence (CHEF) as 
summarized in Figure 5.7. In the absence of a divalent metal, the relaxation process of the 
electron in the excited state to its original ground state is prohibited. Instead, an electron 
from free receptor or lone pair is transferred to the ground state, resulting in quenched 
fluorescence. This event is also known as the photoinduced electron transfer (PET) effect. 
In the presence of a divalent metal, the quenching lone pair from the Sox fluorophore can 
chelate with the metal. As a result, the energy of the bound receptor or lone pair is 
reduced below the energy of the ground state of the fluorophore. In other words, the 
electron from the bound receptor cannot interfere with the relaxation process of the 
electron in the exited state, negating the PET effect. This allows the electron from the 
excited state to return back to the ground state, which results in fluorescence due to the 
CHEF effect.  
 
A B 
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Figure 5.7. (a) Fluorescence quenched in the absence of a divalent metal due to the PET 
effect. (b) Fluorescence enhancement in the presence of a divalent metal due to the CHEF 
effect. 
 
After our initial investigation, we examined the phosphorylation process of the kinase 
enzyme by employing the unphosphorylated Sox-labeled peptide (JNKS19). The steady-
state spectra of JNKS19 and JNKP19 in the presence of 10 mM Mg
2+
 is presented in 
Figure 5.8. For JNKS19, a band near 320 nm was noted, which was not observed for 
JNKP19. This is likely due to the fluorophore chelating with Mg
2+
 in the absence of the 
phosphoryl. The chelation of the phosphoryl group contributes to a greater chelation 
enhancement of the Sox fluorophore, leading to the reduction of the absorption band near 
320 nm for JNKS19. A fluorescence enhancement of approximately 5-fold was noted 
when the Sox labeled peptide is phosphorylated. This change in fluorescence will allow 
us to monitor the phosphorylation process.  
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Figure 5.8. (A) Absorption and (B) emission spectra of JNKS19 (red) and JNKP19 
(black) in the presence of 10 mM MgCl2.  
 
The phosphorylation process was monitored by employing JNKS19. The reaction was 
carried out at conditions of 50 mM Tris (pH 7.4), 10 mM MgCl2, 1 mM EGTA, 2 mM 
DTT, 0.01% Brij-35P, 0.4 mM ATP, 2 μM JNKS19, and 0.2 ng/μL JNK2 recombinant 
enzyme. As shown in Figure 5.9, fluorescence measurements were collected every 5 min. 
The fluorescence did not change after 150 min, indicating that the peptide has become 
fully phosphorylated. This demonstrates that JNKS19 can be used as a kinase assay to 
monitor and detect kinase activity with continuous real-time analysis.  
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Figure 5.9. The fluorescence of JNKS19 was monitored as a function of time in the 
presence of JNK2, ATP, and MgCl2.  
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After demonstrating that JNKS19 can be utilized to monitor kinase activity, our 
objective was to investigate kinase activity in live cells. In general, cell lysates or extracts 
are used to examine the activity of enzymes in vitro. However, there remain several 
limitations with this methodology. First, the addition or inclusion of inhibitors is required 
to improve sensitivity and specificity.
10
 Another issue using cell lysates is that the kinase 
activity cannot be monitored at physiological conditions. This is critical when examining 
newly developed drugs as its efficacy and activity can change if environmental conditions 
are varied. Finally, cell-based studies can simultaneously assay for compound 
characteristics, such as efficacy, toxicity, and cell permeability. 
 
The first goal of this project was to transfect HeLa cells with a control fluorescein-
labeled antibody to demonstrate our technique. This was accomplished by transfecting 
the cells using the BioPORTER transfection or protein delivery kit. 2.5 μL of transfection 
reagent was added to a centrifuge tube. The solvent was allowed to evaporate for 2 h to 
form a film. 10 μL of 100 ng/mL of the control fluorescein-labeled antibody was added 
and allowed to incubate at room temperature for 5 min. 250 μL of DMEM (serum-free 
and antibiotic-free) was added the centrifuge tube. The cells were incubated with the 
mixture for 4 h. The cells were imaged using confocal microscopy as shown in Figure 
5.10. The cells exhibit little to no autofluorescence with an excitation wavelength of 490 
nm. Clearly, fluorescence was detected after transfecting the cells with the control 
protein, verifying the successful transfection of the control fluorescein labeled protein.  
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Figure 5.10. Confocal microscopy image of cells (A) before and (B) after transfection of 
fluoreceine labeled goat antibody. λex = 490 nm. 
 
After demonstrating our transfection technique, JNKP19 was transfected into the cells 
as presented in Figure 5.11. It was rather difficult to determine if the peptide was 
successfully transfected due to the autofluorescence from the cells. There are several 
issues with the Sox-peptide. First, the excitation and emission wavelength is approximate 
to the organelles in the cells. The major contribution of autofluorescence is due to 
NAD(H) in the cytoplasm. Additionally, the granules are attributed to NAD(H) 
concentrated in the mitochondria.
20
 Another issue with the Sox-labeled peptide is that it is 
dependent on the concentration of intracellular Mg
2+
. Because of this, the sensitivity of 
the peptide was investigated at lower concentrations of Mg
2+
 (Figure 5.12). It is 
important to note that the fluorescence did not change significantly until 1 mM of MgCl2 
is reached. This indicates the Sox-peptide is not sensitive a sub-millimolar 
concentrations. It has been reported that the intracellular concentration of magnesium in 
live cells range from 5 – 20 mM with 1 – 5 % ionized or free magnesium.21 This suggests 
that the peptide is not sensitive at our experimental conditions. Thus, an increase in the 
A B 
169 
 
intracellular concentration of magnesium may be required to increase the sensitivity of 
the Sox-peptide.   
  
Figure 5.11. Confocal microscopy image of cells (A) before and (B) after transfection of 
JNKP19. λex = 780 nm. 
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Figure 5.12. Fluorescence change of JNKP19 (5 μM) at varied concentrations of MgCl2. 
 
A B 
170 
 
Ionophores are chemical compounds used to transport ions across membranes,which 
work by reversibly binding with ions that are later transported in/out of the cell. There are 
two types of ionophores. First, carrier ionophores bind to specific ions while shielding its 
charge from the local environment, allowing the ions to bypass the membrane.
22
 Second, 
channel ionophores work by introducing a hydrophilic hole in the cell membrane that 
allows the ions to travel across the membrane.
23
 In order to increase the intracellular 
concentration of ions within the cell, the medium must contain a higher concentration of 
ions than the cell. A23187 ionophore was used to increase the intracellular concentration 
of magensium. This ionophore was selected because it has been extensiviely studied and 
exhibits low cytotoxicity. The ionophore forms stable 2:1 complexes with divalent 
metals, such as magenisum and calcium
24
 to transport them across the membrane. In fact, 
the ionophore shields the charge of the ions, rendering them soluble in organic solvents. 
Although the ionophore increases the intracellular concentration of magensium, there 
remain issues with the autofluorescence from the cells.  
In order to distinguish between the Sox-peptide from the autofluorescence, 
fluorescence lifetime imaging microscopy (FLIM) was employed. As noted above, a 
majority of the autofluorescence is due to NAD(H). The fluorescence lifetime of JNKP19 
was examined at various concentrations of MgCl2 as shown in Figure 5.13. The 
fluorescence lifetimes are summarized in Table 5.1 The shorter component is relatively 
the same regardless of the concentration of MgCl2, which is likely due to the non-
chelated Sox-fluorophore. The longer component is attributed to the Sox-fluorophore 
bound with Mg
2+
. The longer component of JNKP19 is not significantly different than the 
autofluorescence from the cell until approximately 1 mM MgCl2 is reached. This 
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suggests that FLIM can only be used to distinguish between the autofluorescence from 
the bound NAD(H) and JNKP19 if a high enough concentration of intracellular Mg
2+
 is 
achieved.  
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Figure 5.13. Fluorescence lifetime decay of JNKP19 at various concentrations of MgCl2.  
 
 
Table 5.1. Summarized fluorescent lifetime of JNKP19 at various concentrations of 
MgCl2. 
[MgCl2] (mM) τ1 (ns) τ2 (ns) 
0 0.20 2.2 
0.1 0.21 2.8 
0.25 0.22 3.1 
0.5 0.23 2.9 
1 0.22 4.5 
2 0.22 6.1 
5 0.21 7.3 
10 0.21 8.6 
 
The FLIM images from the autofluorescence of the control cells were compared to 
the cells transfected with JNKP19. The lifetime distribution is nearly identical, which 
indicates that either the JNKP19 peptide was not delivered into the cell or the 
concentration of Mg
2+
 is not high enough to differentiate between the fluorescence 
172 
 
lifetimes. As a consequence, A23187 ionophore was employed to increase the 
intracellular concentration of divalent metals. Interestingly, small localized spots with a 
lifetime of nearly 2.2 ns were noted. The lifetime of the A23187 ionophore was found to 
be 2.4 ns by TCSPC. Hence, these localized bright spots are due to the A23187 
ionophore. A notable shift in the distribution of the lifetime was observed when 
comparing the blank cells to the JNKP19 transfected cells in the presence of the 
ionophore. The average lifetime of the blank cells was nearly 2.0 ns while the average 
lifetime of the transfected cells was approximately 3.1 ns. In order to determine if the 
ionophore is causing an increase in the fluorescence lifetime, the cells were incubated in 
the presence of only the ionophore. The fluorescence lifetime of the cells containing only 
the ionophore was similar to cells transfected with JNKP19 and incubated with the 
ionophore. It is difficult to determine if JNKP19 was delivered into the cells.  
It was reported that a majority of the autofluorescence from cells originates from 
NAD(P)H with a lifetime of 0.4 – 0.5 and 2.0 – 2.5 ns in the unbound and bound form, 
respectively.
25
 The granules in the FLIM images from the autofluorescence are due to 
NAD(P)H found in the mitochondria.
26
 Preliminary experiments were conducted before 
carrying out the FLIM experiments. The fluorescence lifetime of JNKP19 was measured 
at various concentrations of Mg
2+
 utilizing time-correlated single-photon counting 
(TCSPC). The long component increased from 2.9 ns to 4.5 ns when the concentration of 
MgCl2 was increased from 0.5 mM to 1 mM. The short component of JNKP19 did not 
change significantly, regardless of the concentration of MgCl2. This indicates that the 
short component is likely attributed to the non-chelated Sox-fluorophore. Based on the 
lifetimes of JNKP19, an ionphore will be required to increase the intracellular 
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concentration of divalent metals. The fluorescencc lifetime of the A23187 ionophore was 
examined by employing TCSPC. A23187 ionophore exhibited a short and long 
component of 0.5 and 2.4 ns, respectively. 
 
  
  
Figure 5.14. FLIM images of cells incubated with ionophore A23187 in the (A) absence 
and (B) presence of JNKP19. The cumulative histogram of fluorescence lifetime values 
are shown below the images.  
 
 
In order to confirm the delivery of JNKP19 into the cell, FLIM imaging experiments 
were carried out with the cells incubated in the presence of the ionophore. We were 
concerned that an increase in divalent metals can interfere with other cellular processes, 
thus increasing the overall lifetime of the blank cell. The FLIM images of blank cells 
incubated with the ionophore are shown in Figure 5.14. Based on the images and 
fluorescence lifetime histogram distribution, it is difficult to determine if the Sox-peptide 
was successfully delivered into the cell. Because of this, we decided to move away from 
A B 
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using the ionophore as it may interfere with other biological processes. Ultimately, our 
objective was to monitor protein phosphorylation at physiological conditions, which will 
require the absence of an ionophore. As demonstrated, the ionophore can cause a 
significant change in the biological environment.  
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Figure 5.15. Fluorescence dynamics of JNKP19 at varying peptide concentrations. 
Experiments were carried out at pH = 7.4 and 1 mM MgCl2. 
 
 
  
Figure 5.16. FLIM images of HeLa cells transfected (A) without and (B) with 16.6 μM 
JNKP19. 
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Figure 5.17. Cumulative histogram of fluorescence lifetime values of cells transfected 
with various concentrations of JNKP19.  
 
A new approach was required to determine if JNKP19 was successfully delivered into 
the cells. Before the FLIM experiments were carried, the fluorescence lifetime of 
JNKP19 at varying concentrations was investigated by TCSPC as shown in Figure 5.15. 
It is important to note that the concentration of MgCl2 was held constant at 1 mM with a 
pH of 7.4. Interestingly, the fluorescence lifetime increased with increasing peptide 
concentration, indicating that FLIM could be employed to determine if the peptide could 
be delivered into the cells. The cells were transfected with various concentrations of 
JNKP19 and imaged by FLIM as shown in Figure 5.16. However, it is difficult to 
determine if the peptide was delivered into the cell based on the pseudocolor lifetime 
distribution key. Because of this, the cumulative histogram of fluorescence lifetime 
obtained from the FLIM images were examined as presented in Figure 5.17. As 
illustrated, the fluorescence lifetime histogram shifts as the incubation concentration of 
JNKP19 is increased, indicating that the peptide is successfully transfected into the cells. 
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This demonstrates that the transfection kit was compatible with the Sox-peptide. This is 
significant as many peptide/protein transfection kits are not compatible with neutral 
peptides. Furthermore, this allows us to examine the kinase activity without disrupting 
physiological conditions. This is the first step that will allow us to examine the 
phosphorylation process or kinase activity in live cells with continuous real-time analysis.  
 
5.4. Conclusion 
Kinase enzymes are nearly essential in all biological processes since it’s required for 
cellular communication. Several disorders, such as cancer, are associated with abnormal 
kinase activity. Hence, it is important to examine kinase activity for the development of 
therapeutics. The objective of this project was to examine kinase enzyme activity in live 
cells with continuous real-time analysis. Before we carried out such experiments, the 
steady-state properties of the Sox-peptide were investigated. The results indicate that the 
Sox-peptide is highly sensitive in the presence of divalent metals, such as Mg
2+
. The next 
goal was to deliver the Sox-peptide into the cells. However, several issues were 
encountered. First, the excitation wavelength required caused a significant amount of 
autofluorescence when the bio-imaging experiments were carried out utilizing single-
photon and two-photon excited fluorescence confocal microscopy. This caused 
challenges in determining if the Sox-peptide was successfully delivered into the cells. As 
a consequence, a new imaging technique was employed. FLIM was an excellent 
technique because it allowed us to differentiate between the autofluorescence and Sox-
peptide fluorescence after transfection. The major accomplishment of this project is that 
we were able to confirm the delivery of the Sox-peptide into the cell by examining the 
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fluorescence lifetime histogram distribution. The results presented in this chapter are 
preliminary. The project will be continued by a future graduate student who will examine 
the kinase activity with continuous real-time analysis in live cells by employing the 
unphosphorylated Sox-peptide.  
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Chapter 6 
Microporous Inorganic/Organic Hybrids via Oxysilylation of a Cubic Symmetry 
Nanobuilding Block [(HMe2SiOSiO1.5)8] with RxSi(OEt)4−x 
 
 
6.1 Original Publication Information 
A majority of this chapter was originally published as the following: 
Pan, D.; Yi, E.; Doan, P.; Furgal, J. C.; Schwartz, M.; Clark, S.; Goodson III, T.; 
Laine, R. M. “Microporous Inorganic/Organic Hybrids via Oxysilylation of a 
Cubic Symmetry Nano-Building Block [(HMe2SiOSiO1.5)8] with RxSi(OEt)4-x” J. 
Ceram. Soc. Jpn. 2015, 123, 756.  
Modifications were made to the original document to adapt to the context to this 
form. The data and results that I analyzed will be mainly discussed. The data collected 
from the other authors may not be included.  
 
6.2. Abstract 
Mesoporous copolymer gels were synthesized using B(C6F5)3 Lewis acid catalyst to 
promote the Piers-Rubinsztajn of Q-type silsesquioxane with various ethoxysilanes to 
form 3-D network materials. The materials possessed high surface areas (> 700 m
2
/g) and 
thermal stability to 350 
o
C. Micropores of 0.6 – 2.0 nm as well as mesopores of 2 – 40 
nm were noted. Changes in the reaction time and conditions did not significantly change 
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the characterization of the material. Smaller R groups gave higher specific surface areas 
(SSAs) than those with large R groups. Rigid, bridged compounds [(EtO)3Si-R-Si(OEt)3] 
(R = phenyl, biphenyl) offered high SSAs whereas flexible bridges [R = (CH2)2 or 
(CH2)8] gave reduced SSAs. The materials were characterized by Fourier–transform 
infrared spectroscopy (FTIR), thermal gravimetric analysis (TGA), and X-ray diffraction 
(XRD). Porosity and surface area analyses were done by Brunauer–Emmett–Teller (BET) 
method. Slow drying of the gels achieved monoliths whereas fast drying provided 
powders.  
 
6.3 Introduction 
Micro- (average pore sizes < 2 nm) and meso-porous (pores 2 – 50 nm) materials 
have been subjects of great interest for more than half a century because they offer many 
distinct properties with potential utility to diverse fields ranging from catalyst substrates, 
to bio-adsorbants, to drug storage and delivery, to remediation systems, to living cell 
containers, to gas sieving, to nano-reactors, to gas storage and vacuum insulation panel 
core materials.
1-30
  
Over this period of time, researchers have developed diverse synthetic routes to 
micro- and meso-porous materials in the general categories of amorphous inorganics, 
amorphous organics and crystalline analogs including zeolites, metal organic framework 
(MOFs), and covalent organic framework (COFs). Most of these syntheses are aqueous in 
nature and require strongly basic environments, elevated temperatures, and relatively 
long reaction times. Only a small fraction of the reported synthetic methods rely on the 
formation of covalent bonds to build highly symmetrical 3-D porous structures.
25-33
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We report a method of synthesizing microporous hybrid materials with 3-D ordering 
using a new synthetic method based on the Piers-Rubinsztajn reaction, which we refer to 
here as oxysilylation as shown in Scheme 6.1A.
34-45
 In an oxysilylation reaction, Si-H 
bond is reacted with an alkoxysilane in the presence of catalytic amounts of (C6F5)3B, 
generating a volatile alkane and a new Si-O-Si linkage. The proposed mechanism is 
shown in Scheme 6.1B.
38-41 
Oxysilylation reactions can be carried out in hydrocarbon 
solvents at modest temperatures and short reaction times to provide an ordered, 
hydrophobic, microporous materials with high surface areas with the potential to be 
tailored so that multiple functionalities can be introduced. 
 
 
 
Scheme 6.1. (A) Oxysilylation reaction with a catalytic amount of (C6F5)3B. (B) 
Proposed mechanism of oxysilylation reaction. 
 
A general synthesis of the porous materials is shown in Scheme 6.2. Various 
ethoxsilane species were reacted with octakis(dimethylsiloxy)octasilsesquioxane (OHS) 
to form the network polymer gels. A key to this reaction is to use molar amounts of 
catalyst (C6F5)3B. Another advantage is that the leaving group is an alkane. Finally, the 
reactions can be carried out in low boiling solvents that are easily removed to give 
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microporous powders or monoliths. If one component is used in excess (e.g. OHS) then 
the material will contain reactive sites for the introduction of secondary and tertiary 
functional groups, providing a simple route to multiple types of materials for diverse 
applications. 
 
 
Scheme 6.2. General oxysilylation reaction of OHS with RSi(OEt)3 with a catalytic 
amount of (C6F5)3B. 
 
6.4 Experimental  
Copolymerization of OHS with TEOS. 1:1 molar equivalents of OHS:TEOS (Si-
H/Si-OEt) were used. OHS (0.500 g, 3.94 mmol) was dissolved in 15 mL of hexane in a 
25 mL round-bottom flask equipped with a magnetic stirrer. TEOS (0.206 g, 3.94 mmol) 
was added to the solution. The solution was stirred at 60 
o
C for 5 min. B(C6F5)3 (3 mg, 7 
μmol), dissolved in 500 µL of CH2Cl2, is  then added using a 1.0 mL syringe. A gel forms 
1 – 2 min after addition of B(C6F5)3. Aluminum foil was used to cover the neck of the 
round-bottom flask to reduce the drying rate. The gel was allowed to dry at 20 
o
C
 
for 120 
h. A 0.7 mm syringe needle was used to pierce a single hole through the foil. The gel was 
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dried at 20 
o
C
 
for an additional 48 h. Significant shrinkage was observed upon drying. 
Single piece, glassy solids were obtained. Faster drying rates provide powders. 
General copolymerization of OHS with RSi(OEt)3 where R = Ph, vinyl, CH3, 
(CH2)3Cl, (CH2)2CF3, (CH2)8H. 1:1 molar equivalents of OHS:RSi(OEt)3 (Si-H/Si-OEt) 
were used to prepare the gels. OHS (0.500 g, 3.94 mmol) was dissolved in 15 mL of 
hexane in a 25 mL round-bottom flask equipped with a magnetic stirrer. RSi(OEt)3  (3.94 
mmol) was added to the flask. The solution was stirred at 60 
o
C for 5 min. B(C6F5)3 (3 
mg, 7 μmol) was dissolved in 500 µL of CH2Cl2 then added to the resulting solution. The 
gel was dried as described above.  
Fourier–transform infrared spectroscopy (FTIR). Diffuse reflectance Fourier 
transform (DRIFT) spectra were obtained using a Nicolet 6700 Series FTIR spectrometer 
(Thermo Fisher Scientific, Inc., Madison, WI). Optical grade KBr (International Crystal 
Laboratories, Garfield, NJ) was ground with 1.0 wt % of the sample to be analyzed. The 
ground powder was packed into a sample holder and leveled off with a glass plate to give 
a smooth surface. The FTIR sample chamber was purged continuously with N2 prior to 
data acquisition. 64 scans were averaged for each spectrum in the range 4000 – 400 cm-1 
with a precision of ± 4 cm
-1
. 
Specific surface area (SSA) and porosity analyses were carried out using an ASAP 
2020 sorption analyzer (Micromeritics Inc., Norcross, GA). Samples (100 mg) were 
degassed at 150 °C/10 h. Each analysis was run at −196 °C (77 K) with N2. The SSAs 
were determined by the BET multipoint method using ten data points at relative pressures 
(P/P0) of 0.05 − 0.30. The micropore size distribution was determined by the Horvath-
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Kawazoe method. Data points were collected with low pressure incremental dose mode at 
0 < P/P0 ≤ 0.1.  
Thermal gravimetric analysis (TGA). Thermal stabilities of materials under 
synthetic air were measured on a Q600 simultaneous TGA-DSC Instrument (TA 
Instruments, Inc., New Castle, DE). Before analysis, samples were ground into a powder 
and 15 – 25 mg were placed into alumina pans and then ramped from 25 to 1000 oC (10 
o
C/min). The air flow rate was 60 mL/min.  
X-ray diffraction (XRD). XRD patterns were collected on a Rigaku Rotating Anode 
Goniometer (Rigaku Denki., LTD., Tokyo, Japan). The Jade Program 2010 (Version 
1.1.5 Materials Data, Inc., Livermore CA) was used to determine the presence of 
crystallographic phases. XRD scans were made from 5° to 40° 2θ, using a scan rate of 2° 
min
-1
 in 0.01° increments and Cu Kα radiation (1.541 Å) operating at 40 kV and 100 mA.  
 
6.5 Results and Discussion  
In this initial work, our objectives was to analyze a material with the basic 
nanobuilding block OHS, and study the oxysilylation reactions with Si(OEt)4 to explore 
the range of conditions that can be used to produce microporous gels. We replaced 
Si(OEt)4 with selected RSi(OEt)3 and (EtO)3Si-R-Si(OEt)3 systems to identify sets of 
materials with a range of properties. This work is considered a prelude to using excess 
vinyl and/or -OSiMe2H groups in oxysilylation, leaving these functionalities available for 
the introduction via hydrosilylation or oxysilylation of second and tertiary functional 
groups. However, it should also be possible to form catalyst particles within these 
microporous gels given that -OSiMe2H groups are also potential points of reduction. 
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Therefore, we have established the groundwork for more complex studies. We begin with 
a detailed analysis of oxysilylation in a OHS: Si(OEt)4 system with a 1 Si-H:1 Si-OEt 
ratio that results in micro/mesoporous gels and then introduce OHS:RSi(OEt)3 systems 
with 1:1 Si-H:Si-OEt ratios. These gels were characterized by FTIR, TGA, N2 absorption, 
and XRD.  
The reactions were carried out in 15 mL of hexane where 5 µm mol (C6F5)3B as a 
dichloromethane solution was added. Reactions were heated to 60 ° C with initiation 
typically observed within a few minutes as evidenced by the evolution of ethane bubbles. 
Caution should be used as these reactions can evolve gas violently especially if the 
alkoxy group is MeO. 
 
Table 6.1. Specific conditions explored for the synthesis of the gels.  
OHS:TEOS Hexane Vol. (mL) 
Temp 
(°C) 
mg 
B(C6F5)3 
(µmol) 
SSA 
(m
2
/g) 
Ave Pore 
Size (nm) 
1:1 10 60 2.5 (4.89) 680 0.7 
1:1 20 60 2.5 (4.89) 618 0.7 
1:1 50 60 5.0 (9.78) 706 0.8 
 
 
The resulting materials are relatively similar with roughly the same SSAs and average 
pore sizes regardless of the solvent volume or catalyst concentration. These results 
suggest that almost complete crosslinking despite the very low catalyst concentrations 
and solvent volume as suggested by the FTIR studies, which are discussed below. Thus, 
solvent does not influence the reaction rate or the extent to which the reaction reaches 
completion under these conditions. Note that the reactions can also be carried out in 
CH2Cl2. The reaction temperature must be limited to the boiling point of 40 °C. 
Reactions conducted in THF or EtOH are much slower as they are mild Lewis acids and 
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the reaction is difficult to drive to completion. However, the intermediate stages lead to 
materials that can be used to form coatings.
66 
The recovered gels are hydrophobic as shown in Figure 6.1. Rapid drying leads to 
cracking driven by changes in osmotic pressure. Slowly dried samples retain the vessel 
shape whereas rapid drying leads to cracking driven by changes in osmotic pressure. 
 
   
Figure 6.1. 1:1 OHS:TEOS (A) gel immediately after reaction and (B) after drying for 3 
weeks.  
 
The gels were characterized by FTIR. Figure 6.2 compares the FTIR of OHS with the 
reaction product obtained from the stoichiometric reaction of all the Si-H groups with an 
equal amount of Si-OEt at 60 °C in hexane. The key features of the product are the 
complete absence of νSi-H and the appearance of a new νSi-O band at 1040 cm-1 with 
retention of the original cage νSi-O band at 1120 cm-1. The FTIR spectrum of the final 
product is nearly identical to a typical FTIR spectrum of polydimethylsiloxane with the 
exception of the νSi-O band at 1040 cm-1.52 It is important to note that no νSi-OH bands 
were observed. This indicates that there is no cleavage of the Si-O bonds, which is 
important for maintaining the structural composition.  
 
A B 
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Figure 6.2. FTIR spectrum of (A) OHS and (B) 1:1 OHS:TEOS.  
 
TGA was used to examine and characterize the dried gels. Shown in Figure 6.3, the 
TGA/DTA of the 1:1 OHS:TEOS product indicates an initial mass loss at 320 °C. The 
mass loss is associated with an exotherm, which is likely attributed to the oxidation of 
residual Si-H groups and the Si-Me groups. The ceramic yields (CY) are presented in 
Table 6.2 and 6.3. For the 1:1 OHS:TEOS material, the experimental CY was 85.5% with 
a theoretical CY of 90.6%. There are several reasons in which the experimental CY 
varies as compared to the theoretical CY. First, the residual ethoxy groups are not 
accounted for when calculating the theoretical CY; it is assumed that all the ethoxy 
groups have reacted. Another reason is that some of the starting material may be lost to 
sublimation; for instance, OHS sublimes at 280 
o
C. Finally, some of the polymer 
A 
B 
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fragments may leave as volatiles. It is worth noting that the mass loss continues to at least 
800 
o
C. This is typical of hybrid materials that decompose into gaseous char and 
fragments. The char oxidizes at higher temperature in air, but remains relatively stable if 
heated under nitrogen.
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Table 6.2. Selected properties for various gels, 1:1 OHS:RSi(OEt)3 (Si-H/Si-OEt). 
R Density (g/cm
3
)* 
SSA 
(m
2
/g) 
Pore 
dia.(Å) 
Max. pore 
volume (cm
3
/g) 
Found 
CY 
(%) 
Theor. 
CY 
(%) 
OCH2CH3 0.89 ± 0.08 665 7.2 0.28 85.5 90.6 
CH3 1.05 ± 0.06 579 6.3 0.22 88.9 89.5 
Ph 1.03 ± 0.09 452 5.9 0.18 75.6 79.1 
(CH2)2CF3 1.15 ± 0.08 141 N/A N/A 74.0 76.2 
Vinyl 1.09 ± 0.07 485 7.1 0.19 85.4 87.5 
(CH2)3Cl 1.17± 0.05 112 N/A N/A 77.9 79.0 
(CH2)8H N/A 6 N/A N/A 71.4 74.1 
* The value represents the average of 3 replicates (n = 3). 
 
 
Table 6.3. Selected properties for various gels, 1:1 OHS:R[Si(OEt)3]2 (Si-H/Si-OEt). 
R Density (g/cm
3
)* 
SSA 
(m
2
/g) 
Pore 
dia. 
(Å) 
Max.pore 
volume 
(cm
3
/g) 
Found 
CY 
(%) 
Theor. 
CY 
(%) 
Benzene 0.91 ± 0.05 710 5.5 0.27 81.4 83.8 
Biphenyl 0.96 ± 0.07 655 6.0 0.25 74.9 79.2 
(CH2)2 0.94 ± 0.08 448 6.2 0.19 86.3 89.7 
(CH2)8 1.07 ± 0.09 396 7.0 0.17 79.3 78.2 
    * The value represents the average of 3 replicates (n = 3). 
  
XRD was utilized to characterize the periodicity of the dried gel. The XRD patterns 
of OHS and 1:1 OHS:TEOS are shown in Figure 6.3. The XRD suggests that the dried 
gel has some periodicity as evidenced by peaks at approximately 7.2, 17, and 23 °2θ. The 
XRD pattern for OHS showed peaks at 8.3, 18.9 and 24.4 °2θ which represented periodic 
distances of 1.1, 0.5 and 0.3 nm, respectively. They are tentatively assigned to the (100) 
or (010) (120) and (112) planes, respectively.
67 
The broad peak at approximately 7.2 °2θ 
suggests that a larger unit cell of 1.3 nm arises from the incorporation of Si-O units to the 
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original OHS cell. The peak centered near 17 °2θ corresponds to the SQ cage, which has 
expanded with the addition of eight Si-O bonds, which indicates a distance near to 0.6 – 
0.7 nm. The peak near 24 °2θ corresponds to the separation between faces of the cage.67 
It appears that there is some extended periodicity in the formed gel, which is not 
influenced by the varying conditions of the reaction.  
 
 
Figure 6.3. XRD pattern of (A) OHS and (B) 1:1 OHS:TEOS gel.  
 
Highly periodic materials, such as zeolites, are generally prepared under 
hydrothermal conditions in which an equilibrium is established, allowing the defects to 
dissolved and removed to be replaced with more uniform and ordered structures over a 
period of time. Contrarily, the gels formed via oxysilyation are kinetic products. These 
materials are formed in minutes at room temperature. The byproduct of ethane gas 
removes the ability to form an equilibrium. Therefore, the defects or unordered structures 
A 
B 
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are retained due to the lack of mechanism to remove these defects. The periodic 
structures will display short ranged ordering as observed with other tethered cage 
structure systems.
69
 Other methods, such as mass spectrometry, could not be employed to 
characterize the material due to the rapid polymerization reaction.   
The surface area and porosity of the gels were analyzed utilizing the BET method. 
Pore sizes are classified into three classes, depending on the pore diameter (D); 
micropores (D < 20 Å), mesopores (D = 20 – 500 Å), macropores (D > 500 Å).5 The gels 
were found to have pore diameters of 6 – 7 Å as listed in Tables 6.2 and 6.3. Supercritical 
processing was not required to dry the gels in order to retain high specific surface areas 
(SSA). The porosity measurements were conducted from the adsorption stage to 
minimize hysteresis.  
The SSA ranged from 6 – 665 m2/g with the gels containing the R-Si(OEt)3 linkers. 
The trend on porosity and SSA were shown to be dependent on the flexibility of the R 
group on the linker. The gels containing the non-flexible functional groups (R = CH3, Ph, 
vinyl) had SSA greater than 450 m
2
/g. The linker with R = Me had the highest SSA of 
579 m
2
/g among the R-Si(OEt)3 linkers. Interestingly, the SSA decreased as the chain 
length increases from C1 to C8. For example, R = (CH2)7CH3 offered the lowest SSA of 6 
m
2
/g. This is likely due to flexibility of the linker interfering with formation of the pores 
upon polymerization. The rigid linkers do not have the flexibility and stay in place, thus 
not affecting the formation of the pores.  
Another interest was the effect on the SSA due to the size of the linkers for the 
bistriethoxysilane spacers, Si(OEt)3-R-Si(OEt)3. The gels containing the rigid linkers 
displayed higher SSA as compared to the linkers that were flexible. The SSA of gels with 
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rigid spacer had SSA greater than 650 m
2
/g. As the length of the rigid spacer increased, 
there was a decrease in the SSA. For example, the SSA decreased from 710 to 655 m
2
/g 
as the length of the linker was increased with R = phenyl to R = bisphenyl. This finding 
agreed with the work done by Oviatt et al.
71 
However, these finding was contrast with 
work done by Corriu et al.
40
 in which the flexibility of the linker was not a factor in the 
porosity and SSA of the material.  
 
6.6 Conclusion 
In summary, we have demonstrated a new synthetic route to form network polymer 
gels through the oxysilyation reaction of cubic symmetry Q-type cages (OHS) with 
various ethoxysilane linkers. The materials were found to be hydrophobic with 3-D 
periodic microporous with high SSA and thermal stability. In addition, the gels were 
synthesized in mild conditions in the presence of a Lewis acid. The properties were 
investigated using a series of ethoxysilane linkers. It was found that more rigid structural 
elements gave higher SSA as compared to more flexible structural elements. 
Additionally, the gels displayed a short range of periodicity as evident from XRD. With 
the use of BET, it was reported that the diameter of the pore was, on average, 6 – 7 Å. 
Variation in the reaction conditions, such as solvent volume and catalyst concentration, 
did not change the properties of the final gels indicating that the reaction goes to 
completion as a kinetically favored product. The findings suggest that the gels can be 
easily functionalized to give materials towards other applications. 
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Chapter 7 
Avoiding Carbothermal Reduction: Distillation of Alkoxysilanes from Biogenic, 
Green, and Sustainable Sources 
 
 
7.1 Original  
A majority of this chapter was published as the following document:  
Laine, R. M.; Furgal, J. C.; Doan, P.; Pan, D. Popova, V. “Avoiding Carbothermal 
Reduction: Distillation of Alkoxysilanes from Biogenic, Green, and Sustainable 
Sources” Angew. Chem. Int. Ed. Engl. 2015, 127, 1.  
Modifications were made to the original document to adapt the context to this form. 
Data that was not published in the manuscript may also be discussed.  
 
7.2 Abstract  
We report here the first examples of base catalyzed depolymerization of silica to 
produce distillable spirosiloxanes and alkoxysilanes in large quantities. Hindered diols, 
such as 2-methyl-2,4-pentanediol (b.p. 197 °C) or 2,2,4-trimethyl-1,3-pentane-diol (b.p. 
232 °C) were reacted with a variety of silica sources including rice hull ash (RHA, ≈ 20 
m
2
/g), vermiculite (4 m
2
/g), diatomaceous earth (20 m
2
/g DE), ashed rice hulls (A-RH, > 
200 m
2
/g), or fumed silica (340 m
2
/g) in the presence of catalytic amounts of NaOH (10 
mol % of SiO2) to form spirosiloxanes, (2-Me-2,4-pentanediolato)2Si (II) and (2,2,4-
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trimethyl-1,3-pentane-diolato)2Si  (III). Conversions of 5 – 98 % were obtained under 
standard conditions that were governed by surface area, crystallinity of the silica source, 
and distillation temperature. If ethylene glycol is used, a undistillable glycoxysilane is 
produced, Si(OCH2CH2OH)4, which forms a polymeric material Si(OCH2CH2O)2 upon 
heating and vacuum. Additionally, the material was mixed with EtOH in the presence of 
catalytic amount of acid gave Si(OEt)4 with yields of 60% unoptimized. Similar 
conversion of II gave unoptimized 60 % yields of Si(OEt)4. 
The spirosiloxanes and Si(OEt)4 are hexane soluble. Therefore, solutions of Si(OEt)4 
or II and unreacted diol in hexane can be washed with water to remove starting diol to 
form pure II, which crystallizes at ambient temperatures and Si(OEt)4 as a recovered 
liquid. Hexane solutions containing III and the starting diol were washed with MeOH 
followed by the removal of hexane to give pure III. All compounds can be distilled to 
produce higher purities. This process represents a green route for the production of 
alkoxysilanes, which can be used for precipitated silica, colloidal silica, fumed silica, and 
as precursors to compounds with Si-C bonds. These alkoxysiloxanes and spirosiloxanes 
can be used to make high purity precipitated, colloidal and/or fumed silica directly from 
low cost biogenic silica sources. The process is described as renewable, sustainable, and 
has a minimal carbon footprint.  
 
7.3 Introduction 
We report the first example of the direct, base catalyzed depolymerization of silica by 
the reaction with hindered diols yielding spirosiloxanes that can be distilled with in high 
purity. This work represents the culmination of over 80 years of literature efforts 
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targeting similar objectives. The spirosiloxanes can be used to produce fumed, colloidal, 
or precipitated silica. Additionally, the spirosiloxanes can be used as precursors for the 
formation of compounds containing Si-C bonds.  
Although coal and crude oil make up less than 0.01 % of the Earth’s crust, their utility 
to society is enormous given that they serve as the basis for much of the world’s fuel, 
organic materials ranging from plastic bags to fibers for textiles, and food packaging to 
major components in flat panel displays. Contrarily, silicon lies in the same column just 
below carbon in the periodic chart, which offers many chemical bonding similarities. 
Silicon makes up more than 40 % of the Earth’s minerals, and is less impactful on our 
society despite being important for applications ranging from solar cells to silicone 
rubbers.
1-4 
Silicon-silicon and silicon-carbon double bonds are difficult to synthesize unless 
sterically stabilized and are not easily polymerized using the same chemistries as used for 
carbon. Additionally, the silicon-oxygen bond (534 KJ/mol) is one of the strongest bonds 
found in nature, which has a contribution to this problem. Thus, most Si containing 
compounds and materials are produced from Simet, which is made by carbothermal 
reduction of silica with carbon in a high temperature and energy intensive process as 
shown in reactions (7.1) – (7.7).6-10 The higher purities required for photovoltaic (Sipv) 
and electronic (Sieg) grade silicon require additional processing steps, typically those of 
the Siemens process, reactions (5) and (6), which generate byproduct HCl, which is 
normally recycled.  
 
 
 
201 
 
SiO2 + 2C 
1900°C 
> 2CO + Simet (met = metallurgical grade, ≈ 98 % purity)           (7.1) 
Simet  + HCl  
Cu/Sn catalyst/300°C 
> HSiCl3 + SiCl4                       (7.2) 
Simet  + EtOH (MeOH) 
catalyst 
> Si(OEt)4 [Si(OMe)4] + H2                        (7.3) 
Simet + MeCl 
Cu/Sn catalyst/300°C 
> MeSiCl3 + Me2SiCl2             (7.4) 
4HSiCl3 
disproportionaton catalyst 
> SiH4 + 3SiCl4                        (7.5) 
H2 + HSiCl3/SiCl4 (or SiH4) 
hot wire/rod 
> Sipv/Sieg (6-9 N) + HCl                     (7.6) 
SiCl4 + 2H2/O2 
 >900°C
> SiO2 (fumed silica) + 4HCl                         (7.7)
  
 
All chlorosilanes and HCl gas are corrosive, toxic and polluting, such production 
processes including those used to produce fumed silica (reaction 7.7) require extensive 
safeguards adding to the overall cost of the final products. Because Simet is a kinetic 
product, where SiC is the thermodynamic product, its synthesis requires electric arc 
furnace processing at 1900 °C adding to the overall cost for the production Si(OEt)4 or 
Si(OMe)4. 
Precipitated silica is most commonly made through high temperature reactions of 
sand with sodium carbonate followed by the dissolution and precipitation with H2SO4 as 
given by 
 
SiO2 + Na2CO3 
__1300°C__
> Na2SiO3 + CO2                                     (7.8) 
Na2SiO3 + H2SO4 
____
> Na2SO4 + SiO2                                (7.9) 
 
Each mole of Na2SiO3 produced results in one mole of CO2 and requires one mole of 
H2SO4 producing one mole of precipitated silica and one mole of Na2SO4, which must be 
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disposed. Therefore, the production of precipitated (ppt) silica, such as used as filler in 
polymers or as abrasives in toothpaste, requires high temperatures and generates 
unwanted byproducts, especially CO2 and Na2SO4.
11 
Reactions (7.1) – (7.7) start with 
SiO2, which is reduced to Simet and then re-oxidized back to some form of SiO2. This 
approach is not cost effective because these processes are equipment and energy 
intensive. 
 
In the early 1930’s, repeated attempts were made to develop low temperature and cost 
effective methods to depolymerize silica in generating alternate routes to silicon 
containing compounds as well as precipitated silica. The success of such a process can be 
considered a “Grand Challenge” for silicon chemists as suggested by reaction (7.10). The 
idea of distilling the resulting product should allow the direct production of very high 
purity silicon containing materials including directly from any silica source at low 
temperatures, which significantly reduces cost. High purity silica can be used in several 
applications including edible products (e.g. toothpaste), polishing aids for planarizing 
silicon wafers, production of high purity silica for optical applications (lenses, gratings, 
photonic band gap materials), and the production of crucibles for growing electronics 
grade silicon boules.
6,7,10 
 
                                                    (7.10) 
 
In regards to the “Grand Challenge”, research began with Rosenheim et al. (1931)12 
followed by Weiss et al. (1961),
13 
Frye (1964),
14
 Boer and Flynn (1968),
15,16 
Barnum 
SiO2 + 4ROH
Catalyst/-2H2O
Si O
O
O
O
R
R
R
R
Distills
< 200°C
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(1970),
17,18
 and Corriu (1986),
19,20 
to explore the depolymerization of SiO2.
 
This work 
here covers a wide variety of SiO2 sources ranging from amorphous silica to quartz 
powder. These studies focused on reaction (11) or similar generating hexacoordinated 
triscatecholato Si, I.
12-19  
 
                      (7.11) 
 
Silicon, unlike carbon, has the ability to form five and six bonds where the original 
Si-O bond strength of tetrahedral silicon is diminished, which is key to the success of the 
reaction. Unfortunately, I cannot be distilled. Additionally, I is highly stable in which it is 
water-soluble and has to be reacted with H2SO4 to produce precipitated silica. From a 
practical perspective, this process, while offering a low temperature route to precipitated 
silica, would require three moles of catechol per mole of precipitated silica or 330 g of 
catechol to produce 60 g of precipitated silica and 280 g of Na2SO4. This is unattractive 
due to the large amount of precursors required to yield a small amount of precipitated 
silica although no CO2 would be produced.  
A search for something more practical than catechol led us to try ethylene glycol to 
promote the depolymerization of silica as shown to reactions (7.12) and (7.13).
21,22
 The 
depolymerization mechanism builds on expansion of the coordination sphere around 
silicon. The pentacoordinated silicate of reaction (7.12) provided the basis for Herreros et 
al.
23
 to determine that this compound is the primary intermediate in the ethylene glycol 
SiO2 + 2KOH + 3
OH
OH
-H2O/<100°C
O
O
Si
O
O
2
K2 I 
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mediated synthesis of silicalite zeolites. Likewise, it allowed Kinrade et al.
24
 to propose a 
mechanism where sugars formed similar pentacoordinated silicates, allowing plants to 
transport silica within the plant as the basis for biosilification processes.
 
 
                                   (7.12) 
                                                        (7.13) 
 
We were able to demonstrate the reaction (7.12) can be promoted catalytically using 
an alkali base as presented in reaction (7.13).
25,26
 These studies were done with fumed 
silica (SSA = 350 m
2
/g), which defeats the overall objective of the “Grand Challenge”. 
However, these studies were critical as they determined that reaction (7.14) is first order 
in base concentration and surface area, the activation energy for the reaction is 
approximately 60 kJ/mol, and the reaction is faster with amorphous rather than crystalline 
silica.
23 
Unfortunately, the glycolatosiloxane (GS) product cannot be distilled as it forms 
polymers on heating resulting in purification difficulties.  
 
                  (7.14) 
 
SiO2
+ EGH2/-H2O/200°C
Catalytic, 1 mol % MOH, M = Li, Na, K, etc
Si O OH
Si(egH)4
O
O
O
OH
HO
HO
GS
Heat/Vacuum
Si O O
Si(eg)2
O
O
-HO OH
n
Si O O
O x
O
OH
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Other amorphous silica sources with high surface areas, such as rice hull ash (RHA) 
and diatomaceous earth (DE) could be used as potential replacements for fumed 
silica.
27,28
 RHA is produced in 250k ton/yr quantities in the U.S. alone. Additionally, it is 
mainly amorphous and offers specific surface areas (SSA) of 20 m
2
/g. The samples used 
in our study were 90 wt % silica, 5 wt % carbon, and 5 wt % minerals that are easily 
removed by washing with dilute HCl.
29
 In addition, we obtained a sample of rice hulls 
that had been ashed at ≥ 600 °C (A-RH) to produce a material that was > 95 wt % silica 
and with SSA of nearly 230 m
2
/g. DE is available from multiple commercial sources with 
a SSA ranging from 1 – 70 m2/g with an amorphous structure.  
We report here the first examples of the synthesis of distillable spirosiloxanes directly 
from biogenic silica sources in the presence of a catalytic amount of base. Sterically 
hindered diols are key to the formation of spirosiloxanes.
30 
2-methyl-2,4-pentanediol is 
the hydrogenated product of base catalyzed acetone condensation and is the lowest cost 
diol available. This and 2,2,4-trimethyl-1,3-pentanediol permit extension of reaction 
(7.14) to (7.15) and (7.16).   
 
                                                                  (7.15) 
                                       (7.16) 
 
OH
OH
2-Methyl-2,4 pentanediol
+ SiO2
catalytic NaOH
O
O
Si
O
O-H2O
O
OO
O
Si
RHA + 10 mol % NaOH +
O
O
H
H
200 °C/-H2O
II 
III 
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7.4 Experimental  
Materials. Chemicals and solvents were obtained from commercial suppliers and 
used without further purification, unless otherwise indicated. Fumed silica and Celite 545 
filter aid were supplied by Wacker Chemie AG and Fisher Scientific, respectively. DE 
was manufactured by Safer Brand. RHA was supplied from Wadham Energy. Prior to 
use, DE and RHA were boiled with water, filtered, and dried. All other chemicals were 
purchased from Fisher Scientific and used as received. The A-RH was received from the 
J. Cervantes group of the University of Guanajuato, Mexico. 
NMR analyses. 
1
H, 
13
C, and 
29
Si NMR were measured in chloroform-d with TMS 
(0.00 ppm) as the internal reference on a Varian VNMRS 500 spectrometer. 
1
H NMR 
spectra were collected at 500 MHz using a 7998.4 Hz spectral width, a pulse width of 
45°, relaxation delay of 0.5 s, 65K data points. 
13
C NMR spectra were collected at 100 
MHz using a 25,000 Hz spectral width, a pulse width of 40°, relaxation delay of 1.5 s, 
and 75K data points. 
29
Si NMR spectra were collected at 99.35 MHz using a 4960 Hz 
spectral width, a pulse width of 7°, a relaxation delay of 20 s, and 4K data points. 
Mass spectroscopy (MS) analyses were conducted using a VG 70-250-S magnetic 
sector instrument (Waters) by electron impact ionization (EI). The instrument was 
calibrated with perfluorokerosene-H. The samples were conducted in EI mode at 70 eV 
electron energy with an ion source temperature of 240 °C.  The mass range was scanned 
from 1000 to 35 m/z.  
Electrospray ionization (ESI) was performed on an Agilent Q-TOF system with a 
dual ESI ion source. The mobile phase consisted of a 9:1 mixture of acetonitrile:water 
with 0.1% formic acid. Lock mass correction was used to obtain mass accuracy. 
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Matrix assisted laser desorption ionization time of flight (MALDI-TOF) was 
performed on a Micromass TofSpec-2E equipped with a 337 nm nitrogen laser in 
positive-ion reflectron mode using poly(ethylene glycol) as the calibration standard, 
dithranol as matrix, and AgNO3 as ion source. Samples were prepared by mixing a 
solution of 5 parts matrix (10 mg/ml in THF), 5 parts sample (1 mg/ml in THF), and 1 
part of AgNO3 (2.5 mg/ml in water) and blotting the mixture on the target plate then air 
dried.  
Thermal gravimetric analysis (TGA). Thermal stabilities of materials under 
synthetic air were measured on a Q600 simultaneous TGA-DSC Instrument (TA 
Instruments, Inc., New Castle, DE). Samples (15 – 25 mg) were placed into alumina pans 
and then ramped from 25 to 1000 
o
C (10 
o
C/min). The air-flow rate was 60 mL/min.  
Synthesis of Spirosiloxane. The dissolution reaction was established by reacting of 
silica (0.33 moles) with NaOH (1.33 g, 0.03 moles) in 150 ml of diol in a distillation 
apparatus. The solution was heated 15 
o
C below the boiling point of the diol and stirred to 
promote complete dissolution. The reaction was stirred for 24 h to drive the reaction 
forward with the removal of water. Small amounts of water were collected (2 – 5 mL) via 
distillation. After 24 h, the diol was distilled to drive the reaction forward. 100 mL of diol 
was distilled then an additional 100 mL of diol was added to the reaction flask. A second 
distillation of 100 mL was undertaken after stirring for several hours. The dissolved silica 
remained in the reactor for EGH2 and 1,4-butanediol since the spirosiloxane could not be 
distilled. The product was isolated by filtration.  
Conversion of II to Si(OEt)4. A 500 mL round-bottom flask was flame dried prior to 
the experiment. 25 mL of activated 4 Å molecular sieves, 10 g (0.038 mol) of II and 400 
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mL of dry 100 % ethanol were added to a 500 mL round-bottom flask equipped with a 
stir bar under nitrogen. The reaction was stirred 1 h prior to adding 2.5 mL (0.015 mol) of 
TFA. The reaction was allowed to stir at room temperature for 24 h under nitrogen. The 
contents in the reaction were then filtered to remove the molecular sieves and precipitated 
solids that formed during the course of the reaction. The filtrate was added to hexanes 
(400 mL) and washed with water (3 x 150 mL) to remove the diol and TFA. The hexanes 
solution was dried wit Na2SO4 then filtered. The solvent was removed under reduced 
pressure to yield Si(OEt)4 (5.2 g, 65 %), which was characterized with NMR and EI-MS 
(m/z = 208.1).  
Conversion of II to Si(OMe)4. A 500 mL round-bottom flask was flame dried prior 
to the experiment. 25 mL of activated 4 Å molecular sieves, 10 g (0.038 mol) of II, 200 
mL of dry methanol, and dry hexanes were added to a 500 mL round-bottom flask 
equipped with a stir bar under nitrogen. The reaction mixture was allowed to stir for 1 h 
prior to adding 2.5 mL (0.015 mol) of TFA. The reaction was allowed to stir at room 
temperature for 24 h. The mixture was then poured into a separatory funnel and the two 
layers were separated. The methanol layer was discarded. The hexane layer was washed 
with water (3 x 300 mL) to remove unwanted diol and TFA. The solution was dried with 
Na2SO4 then filtered. Hexanes was removed under reduced pressure to yield Si(OMe)4 
(3.0 g, 40 %), which was characterized using NMR and MS (m/z = 153.1).  
Conversion of II to Precipitated Silica. II (10 g, 0.038 mol), 100 % ethanol (50 
mL), H2O (4 mL), and 12N HCl (2 mL) were added to a 250 mL round bottom flask 
equipped with magnetic stirrer. The reaction was allowed to stir at room temperature for 
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24 h. Na2CO3 was used to neutralize the reaction resulting in a transparent colloidal 
dispersion of silica particles. 
 
7.5 Results and Discussion 
Shown in Table 1, the characterization data and dissolution rate to dissolve a series of 
biogenic silica sources using diols ethylene glycol (EGH2), 1,4-butane diol, 2-methyl-2,4-
pentanediol, and 2,2,4-trimethyl-1,3-pentanediol. EGH2 and 1,4-butane diol were not 
expected to form spirosiloxanes whereas 2-methyl-2,4-pentanediol and 2,2,4-trimethyl-
1,3-pentanediol were likely candidates. Two other hindered diols were also tried, which 
included 2-methyl-1,3-propanediol and 1,3-butanediol that yielded spirosiloxanes, but did 
not distil. These were not fully characterized because of their tendency to gel, but 
29
Si-
NMR gave peaks in the 62-65 and 70-73 ppm regions that we have previously associated 
with simple spirosiloxanes and ring opened polymer analogs. 
 
Table 7.1. Percent SiO2 depolymerization and characterization data given. 
Diol    
(bp°C) 
 
SiO2 
SSA 
m
2
/g 
EGH2 
(197°) 
HO(CH2)4OH 
(235°) 
2-methyl-2,4- 
pentanediol 
(197°) 
2,2,4-
trimethyl- 
1,3-
pentanediol  
(232°) 
Celite 1 12% 13 % 4% 1.5% 
Vermiculite 4 2.5 3 3 -- 
RHA 26 20 23 24 12 
RHA 85 40
†
  40
†
  
DE 23 16 18 4 3 
Fumed 
SiO2 
350 98
+ 
98
+
 98
+
 98
+
 
A-RH 230   60 -- 
Mass  
Spec.
†† 
 
Spiro 
149, 80 %  
intensity
23
 
Spiro 
205,15 %  
intensity 
Spiro  
260, I = 15% 
-CH3 245 100% 
Spiro 
316, I = 7 % 
273 (-Me2CH) 
I = 30% 
1-
H-NMR 
 
Si(glycoxy)4
23
 
CH2O 3.74 
CH2OH 3.94 
 
CH2O 3.41, 
CH2 1.45 
Si(OROH)4 
CH2O 3.70 
CH2 1.65  
CHOH 4.20, 
CH2 1.47,1.64 
CH3 1.30,1.24, 
1.18 
II 
CHOH 3.7, 
CH2OH, 3.32, 
CH 1.87 
CH3 0.73, 
0.75, 0.95, 
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 CH2O 4.30,  
CH2 1.48, 1.66 
  CH3 1.28, 1.22, 
1.18, 
III 
CHO 3.4, 
CH2O, 3.20, 
CH 1.59 
CH3 0.87, 
0.88, 0.97, 
13-
C-NMR
 
 
Si(glycoxy)4
23
 
CH2O 3.74 
CH2OH 3.94 
CH2O 62.55 
 CH2 29.84 
Si(OROH)4 
CH2O 64.80 
  CH2 31.99 
C(Me)2OH 
71.56,  
C(H,Me)OH 
65.64,  
CH2 49.47  
(CH3)2 31.82, 
27,71,  
CH3 24.31 
II 
C(Me)2OH 
74.63,74.38 
C(H,Me)OH 
67.82,67.60 
CH2 48.40,48.32 
(CH3)2  32.20, 
27.98  
CH3 24.17 
CH2OH, 83.11 
CHOH 73.3, C 
39.04,  
CH 29.08 CH3 
23.27, 19.66, 
16.60, 
III 
CHO 82.52, 
CH2O 69.17, 
C 40.80? 
CH 30.57 CH3 
23.11, 18.72, 
15.16 
 
29
Si-NMR  -82 -82 -82 -81.85 
† 
630 g RHA 75 wt % silica by TGA or 7.87 mol SiO2, 7 l EGH2, 10 mol % NaOH, 24 h 
distillation.
 ††
MALDI, EI, FABS, 
29
Si NMR show GS is analogous to TEOS and Si(OBu-
OH)4 peak, spirosiloxane shifted. 
1
H, 
13
C NMRs suggest chirality in spirosiloxanes, likely 
a racemic mixture. 
 
The silica sources explored included RHA, DE, celite (low surface area DE), 
vermiculite (iron magnesium aluminosilicate with 10-12 wt % silica), ash rice hulls (A-
RH), and fumed silica. All silica materials were first boiled in dilute HCl (24 h, 5 wt %), 
washed with water, acetone and then oven dried (115°C, 24 h) prior to use. The starting 
materials, isolated products and undissolved silica samples were characterized by mass 
spectroscopy, NMR, XRD, BET and TGA.  
Table 7.1 presents the characterization data for the starting materials, the reaction 
products and coincidentally compares the extent of dissolution using standard conditions. 
The characterization spectra are shown in Figures 7.1 – 7.16. With the exception of 
vermiculite, all of the sources are amorphous silica. The XRD pattern of RHA is shown 
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in Figure 7.17. In general, the amount of SiO2 that dissolves for all sources is directly 
related to specific surface areas, SSAs and reaction temperatures. Vermiculite’s low 
silicon content and crystallinity are likely at least partially responsible for its poor 
dissolution rates.  
 
 
Figure 7.1. EI-MS of II.  
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Figure 7.2. 
1
H-NMR of II.  
 
 
 
 
Figure 7.3. 
13
C-NMR of II.  
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Figure 7.4. 
29
Si-NMR of II.  
 
 
 
Figure 7.5. FTIR spectrum of II.  
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Figure 7.6. TGA of II.  
 
 
 
Figure 7.7. 
1
H-NMR of spirosiloxane synthesized from 1,4-butanediol. 
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Figure 7.8. 
13
C-NMR of spirosiloxane synthesized from 1,4-butanediol.  
 
 
 
Figure 7.9. 
29
Si-NMR of spirosiloxane synthesized from 1,4-butanediol. 
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Figure 7.10. EI-MS of spirosiloxane III.  
 
 
 
Figure 7.11. 
1
H-NMR of III.   
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Figure 7.12. 
13
C-NMR of III. 
 
 
 
Figure 7.13. 
29
Si-NMR of III.  
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Figure 7.14. FTIR spectra of exchange reaction with MeOH and 1,4-butanediol 
spirosiloxane is shown in blue. Si(OMe)4 is shown in red. 
 
 
 
 
Figure 7.15. 
1
H-NMR exchange reaction with MeOH and of spirosiloxane synthesized 
from 1,4-butanediol. 
 
 
219 
 
 
Figure 7.16. 
29
Si-NMR exchange reaction with MeOH and of spirosiloxane synthesized 
from 1,4-butanediol. 
 
 
 
 
 
Figure 7.17. XRD pattern of RHA.   
 
SiO2 depolymerization in 1,4-butanediol was greater than in EGH2 (b.p. 200 °C) as 
the boiling temperature is 40 °C higher. The depolymerization rates for 2-methyl-2,4-
pentanediol (b.p. 200 °C) are nearly the same as EGH2 with the exception of celite and 
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diatomaceous earth in which the mass spectral analyses suggest that the diol “cracks” 
producing propanol as the major product rather than then II. Both DE and Celite likely 
have highly acidic sites that account for the observed cracking products. The ashed rice 
hulls gave the second highest dissolution under standard conditions, which is likely due 
to the SSA of approximately 230 m
2
/g. One experiment was conducted on a scale of 630 
g of RHA (85 m
2
/g, 7.87 mol SiO2), 10 mol % NaOH, 7 L of EGH2. TGA determined the 
RHA contained 75 wt % silica content gave an approximately 40 % silica dissolution 
after 20 h of distillation as determined by TGA of the recovered RHA. 
Vermiculite is a common aluminosilicate mineral with no free SiO2 available for 
dissolution, however, some dissolution was noted. We have not characterized the 
product(s), although some alumina dissolution may occur concurrently given Al-EG 
complexes have been reported previously.
31 
The distillation of 2-methyl-2,4-pentanediol and II occur at nearly the same 
temperature making isolation and purification problematic. However, we found that both 
II and 2-methyl-2,4-pentanediol are hexane soluble with the diol also being water 
soluble. Thus, simply washing the hexane solutions of the recovered, distilled mixture or 
the reaction filtrate removes the diol and leaves pure II, which is easily recovered and can 
be redistilled at 200 °C to give higher purities. Removal of the hexane yields II as a 
liquid that slowly crystallizes upon cooling. 
Compound III and the parent diol are also hexane soluble but the diol is not water 
soluble; however, III can be isolated simply by washing with MeOH. Both spirosiloxanes 
can be distilled to higher purity. II and III are the first examples of a distillable form of 
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silica made at low temperatures directly from biogenic silica sources. This is significant 
as it is not energy intensive and does not require expensive equipment.   
We explored the potential to use II as a precursor to Si(OEt)4 (TEOS) and Si(OMe)4 
(TMOS) since TEOS and TMOS represent the optimal products. We found that it is easy 
to affect an exchange that provides TEOS and TMOS in 65 and 40 % yields, respectively 
via a simple acid catalyzed exchange reaction. This success prompted us to explore the 
direct synthesis of TEOS from Si(EG)2 as shown in reaction (14). We report the 
successful synthesis of TEOS per reaction (17) again in unoptimized yields of 55 % using 
essentially the same conditions.  
We explored the utility of using II and III to form pure precipitated silica. Mixing II, 
III, TEOS, or TMOS with water and catalytic amounts of HCl precipitates very fine 
silica particles at ambient conditions. This indicates that high purity precipitated silica 
can be easily produced without reverting to reactions (7.3), (7.8) or (7.9). If II dissolved 
in ethanol is acidified to pH 1 with HCl, precipitated silica is not observed as shown in 
Figure 7.18.  However, the solution gels upon neutralization with Na2CO3. It appears that 
the diol stabilizes the colloid with the addition of ethanol resulting in precipitated silica. 
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.    
Figure 7.18. (A) Colloidal silica at pH 1 is transparent without scattering light. (B) A gel 
forms scattering light on neutralizing with Na2CO3 (pH 7, 30 min).  
 
This approach provides a low-cost means of “petrifying wood”, which is infusing 
wood with a silicon material to produce a more flame retardant material. Moreover, the 
water-soluble diol can be recycled meaning this process is renewable. This approach 
requires only catalytic acid and does not produce CO2 or Na2SO4 by-products making it a 
green and low cost route to produce high purity precipitated silica.     
 
7.6 Conclusion 
The work reported demonstrates the first examples of based catalyzed 
depolymerization of silica to form distillable and easily purified spirosiloxanes. We also 
present the utility of this low cost and renewable approach as a potential route to the 
production of silicon compounds and their potential to serve as precursors for the 
formation of highly pure silicon-based materials, which does not require the production 
of metallurgical grade silicon, and corrosive and toxic SiCl4. Additionally, these low cost 
spirosiloxanes can be used to produce flame retardant “petrified wood”. This process 
represents the first clear solution to the “Grand Challenge” of depolymerizing silica to 
A B 
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make high purity silicon containing materials using sustainable, green starting materials 
that does not produce byproducts CO2 or Na2SO4 without the need for capital equipment 
or energy intensive processing.   
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Chapter 8 
Overview: Summary, Importance, and Future Work of Dissertation  
 
 
8.1 Explanation 
As research scientists, it is important to connect the research with its impact and 
importance in regards to the field. In this chapter, the importance of the work as well as 
future work relative to this dissertation will be discussed. This chapter is significant as it 
summarizes the work to the general audience. Since my dissertation is diverse, each 
project will be discussed separately. The main focus of this chapter is to relate the 
research to the “big picture” of the problem. Although the work only addresses a small 
portion of the big picture, the research has contributed to each field in some aspects. 
Perhaps, the research can be applied to future work, which may lead to significant 
contributions in regards to the big picture. The work here paves the way for future 
research.  
In addition to providing contributions to the big picture, there remains future work 
relative to each project. The future work is important as it extends our research. Research 
is a continuous process that never ends as researchers are trying to solve and understand 
complex issues. Research generally begins with solving the more simple challenges then 
moving onto the complex problems. Although the work here has aided in the 
understanding of these complex challenges, more research can be conducted to further 
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understand these issues and how they relate to the big picture. The objective of this 
chapter is to present future work at the end of each sub-chapter. The work will be carried 
out by future students and/or researchers. This chapter is important because it provides 
the foundation and background for others to continue future research.  
 
8.2. The Drug Development Process  
In order to commercialize a drug, there are various stages that must be endured. In 
this section, the drug development process will be briefly discussed to educate the reader. 
The successful drug development process begins with identifying a potential class of new 
drugs in a research setting. Once the news class of drugs has been synthesized and 
characterized, testing of these compounds is conducted in animals then humans. 
Ultimately, the drug will be approved by the FDA before being released to the public. 
The drug discovery phase is one of the most critical stages.  
The first stage of drug development process is the discovery phase of the drug. This 
phase can last between two years to more than a decade.
1
 The reason for this large time 
range is because there several factors that must be considered for a drug candidate to 
become eligible for testing in humans, which includes the chemical properties of the 
drug, complexity of the disease, and the amount of resources a company is willing to 
invest.
2,3
 Once a drug has been selected as a potential candidate, the drug will be screened 
through the final stages called the preclinical development stage, which involves testing 
in live animals.
4
 Pharmaceutical companies are required to test the drug in at least two 
different animal species as well as investigating the toxicology of drug. The preclinical 
development stage is governed by FDA approved good laboratory practices (GLP).
5
 After 
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promising preclinical results, the drug will be moved to Investigational New Drug (IND) 
status where further studies will be conducted.
6
  
The next stage of the drug development process is clinical trials. During this stage, 
there are three main phases. Each phase is regulated by strict FDA guidelines that are 
governed by Good Clinical Practices (GCP). Phase I tests the safety of the drug in a small 
number of healthy individuals.
6
 The volunteers will receive increasing doses of the drug 
until side effects arise. This allows researchers to establish the maximum tolerate dose of 
the drug. This is critical because it becomes the benchmark for the remaining trials. 
During this phase, the number of applicants is relatively low ranging from 5 – 100 
participants.
7
 After Phase I, Phase II begins with testing and measuring the efficacy of the 
drug. Researchers monitor the progression of the disease as the participants are 
administered with the drug. For example, tumor growth and blood pressure are monitored 
in the case of developing drugs aimed at cancer and diabetes, respectively. It important to 
note that a control group is require during Phase II where the applicants receive a 
placebo.
5
 Expected and unexpected effects of drug treatment are monitored throughout 
Phase II. Phase II trials generally contain 50 – 1000 participants.8 The final phase of the 
drug development process is Phase III where efficacy and safety are evaluated in a much 
larger group of applicants. Generally, a test group of 300 – 5000 participants are 
monitored.
9
 This large group allows for a better statistical analysis. In addition, double-
blind studies are conducted to allow random assignment of the drug. This is important as 
it allows the study to be completely unbiased by both researcher and patient.
10
 If the drug 
appears to be effective, patients will be allowed to continue treatment after the conclusion 
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of the trial before if the drug is approved for market.
11
 If the FDA approves the drug, it 
will be available to the public.  
As noted, it clear that the drug development process is complex and time-consuming. 
It should be emphasized that the most important phase is the drug discovery phase. 
Without this phase, the preclinical and clinical stages cannot be carried out. During the 
discovery phase, new drugs will be synthesized and characterized. In order to develop 
drugs that target specific processes or biological molecules, such as DNA or kinase 
activity, it is important to understand these processes with great depth. In addition, it is 
also critical that researcher have techniques and methodologies to examine such 
processes. This is where my research presented in the dissertation relates to the big 
picture as it contributes directly to the drug discovery phase. My research has focused on 
examining the DNA-binding interactions of small organic molecules. In addition, kinase 
activity was investigated, which plays a critical role in nearly all biological processes. In 
fact, both kinase and DNA-related processes have been targeted in the development of 
therapeutics. The impact and future work will be discussed in further detail in each 
chapter.  
 
8.3 Investigating the DNA-Binding Interactions of Small Organic Molecules 
(Chapters 3 and 4) 
8.3.1 TPA as a New Sensitive Methodology to Diagnose the DNA-Binding 
Interactions of Small Organic Molecules  
The DNA-binding interactions of small organic molecules play a critical role in 
medicine as several therapeutics are aimed at DNA. Therefore, it is important to 
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understand such interactions since they can significantly influence the performance of 
DNA-targeted drugs. However, there remain limitations to investigate DNA-drug 
interactions at physiologically or biologically relevant conditions as several common 
techniques do not exhibit high sensitivity. It is important to study DNA-drug interactions 
at these conditions because their performance can be altered at non-biologically relevant 
conditions. In addition, common methods, such as circular dichroism, are very 
ambiguous when examining the DNA-binding mechanism of drugs. In other words, it is 
very difficult to understand how drugs interact with DNA based solely on these 
techniques. As a consequence, a combination of selected methodologies is required to 
gain a better understanding of such interactions. Many reliable techniques, such as X-ray 
diffraction, yield critical information, but they are often time consuming, expensive, and 
difficult to employ. Hence, new methodologies that provide valuable information while 
avoiding these undesirable conditions are of considerable interest. 
Herein, we developed a new sensitive methodology to investigate the DNA-binding 
mechanism of small organics molecules targeted at DNA utilizing two-photon 
spectroscopy. Our methodology has contributed to the field of medicinal chemistry 
because it provides a means for pharmaceutical companies and researchers to probe 
DNA-drug interactions at biologically relevant conditions. This is critical especially in 
the research and development phase of new drugs. Our approach can be applied to 
examine the DNA-binding interactions with other macromolecules, such as proteins and 
peptides. This is significant as therapeutics can target these processes as well. Our 
methodology will be more applicable in the future as the size and cost of femtosecond 
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lasers are reduced significantly. Additionally, the process could be automated, which will 
allow for high-throughput screening.   
We have demonstrated a new methodology to diagnose DNA-binding interactions by 
implementing two-photon spectroscopy. The proposed mechanism relative to the change 
in the TPA cross-section upon binding with DNA was presented. We hypothesized that 
the local DNA electric field from the DNA back-bone influences the transition dipole of 
the binding molecule upon DNA binding. For groove binding, the transition dipole of the 
binding molecule is parallel with the DNA electric field. As a result, the induced dipole is 
enhanced. Hence, we observed an increase in the TPA cross-section upon complexing 
with DNA. On the other hand, the transition dipole of an intercalator is perpendicular 
with the DNA electric field leading to a reduced induced dipole. As a consequence, a 
decrease in the TPA cross-section was noted upon binding with DNA.  
We are interested in further examining the change in the TPA cross-section of the 
small molecule upon binding with DNA by either confirming or refuting our hypothesis. 
This can be achieved by carrying out molecular modeling and/or computational studies. 
A local DNA electric field can be generated in the computational software. The influence 
of the DNA electric field can be monitored by positioning the binding molecule at 
different angles relative to the DNA helical axis. The TPA cross-section would then be 
calculated as a function of the binding angle with respect to the DNA electric field. In 
addition, we can conduct experiments with other binding molecules with known binding 
angles relative to the helical axis. We expect a binding molecule to exhibit a larger TPA 
cross-section enhancement if the transition dipole moment of the molecule is aligned 
more parallel with the DNA electric field. Contrarily, we expect a larger TPA cross-
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section decrease if the transition dipole moment of the molecule is more perpendicular 
with the DNA electric field. This will allow us to compare the experimental data with the 
computational studies to either confirm or disprove our proposed hypothesis. 
The dipole of DNA is not necessarily known. This is something that we found 
interesting because we thought this property would be known. Another hypothesis is that 
the dipole of DNA can influence the transition dipole of the binding molecule upon DNA 
binding rather than the DNA electric field. Calculations can be carried out with various 
lengths of DNA to confirm or refute this hypothesis. One issue with this task is that the 
dipole of DNA is challenging to calculate because the value is uncertain. The TPA cross-
section of the binding molecule can be measured experimentally with different lengths of 
DNA, which can be correlated with the calculations. Custom DNA with well-defined 
sequences can be purchased to avoid variations in the experimental data. This will allow 
us to compare the computational results with the experimental findings.  
 
8.3.2 A New Design Strategy to Tailor the DNA-Binding Mechanism of Small 
Organic Molecules and Drugs 
Design criteria for DNA-targeted therapies are important for drug discovery. The 
DNA-binding mechanism of small organic molecules is key to their performance. 
Because of this, it is important to control and modify the DNA-binding mechanism of 
small organic molecules, such as therapeutics, aimed at DNA. In order to develop drugs 
with specific properties that exhibit high selectivity and performance, selected moieties 
are of considerable interest. To be an effective drug, it must overcome many barriers, 
such as metabolic pathways.
122
 Once the drug enters the nucleus of the cell, the drug has 
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the capability of interacting with DNA, thus affecting physiological pathways. The 
design and development of DNA-targeted drugs is a complex task as their performance is 
dependent on several factors, such as the DNA-binding mechanism and biological 
conditions. The objective in drug design is to make the drug more selective and cytotoxic 
towards abnormal cells, such as cancer and/or tumor cells as compared to healthy cells. In 
order to accomplish this, design criteria of drugs with specific structural motifs and 
scaffolds are of considerable interest. Some common drugs that have been reported 
include acridines, alkaloids, and anthracyclines derivatives.
1
 The field of designing and 
developing drugs is a continuous, ongoing field that has been explored. Thus, it is 
important to establish structure-property relationships of small organic molecules relative 
to its DNA-binding mechanism as it directly relates to its selectivity and performance.  
Our work has led to the emergence of structure-property relationships of DNA-
binding molecules that adopt a crescent or V-shaped scaffold. The findings reveal that the 
structure of these fluorophores can be designed to either intercalate or groove bind with 
calf thymus dsDNA by structurally modifying the electron accepting properties of the 
central heterocyclic core. This is the first example that has demonstrated an induced 
change in the DNA-binding mode of small organic molecules that adopt a crescent shape, 
which disagrees with the classical model for DNA groove binding molecules as it states 
that groove binding molecules should possess a crescent shape to closely match the 
helical groove of DNA. We present a new design strategy that does no obey this classical 
model. The results suggest that the electron accepting properties of the central 
heterocyclic core is the key factor in the DNA-binding mechanism. Our work represents a 
new strategy for the design and development of small molecules aimed at DNA. We hope 
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our contribution can be applied in drug discovery to target specific diseases and 
disorders. Perhaps our structure-property relationships will allow researchers to design 
new therapeutics that can target specific disorders based on the DNA-binding mechanism 
since this property is key to their performance and selectivity. 
We have demonstrated that the optical properties of a series of novel fluorescent 
nuclear dyes can be finely tuned by varying the conjugation length and electron accepting 
properties of the heterocyclic core. Based on our work, new fluorophores and/or drugs 
can be developed and examined using modified heterocyclic cores and pendant arms. The 
motif of the fluorophore can also be altered to determine if the optical properties can be 
improved. For example, the motif can be varied to an acceptor-donor-acceptor motif. 
Other donor moieties may include carbazole-based structures. Carbazole-based 
fluorophores have been reported to exhibit excellent TPA properties, which have 
applications for two-photon excited fluorescence microscopy.
13–15
 Units that may be 
incorporated as the acceptor moiety include N-methylpyrimidine or benzoimidazole. The 
organic groups have also been shown to act both as an acceptor and recognition units to 
electrostatically with DNA, which have also been reported to exhibit promising TPA 
properties.
16
 Furthermore, new moieties may induce a change in the DNA-binding mode 
that can lead to enhanced and selective performance for small molecules aimed at DNA.  
 
8.3.3 RNA as a Target for Therapeutics Aimed at Diseases and Disorders  
Biological understanding of RNA has evolved as the intermediate between DNA and 
protein that regulates the genes and functions of cells in all living organisms.
17,18
 RNA 
catalyzes protein synthesis,
19
 controls gene expression,
20
 and regulates transcription and 
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translation.
21,22
 RNA is a versatile molecule that has the capability of folding into a wide 
range of structures and conformations, which can be targeted by small organic molecules. 
RNA plays a critical role in the progressive of several diseases, such as HIV, hepatitis C, 
and cancer.
23 
RNA has been recently targeted for therapeutics aimed at diseases and 
disorders. Interestingly, the US Food and Drug Administration (FDA) approved the first 
RNA-based drug for the treatment of cancer in 1998 called Fomivirsen as an antiviral 
drug by blocking the translation of mRNA.
24
 Since the release of Fomivirsen, only one 
other RNA-based drug has been released to market over a 10 year period.
24
 RNA has 
become a considerable target because of its potential to interfere with processes that 
allow gene and protein expression of diseases and disorders. RNA-based therapeutics can 
be classified into categories based on the mechanism of activity including mRNA 
translation, catalytically active RNA molecules (ribozymes), RNA interference (RNAi), 
and RNA that binds with proteins and other molecules.
25
  
One therapeutic approach that is highly promising is RNA interference (RNAi).
26
 
RNAi is a gene silencing technique that was discovered in the 1990’s in petunia plants.27 
Messenger RNA (mRNA) is naturally single stranded and is required for protein 
synthesis and gene expression. Enzymes called Dicer and RISC recognize double 
stranded RNA (dsRNA) and terminate it because dsRNA generally signifies viral 
infection.
28
 This can thought as an evolution consequence of cellular defense against 
viruses. Researchers have developed therapeutics that can take advantage of employing 
gene silencing towards disorders and diseases, which is referred to as target genes. This 
can be achieved by designing short strands of RNA that hybridize to the complementary 
strands of mRNA encoded by the target gene. Dicer and RISC enzymes then recognize 
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the dsRNA and degrade it.
29
 As a result, mRNA is destroyed, which does not allow for 
protein synthesis or expression of the disease.  
The structures of RNA and DNA differ significantly in vivo. Typically, DNA is a 
helical structure because of its double stranded structure. Contrarily, RNA folds into 
diverse conformations that adopt folds more similar to proteins and peptides. These 
differences can be directly attributed to RNA being single stranded, which allows the 
molecule fold onto itself to minimize its energy.
30
 RNA exhibits unique binding pockets 
that can result in structural diversity. Because of this, these binding pockets can be 
exploited and targeted by small organic molecules. For example, small organic molecules 
that bind with RNA have been studied including antibiotics. These molecules have 
modest affinities and selectivity for RNA.
31
 Therapeutics that exhibit high selectivity and 
affinity for RNA are of considerable interest.  
Because of the diverse functions of RNA, small organic molecules that selectively 
bind with RNA may provide points of interest that can be utilized as therapeutic 
intervention. Despite advances in drug discovery, there are only a few compounds that 
target RNA with high specificity and affinity,
30
 which is in contrast to the large number 
of small organic drug molecules aimed at DNA.
32,33
 The groove of DNA has been a well-
exploited target for drugs. One the other hand, only a small number of drugs have been 
targeted at the groove of RNA.
30
 RNA-targeted drugs are a new emerging class of drugs 
that can be utilized as anti-cancer agents. In order to design such drugs, it is important to 
understand the RNA-binding interactions of small organic molecules.  
One project that is currently ongoing by another graduate student is examining the 
binding interactions of small organic molecules with RNA utilizing TPA. The goal of this 
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project is to demonstrate that our methodology can be employed to differentiate between 
the RNA-binding modes. This is attractive since RNA has been recently explored as a 
new target for drug therapy. Thus, it is important to understand the interactions of 
therapeutics targeted at RNA. If our methodology can be employed towards RNA, this 
will be significant as it would allow researchers to probe RNA-drug interactions. If we 
can gain a deeper understanding on how small organic molecules interact with RNA, this 
could lead to an emergence of a new class of drugs targeted at RNA. Additionally, this 
will provide a new approach to probe RNA-drug interactions at biologically relevant 
conditions because TPA has been demonstrated to exhibit high senstivity.
34,35
 
 
8.4 Examining Kinase Activity by Implementing a Chemosensor Peptide with 
Continuous Real-Time Analysis in Live Cells (Chapter 5)  
Signaling in biological systems that are regulated by protein phosphorylation is 
critical for many cellular and biological processes. Such processes are complex and 
strategically orchestrated by diverse cellular species. More importantly, signaling 
cascades are important for cellular function, such as mediating cell proliferation and 
apoptosis.
36
 Kinase enzymes are required for this phosphorylation processes. The 
objective of this work is to gain a better understanding of kinase activity in live cells with 
continuous real-time analysis, which has never been achieved thus far. Additionally, this 
will allow researchers to screen kinase inhibitors and drugs at biologically relevant 
conditions. It is important to note that the kinase catalytic activity is a very complex 
process that is required for cellular communication. Many disorders, such as cancer and 
diabetes, have been directly related to abnormal kinase activity.
37
 Therefore, 
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understanding kinase activity may lead to therapeutics aimed at abnormal kinase activity. 
Progress in molecular biochemistry has led to an emergence of mechanism-based 
processes and pathways, such as epidermal growth factor receptor and kinase inhitbors.
38
 
In fact, kinase inhibitors have been recently explored as chemotherapy medications.
39
 
These therapeutics works by blocking or inhibiting specific kinase activity. For example, 
ZD-1839 (Iressa) is a quinazoline derivative that selectively inhibits tyrosine kinase and 
is under clinical development in cancer patients.
40
 
The impact of our work is imbedded in the information gained, which could be 
applied towards therapeutics aimed at abnormal kinase activity. Additionally, this work 
has the potential to be implemented for high-throughput screening of kinase activity in 
live cells with continuous real-time analysis. Thus, this could have a profound impact on 
the drug research and development field as it will allow researchers to screen drugs at 
biologically relevant conditions. Likewise to the examination of the DNA-binding 
interactions of small organic molecules, the information gained about kinase-peptide 
interactions can contribute to the field of drug research and development. This work here 
will pave new a route to study clinical drugs with respect to kinase activity by continuous 
real-time analysis in live cells.  
We have demonstrated the successful delivery of the Sox-peptide into live HeLa cells 
by FLIM. The next stage of the project is to monitor the phosphorylation process with 
continuous real-time analysis in live cells. This task will be accomplished by delivering 
the JNKS19 (unphosphorylated) peptide into the cell. The change in fluorescence and 
fluorescence lifetime will be monitored by confocal microscopy (multi-photon and 
fluorescence lifetime microscopy). As demonstrated, an excellent route to monitor the 
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phosphorylation process is by FLIM due to the autofluorescence. In particular, the 
autofluorescence has been a major issue in regards to the project. If a lower energy 
excitation wavelength could be used, this would solve many issues. One approach to 
resolve the autofluorescence issue is to integrate a fluorophore adjacent to the Sox-
fluorophore via solid phase peptide synthesis (SPPS) where the fluorescence can be 
monitored at a lower energy emission wavelength through FRET as detailed in Scheme 
8.1. Another issue with this project is that we need to confirm that the peptide is not 
interfering with other biologically processes, which may cause an increase in the 
fluorescence lifetime. Hence, it is important to deliver the Sox-peptide omitted of the 
Sox-fluorophore as a control experiment. In addition, it is critical to stain both the cell 
wall and nucleus utilizing commercial stains as it will allow us to examine the 
localization of the Sox-peptide. Prof. Kuroda has provided excellent comments with 
regards to the future work of this project. I would like to thank him personally for these 
recommendations as it will significantly increase the quality and interpretation of our 
work.  
 
Scheme 8.1. Synthesis of Alexa 488 amino acid derivative. This fluorophore can be 
integrated into the Sox-peptide substrate via SPPS, which can undergo FRET with the 
Sox-fluorophore. This will allow the fluorescence to be monitored at a lower energy 
wavelength to minimize autofluorescence from the cells.  
 
241 
 
Kinase inhibitors will be delivered into the cells to compare the kinase activity in the 
absence and presence of an inhibitor. These inhibitors will be delivered into the cell by 
incubating the cells with the inhibitors since they are cell permeable. One inhibitor that 
will be utilized is SP600125, which is a reversible inhibitor.
41
 SP600125 competes with 
the binding site of ATP during the phosphorylation process, thus inhibiting kinase 
activity. Another inhibitor that will be utilized is JNK-IN-8, which is an irreversible 
inhibitor discovered by Prof. Nathanael Gray at Harvard.
42
 The structures of the 
inhibitors are shown in Figure 8.1. JNK-IN-8 is a potent irreversible inhibitor that 
undergoes a nucleophilic attack on the cysteine residue proximal to the ATP-binding site 
leading to a blockage in the binding site. It has been shown that JNK-IN-8 demonstrates 
superior performance as compared to SP600125 by more than an order magnitude.
42
 This 
will allow us to compare the kinase activity by implementing the JNKS19 peptide with 
both a reversible and irreversible inhibitor. The goal is to correlate the fluorescence 
change (or fluorescence lifetime change) to the kinase activity as well as understanding 
peptide-kinase interactions at physiological conditions. We hope our work will provide a 
new route to examine kinase activity in live cells with continuous real-time analysis and 
high-throughput screening. Perhaps, the information gained will be employed in drug 
research and discovery. If this can be achieved, this will be a major contribution to the 
field. This work is currently being carried out by a new graduate student.  
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Figure 8.1. Chemical structures of kinase inhibitors.  
 
8.5 Synthesis and Characterization of Silsesquioxane-Based Microporous Materials 
(Chapter 6) 
We developed a new route for the synthesis of silsesquioxane-based microporous 
materials by an oxysilyation reaction of cubic symmetry Q-type cages (OHS) with a 
series of ethoxysilane linkers. These materials offer several advantages over traditional 
porous materials, such as zeolites, metal organic frameworks (MOFs), and covalent 
organic frameworks (COFs) as these materials can be synthesized with fast reaction 
times, non-alkaline environments, and low temperatures. These materials are attractive 
because they have the potential to be tailored so that multiple functionalities can be 
introduced to the system. Moreover, these porous materials can be further functionalized 
and tailored for other applications including catalyst substrates, bio-adsorbents, drug 
storage and delivery, gas sieving, gas storage, and vacuum insulation materials.
43–47
 One 
example that will be discussed in greater detail is that these materials can be applied as 
chiral separation materials.  
243 
 
The separation of chiral molecules has been of considerable interest because a 
majority of bioorganic and drug molecules are chiral. Many compounds found in living 
organisms are chiral, such as nucleic acids, peptides, and proteins. Chiral separation is 
also critical for drug development.
48
 Enantiomers of many drugs can have different 
pharmacological activities, mostly exhibiting negative effects. Receptors in humans react 
very specific to chiral molecules resulting in different responses to the drug. One isomer 
of a drug may be therapeutic while the other isomers may have negative consequences or 
may even be deadly. For example, Thalidomide was prescribed as a sedative or hypnotic 
in 1957.
49
 Shortly after the drug was released, thousands of infants were born with 
phocomelia or malformation of the limbs. This was due to the different isomers of the 
drug having negative effects. This incident could have been avoided if the undesirable 
isomers were separated from the therapeutic isomer. Today, pharmaceutical companies 
pay close attention and detail to various isomers when developing new drugs. Thus, 
chiral separation materials are of great importance. 
Several methods have been employed for chiral separation, such as HPLC, capillary 
electrophoresis, and electrochemistry.
50,51
 However, these methods are high cost and 
impractical for real-time analysis. In addition, they cannot be used for high-throughput 
assays. Therefore, new materials for chiral separation are of considerable interest. N-
acetyl-L-cysteine is an excellent candidate to incorporate into such materials because of 
its ability to separate chiral compounds.
52
 One application of interest is the design and 
development of chiral separation materials based on our porous materials. This can be 
accomplished by functionalizing the Si(OEt)3-vinyl with cysteine as shown in Scheme 
8.2. Si(OEt)3-cysteine can then be used a linker to form network polymers containing 
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cysteine functional groups. Because of its high surface area, these porous materials would 
be excellent candidates for chiral separation materials.  
 
Scheme 8.2. Synthesis of Si(OEt)3-cysteine.  
 
 
Another potential avenue of these porous materials is for gas storage applications. 
Gas storage in porous materials has attracted a considerable amount of attention. The 
most well-known current area of research includes storing hydrogen for energy 
applications. However, other gases, such as CO2, SO2, and NO, are of interest as well.
53
 
There are specific criteria that must be required for any gas storage material. The 
advantage of our materials is that multiple functionalities can be introduced to the system, 
which allows the materials to be tailored to meet these specific criteria. Additionally, the 
properties of these materials can be modified, allowing for diverse applications. There are 
several advantages in storing gases in porous materials rather than enclosed volumes, 
such as a tank or a bottle.
54
 Storing gas in tanks require liquefaction at very low 
temperatures and/or high pressures.
55
 In general, there are safety advantages of storing 
gases in porous materials especially if high pressures can be avoided.
53
 Furthermore, 
gases are easier to handle in small amounts when stored in porous materials. Because our 
materials are composed of silsesquioxane, the materials exhibit high thermal stability 
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unlike organic-based materials, indicating that they can be used for high temperature 
applications.
56
 This is one prime example in which porous materials can be utilized for 
real-world applications. In particular, porous materials have contributed to the 
development in applications ranging from medical diagnosis to microelectronics.
57
 
Examples and future work were provided where the porous network materials can be 
used for industrial applications. These materials have the potential for the tailoring of the 
microstructure, chemical composition, surface properties, and porosity. The impact of 
this work is that these materials are low-cost and can be easily synthesized while 
introducing multiple functionalities. Because of its potential and diverse applications, this 
research has contributed to the big picture as it paves the road for the design and 
development of future materials.  
 
8.6 Avoiding Carbothermal Reduction: Distillation of Alkoxysilanes from Biogenic, 
Green, and Sustainable Sources (Chapter 7) 
Rice is considered one of the major food crops in the world. The protective coatings 
of rice grains are referred to as rice hulls, which are considered a byproduct of rice 
consumption. In order to cultivate rice grains for human consumption, the rice hulls must 
be removed since they are ingestible. Rice hulls have applications ranging from fertilizer 
to fuel.
58
 Million of tons of rice hulls are burned each year for the generation of 
electricity resulting in a byproduct called rice hull ash (RHA). RHA is mainly composed 
of amorphous silica (90%) and does not contain heavy metals making it an attractive 
source of silica.
59,60
 RHA is high in silicon content because rice plants uptake silicon 
(water soluble silicates) from the roots directly from the dirt then transports it to the outer 
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surface of the plant to form a cellulose silica membrane.
61
 Upon combustion, silica and 
carbon are left behind. The production of RHA is a sustainable process and does not 
leave a large carbon footprint. A major disadvantage of generating RHA is the disposal 
processes. Because of its high silicon content, there has been considerable interest in 
using RHA as a precursor for many silicon containing materials.
62–64
 RHA has been 
mainly utilized for applications that are considered low-value applications. In order to use 
RHA for high-value applications, the silica source must be extracted to achieve relatively 
high purity (> 99%). Silica has been widely used in chromatograph columns, 
pharmaceutical applications, adhesives, detergents, and ceramics.
65,66
  
A common precursor used for many silicon containing materials include 
alkoxysilanes, which are produced in the following:
67
  
 
SiO2 + 2C 
1900°C 
> 2CO + Simet (met = metallurgical grade, ≈ 98 % purity)           (8.1) 
Simet  + HCl  
Cu/Sn catalyst/300°C 
> HSiCl3 + SiCl4                       (8.2) 
Simet  + EtOH (MeOH) 
catalyst 
> Si(OEt)4 [Si(OMe)4] + H2                        (8.3) 
 
One major disadvantage of this process is that it requires the carbothermal reduction of 
SiO2 to form Simet. This process is energy intensive and requires elaborate equipment. 
Additionally, it produces toxic and corrosive chlorosilanes. Because of this, specialized 
equipment is required to contain the chlorosilane byproducts. If alkoxysilanes can be 
produced directly from SiO2 while avoiding the carbothermal reduction step, this will be 
critical because it could significantly reduce the cost of many silicon containing contents.  
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We have demonstrated the first distillable alkyoxysilane synthesized directly from 
silica, which has been investigated for over 80 years without success.
68–71
 Our process is 
an alternative to the carbothermal reduction of silica, which offers several advantages as 
it is not a high energy/temperature process, does not produce toxic byproducts, and does 
not leave a large carbon footprint. This is significant because this process has the 
potential to reduce the cost of many silicon containing products. Since these 
alkoxysilanes can be distilled, they can be easily purified implying that this process can 
be employed for applications that require high purity silicon. This is very important in 
industries that require solar (6N) or electronic grade silicon (9N). As demonstrated, this 
work can have a profound impact in the real world by reducing the cost of silicon 
precursors as many consumer products contain silicon ranging from toothpaste to 
electronic applications (e.g. cell phones, computers).  
The process and conditions have not been fully optimized to give higher yields. This 
would be considered a major parameter in order to move the technology to a larger scale 
(e.g. pilot lab). The process can be optimized by carrying out design of experiments 
(DOE). The yield would be monitored with respect to the reaction time, amount of 
catalytic base, volume of diol, and temperature. The data would be analyzed in statistical 
software to determine the best parameters to give optimal yields. We have shown that the 
dissolution rate is directly related to the surface area of the silica source. Therefore, the 
biogenic silica source (e.g. RHA) can be processed or modified to yield higher surface 
area silica sources. Such methods include ball milling the silica source before starting the 
dissolution process. Once the process has been fully optimized, it has the potential to be 
scaled up on a commercial level.   
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Other future work includes functionalizing the spirosiloxane with various 
substituents, such as Grignard reagents, then converting the material to silsesquioxanes 
through fluoride catalyzed reactions, which will give T8, T10, and T12 cage structures. This 
has the potential to lower the cost of commercially available silsesquioxanes. 
Furthermore, the spirosiloxane can be used as a precursor to produce high purity fumed 
silica via liquid-feed flame spray pyrolysis (LF-FSP) and precipitated silica. One 
interesting avenue is that other metal alkyl- or alkoxy-based materials may be formed 
from biogenic metal sources, thus providing a low cost and more direct route to 
producing such materials. A summary of potential applications of the spirosiloxane is 
presented in Figure 8.2.  
 
 
Figure 8.2. Potential applications of spirosiloxane synthesized from RHA. 
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